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Abstract 
This thesis by published papers represents a program of research with the overarching 
objective of the development and evaluation of a novel, web-based Type 2 diabetes self-
management and dysphoria intervention.  An initial review of the impact of telemedicine in 
supporting self-management in diabetes found that its impact was limited.  A web-based 
mode of delivery was selected, as it provided greater access, further options for support 
strategies, and a greater opportunity for a novel contribution to the field.  
Social Cognitive Theory was selected as the principal theoretical foundation 
underpinning the intervention, given the substantial empirical support it has obtained.  The 
principle of patient empowerment was seen as fundamental to supporting effective chronic 
disease self-management, and was therefore applied as a major guiding principle.   
The project had three consecutive stages, each of which gave a foundation for the next 
stage.  The aim of the first stage was to obtain an understanding of the experiences of 
individuals living with Type 2 diabetes, their perceived needs for extra support, and 
suggestions for web-based support program content.  The second stage aimed to use this 
information during development of the intervention, in order to build the web-based program 
upon the ethos of patient empowerment and personalised support.  Finally, a pilot trial was 
conducted, which was aimed to gain a preliminary indication of the program’s (i) 
effectiveness in improving clinical, psychological, and behavioural outcomes, (ii) user 
satisfaction, acceptability, usability, perceived ease of use and utility, and (iii) feasibility of 
implementation. 
 The project was comprised of studies that utilised both qualitative and quantitative 
methods.  Stage 1 involved qualitative, semi-structured interviews of 13 adults with Type 2 
diabetes and 12 general practitioners (GPs) to gain their perspectives on experiences related 
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to living with Type 2 diabetes and the types of additional support that patients required.  
Thematic data analysis was used to identify categories and sub-categories, following which a 
comparison was made between the perspectives of the two samples.   
 Paper 2 reports an exploration of patients’ and physicians’ perspectives on self-
perceived barriers and facilitators to effective Type 2 diabetes self-management; emotional 
challenges associated with living with diabetes, and needs for extra support.  Suggestions for 
areas that should be addressed in a web-based support program were explored.  Aspects that 
enhanced and challenged effective self-management were derived, and significant overlap in 
the categories derived from the GP and patient samples was evident.  The frustrations, 
uncertainties, depression and anxiety experienced by Type 2 diabetes patients strongly 
suggested the need for improved emotional and psychological support.  In addition, the two 
samples provided useful suggestions for elements in a web-based support program.   
 Stage 2 of the project involved program development, at which point the intervention 
was named OnTrack Diabetes.  A series of processes that included designing program 
features, which comprised written content for information resources and interactive tools as 
well as information technology development, were involved.  Two papers were produced at 
this stage (Papers 3 and 4), which outlined these processes. 
 Paper 3 described the design of the studies in the PhD project, as well as plans for the 
main randomised controlled trial to evaluate the program.  Paper 4 described the specific 
steps involved in creating the program, from producing the written content to information 
technology development and implementation.   
 Stage 3 was a randomised controlled pilot trial to evaluate the OnTrack Diabetes 
program.  A sample of 38 adults with Type 2 diabetes living in Australia was enrolled.  This 
trial evaluated the feasibility of study procedures, and provided a preliminary indication of 
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the program’s effects on clinical, behavioural, and psychological outcomes.  Qualitative user 
evaluations provided indications of program uptake, acceptability, usability, and utility.  One 
paper (Paper 5) was produced from this stage.  Paper 5 reported results from the pilot 
randomised controlled trial.  The paper made comment on trends produced in the data in 
terms of clinical, emotional, and behavioural outcomes, and users’ perceptions of the 
program.   
 Overall, the project has made an important contribution to the scientific literature in 
its contributions to providing a foundation for research into the potential efficacy and 
feasibility of implementing automated, web-based support for Type 2 diabetes self-
management and dysphoria.  This trial represented the first known intervention of its kind in 
Australia.  Outcomes provided details on the structures and processes required to produce a 
web-based support program of this nature, and further indicated that there is scope to extend 
upon web-based intervention for Type 2 diabetes self-management and associated dysphoria.  
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CHAPTER 1 
INTRODUCTION AND BACKGROUND 
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1.1 Structure and Overview of the PhD Program of Research 
1.1.1 Overview of the PhD Research Program 
 This thesis by publication used qualitative and quantitative methods to develop and evaluate a novel, 
automated, web-based Type 2 diabetes self-management and dysphoria support program in a sample of 
Australian adults aged 18 – 75 years.  This Chapter provides an overview of PhD program of research, an 
introduction to the topic and background literature on the issues that are addressed.  Specifically, these 
issues include Type 2 diabetes and comorbid mood disorders, Type 2 diabetes self-management, patients’ 
perspectives on self-management, and relevant web- and non-web-based interventions.  Attempts made by 
the health system to meet the needs of Type 2 diabetes patients for extra self-management support are 
summarised.  The chapter demonstrates the urgent requirement for Type 2 diabetes self-management 
intervention that can provide outreach and cost-effectiveness.   
 Section 1.2 describes issues presented by comorbid dysphoria and diabetes in detail, and explains the 
inextricable links between these conditions.  The importance of addressing comorbid psychological and 
emotional symptoms in diabetes self-management interventions is discussed.  A review of qualitative 
empirical research on patients’ experiences living with Type 2 diabetes is presented in Section 1.3, with a 
focus on research that explored physicians’ views.  The importance of the doctor-patient relationship to 
effective diabetes self-management is demonstrated.  Qualitative research is primarily used, with some 
references to quantitative studies so that patients’ experiences can be elucidated with minimal bias.  The 
need to assess both patient and physician views to gain a comprehensive account of treatment adherence 
issues is suggested by the marked variations in their perspectives.  Section 1.4 presents a summary of Type 2 
diabetes self-management interventions, including reports on the efficacy of particular intervention 
components and evaluations of non-web-based and web-based interventions.  The novelty in providing 
combined diabetes self-management and dysphoria support using the web is demonstrated.  Section 1.5 
outlines the premise and theoretical underpinnings of Bandura’s (1977) Social Cognitive Theory (SCT; 
Bandura, 1977) and relates the theory to the objectives and aims of this project. 
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1.1.2 Structure of the Research Program 
 Figure 1 shows the sequence of stages involved in this project and the papers that were produced in 
accordance with each progressive stage.  The research project comprised three, consecutive stages, each of 
which formed a foundation for progression to the next stage. 
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Figure 1. Overview of the OnTrack Diabetes Project Undertaken in the PhD Research Program. 
Papers 
(i) Paper 1: Examined effects of behavioural telehealth 
interventions on glycaemic control and diabetes self-
care. 
 
(ii) Paper 2: Reported on categories and sub-categories 
derived from interviews; discussed commonalities 
and differences; indicated suggested online program 
content. 
Paper 
Paper 5: Reported effects of OnTrack Diabetes on primary 
and secondary outcomes and user evaluations of the 
program. 
Stage 3 
Aims: (i) To evaluate program’s efficacy to improve 
clinical, psychological/ emotional, behavioural, and quality 
of life outcomes; and 
(ii) To evaluate users’ uptake, perceived acceptability, 
usability, utility, ease of use, and implementation feasibility 
of the program. 
Methods: Randomised controlled pilot trial implemented 
over 3 months with a sample of 38 Australian adults with 
Type 2 diabetes.  
Papers 
Paper 1: Described project design and sequences of studies 
involved in the project. 
Paper 2: Outlined development of the OnTrack Diabetes 
program, including steps used and details about content. 
Stage 2 
Aims: (i) To establish project protocol 
(ii) To develop web-based Type 2 diabetes self-
management and dysphoria intervention program. 
Methods: (i) Designed protocol linking Stages 1 to 3 + 
main randomised controlled trial. 
(ii) Program content and information technology 
programming development.  
Stage 1 
Aims: (i) To explore telehealth mode of diabetes self-
management intervention delivery. 
(ii) To explore: barriers and facilitators to Type 2 diabetes 
self-care, emotional challenges, perceived acceptability of 
online support, and suggestions for program content. 
Methods: (i) Systematic literature review on telehealth 
(ii) Qualitative, semi-structured interviews with a sample of 
Type 2 diabetes patients (n=13) and GPs (n=12). 
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1.1.3 Overview of PhD Research Program Stages 
 Stage 1 of the research program involved two preliminary steps that were integral to 
establishing the overall research project (Figure 1).  First, an exploration of the effects of 
behavioural telehealth interventions on Type 2 diabetes self-care and glycaemia (Paper 1, 
displayed in Chapter 2) was used to gain information about the current status of interventions 
being delivered by phone; the most common form of intervention delivery to date.  The 
review provided mixed evidence on the efficacy of telehealth interventions and provided 
information about the scope of currently available telehealth interventions.  It was concluded 
that there was nothing additional to contribute to current evidence that was within the 
foreseeable scope of this research project and hence the more novel approach of web-based 
intervention was chosen.   
 The second part of Stage 1 examined patients’ lived experiences with Type 2 diabetes, 
which established a foundation that informed the design of the intervention (Paper 2).  The 
decision to use a patient empowerment approach to diabetes self-management was supported 
by the qualitative study.  This study also explored the views of physicians in understanding 
patients’ experiences in managing Type 2 diabetes so that their perceived gaps in currently 
available supports might be addressed in the intervention.  As discussed in Section 1.4, to 
gain a comprehensive understanding of the difficulties entailed in Type 2 diabetes self-
management it was considered important to have the views of physicians who were highly 
involved in its treatment and who would bring insight into the areas that the intervention 
would ultimately address.  It was also important to determine whether a web-based support 
program could gain the support of primary care physicians, who were expected to heavily 
influence their patients’ engagement in diabetes-related interventions.   
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 The paper indicated that patients commonly experienced emotional challenges related 
to Type 2 diabetes which they tended not to communicate to their physicians.  Many common 
categories across the two samples were derived from the interview responses.  However, 
physicians tended to relate diabetes self-management difficulties to practical issues while 
patients indicated that daily emotional stressors related to diabetes management and fears for 
their health prognosis compromised their practise of adequate self-care.  Both samples 
indicated that they perceived web-based Type 2 diabetes self-management and dysphoria 
support to be potentially acceptable.       
 Stage 2 involved designing the project’s protocol and developing the web-based 
program.  The project protocol is presented in Paper 3, which demonstrated how each stage 
of the project formed the basis for further stages.  Development of the OnTrack Diabetes 
program was presented in Paper 4, which included detailed descriptions of each of the steps 
involved, from the incorporation of Stage 1 results into program content to launching the 
program live-to-air and its implementation.  There was little prior literature to inform the 
project protocols for RCTs of web-based interventions and few studies had reported web-
based program development at the initial stage of the project.  Therefore, Papers 3 and 4 were 
based on the original approaches to project design and development that were used in this 
project.  The contributions of the PhD candidate to the program’s development are described 
in Table 1, below. 
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Table 1. Demonstration of PhD candidate’s contribution to development of the web-based intervention.
Section of Program Tool Contributions 
Eating Well & Feeling Healthy Ideas About Eating Well Candidate created fun healthy eating 
change options. 
Imagery exercise new. 
Good Things About My Idea  
customised to Eating Well… 
Weighing up the Pros & Cons & 
Deciding What To Do from OnTrack 
Alcohol & Depression. 
Fold-up Summary Card by candidate 
and DK. 
 Guidebook page – My Eating Goal Created by Candidate. 
 Feeling Confident – My Eating Goal Wording changed to apply to eating. 
 Enjoyable Eating My Enjoyable Foods list created by 
candidate. 
My Daily Menu of Enjoyable Foods 
adapted from IT logic for Activities I 
Enjoy from OnTrack Alcohol & 
Depression. 
 My Enjoyable Eating Routine Adapted by candidate from IT logic for 
OnTrack Alcohol & Depression Fun 
Activity Planning Tool. 
 Problem Solving To Eat Well Wording changed from OnTrack 
Alcohol & Depression. 
Problem Solving to apply to diabetes & 
eating. 
 Saying No Some wording changes from Alcohol 
& Depression program. 
Saying No tool - to apply to eating 
well. 
Health Routines Ideas About Health Actions IT logic from Activities I Enjoy (in 
OnTrack Alcohol & Depression). 
Candidate created options for My 
Health Action Ideas & Good Things 
About My Idea. 
New Imagery activity by candidate & 
DK. 
Things That Might Get In The Way, 
Weighing Up The Pros & Cons, & 
Deciding What To Do from Alcohol & 
Depression. 
My Health Action Idea fold-up 
summary card – by candidate & DK. 
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Section of Program Tool Contributions 
 Feeling Confident – My Health 
Action Goals 
From OnTrack Alcohol & Depression.  
 
Feeling Confident tool - applied to 
diabetes & health actions. 
 
 Planning My Health Action Goal Wording changed from OnTrack 
Alcohol & Depression Planning tool to 
apply to diabetes and health actions. 
 
 Guidebook page – My Blood 
Glucose Level goal  
Created by candidate. 
More On Health Routines Things In My Health Routine My Health Actions lists created by 
candidate. 
 
Daily, Weekly & Regular health 
actions pages created for OnTrack 
Diabetes. 
 
 Planning My Health Routine IT logic from OnTrack Alcohol & 
Depression Fun Activity Planning tool. 
 
New IT logic created to include daily, 
weekly & regular health actions. 
 
Wording created by candidate for 
diabetes & health routines. 
 
 Problem Solving To Keep In 
Routine 
Wording changed from OnTrack 
Alcohol & Depression Problem 
Solving tool to apply to diabetes & 
health action obstacles. 
 
Thinking Well & Feeling Fine Activities I Enjoy Wording changed from Activities I 
Enjoy tool from OnTrack Alcohol & 
Depression – e.g. options added to 
activity list, wording applied to 
diabetes & mood. 
 
 Fun Activity Planning From Fun Activity Planning in 
OnTrack Alcohol & Depression.  
 
 Making A Relationship Stronger From OnTrack Alcohol & Depression. 
 
 Guidebook page – My Mood Goal  Created by candidate. 
 
More On Thinking Well & 
Feeling Fine 
Emotionally Risky Situations IT logic & tool structure from Risky 
Situations tool in OnTrack Alcohol & 
Depression.  
 
Candidate re-worded tool to apply to 
diabetes and dysphoria & refined & 
added options to lists – e.g. My Most 
Risky Situations. 
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The PhD candidate was involved in collaborating with Principal Supervisor David Kavanagh in 
structuring the OnTrack Diabetes program regarding program content inclusions, interactive tool design and 
Section of Program Tool Contributions 
 Planning For Emotional Challenges Adapted for diabetes and dysphoria 
from Planning For Risky Situations 
Tool in OnTrack Alcohol & 
Depression. 
 
Keeping On Track What’s Getting Better From OnTrack Alcohol & Depression. 
 
 New Horizons From OnTrack Alcohol & Depression. 
 
 Setting Goals That Work From OnTrack Alcohol & Depression. 
 
 Challenges Keeping On Track Adapted from Problem Solving For 
Risky Situations tool in OnTrack 
Alcohol & Depression. 
 
 Planning For A Challenge Adapted from Planning For Risky 
Situations tool in OnTrack Alcohol & 
Depression. 
 
Mindfulness resources  Selected from OnTrack Alcohol & 
Depression. 
 
Videos  From OnTrack Alcohol & Depression. 
 
Information resources  Written by candidate. 
 
My Diary Mood self-monitoring tool 
 
From OnTrack Alcohol & Depression 
 Blood glucose self-monitoring tool Created for OnTrack Diabetes by 
candidate & DK. 
 
 Physical activity & Nutrition goal 
self-monitoring tools 
Created for OnTrack Diabetes by 
candidate & DK. 
 
 Appointment-setting function From OnTrack Alcohol & Depression. 
 
What I’ve Done  From OnTrack Alcohol & Depression. 
 
How I’m Doing  Automated feedback graphs created by 
IT professionals. 
 
Offline Monitoring card  Created by candidate & DK. 
 
Program lay-out  From OnTrack Alcohol & Depression. 
 
Graphic design of program 
interface 
 Created by graphic designer with 
candidate’s input. 
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sequencing, and graphics.  Due to budgeting constraints, the eXtensive Mark-up Language (XML) coding 
for the majority of the program’s tools was based on exclusive XML coding that was developed for the 
OnTrack Alcohol and Depression program.  Relevant videos and mindfulness resources from the OnTrack 
Alcohol and Depression program were also included in OnTrack Diabetes for budgeting purposes.  The 
candidate checked each page that went into the OnTrack Diabetes program and made refinements and/ or 
added content to the majority of pages that were included from the OnTrack Alcohol and Depression 
program.  Further, a number of pages, including the guidebook pages that are presented between the 
program tools, were created specifically for OnTrack Diabetes.   
The candidate coded the web pages for OnTrack Diabetes using XML coding that was taught by the 
Information Technology (IT) professionals.  Following this, a IT professional from Kavanagh’s OnTrack 
team checked and made refinements to the programming as required.  The candidate guided the IT 
professionals on establishing the OnTrack Diabetes administration system and database, which included the 
study’s call calendar, reminders for participant follow-ups, and participant data.  These professionals were 
also responsible for programming the self-monitoring tools, automated feedback graphs, variations in IT 
logic for various tools (e.g. Planning My Health Routine), the logistics of user access to surveys, automated 
emails, program access, and randomisation to study conditions.   
 Finally, Stage 3 comprised the pilot randomised controlled trial (RCT) of the OnTrack Diabetes 
program.  A sample of 38 Australian adults with Type 2 diabetes who were aged 18 – 75 was enrolled in the 
trial.  Aims of the pilot trial were: (i) to evaluate the program’s efficacy in improving Type 2 diabetes self-
management and dysphoria symptoms; (ii) to evaluate the program’s efficacy in improving self-care 
behaviours, diabetes self-efficacy and quality of life, and (iii) to evaluate user perceptions of the program’s 
acceptability, usability, user satisfaction, and feasibility of implementation.  The three experimental 
conditions included: (i) Wait-List Control: received usual diabetes care from Baseline to 3-months Post-
Baseline; (ii) Full Intervention: received access to the full OnTrack Diabetes program from Baseline to 3-
months Post-Baseline; and (iii) Brief/ Modified Intervention: received access only to information resources 
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on diabetes self-care, and the physical activity module from Baseline to 3 months Post-Baseline.  While the 
pilot trial results showed that there were no significant differences between groups in primary or secondary 
outcomes over 3 months duration, findings revealed high user evaluations and implementation feasibility.  
These results provided scope for the upcoming main RCT of the OnTrack Diabetes program. 
 The manuscripts and papers in this thesis are presented in the form in which they were submitted or 
accepted to scientific journals.  Therefore, the way in which the various papers were formatted differs 
according to particular journal specifications. 
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1.1.4 Section Summary and Conclusions 
 This section provided an overview of the PhD research program, its overarching 
objective, and the individual aims for each of the three, consecutive stages that comprised the 
project.  Links between the papers that emanated from each stage of the project are shown in 
Figure 1, above. 
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1.2 The Type 2 Diabetes and Dysphoria Epidemic 
 
Type 2 diabetes has become a global threat to morbidity, mortality, and health system 
resources to the extent that authorities have described the condition as a crisis (International 
Diabetes Federation, IDF, 2012a).  Over 371 million people globally, or 8.3% of the world’s 
population are estimated to have diabetes, with 85 – 90% of cases being Type 2 diabetes 
(IDF, 2012b).  Diabetes was responsible for an estimated 4.8 million deaths globally for 
people aged 20 – 79 years in 2012 (IDF, 2012b), and this number has been projected to 
double between 2005 and 2030 (World Health Organisation, WHO, 2012).   
Long-term micro- and macro-vascular complications are strongly associated with 
inadequate glycaemic control over time, as excess glucose damages small capillaries and 
large blood vessels within the body.  Consequently, diabetes is one of the leading causes of 
blindness, peripheral neuropathy resulting in limb amputation, and chronic kidney disease 
(WHO, 2012).  Furthermore, cardiovascular disease is the primary cause of death for half of 
those with diabetes and kidney failure is responsible for 10 – 20% of mortalities in this 
population.  The overall mortality risk for individuals with diabetes is at least double that of 
the non-diabetic population (WHO, 2012) and 50% of deaths in people with diabetes occur in 
those under 60 years of age (IDF, 2012b).  An estimated 471.6 billion dollars was spent on 
the global diabetes burden in 2012 (IDF, 2012b).  With diabetes prevalence continuing to 
increase world-wide, the condition is expected to impose further substantial strains on the 
public health purse, with countries at both ends of the developmental extreme being impacted 
(IDF, 2012b).  Thus, effective prevention and intervention measures that can assist to curb 
this issue at the broader public health level are urgently required as the diabetes epidemic 
threatens to spiral out of control. 
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 Australia has the fifth-highest prevalence of diabetes when ranked against other 
OECD countries (IDF, 2012b).  In 2011–12, 4% of Australians had diabetes, and Type 2 
diabetes accounted for 85.3% of cases, affecting 746 716 individuals (Australian Bureau of 
Statistics, ABS, 2013).  It is estimated that at least half of Type 2 diabetes cases remain 
undiagnosed (Barr et al., 2006; IDF, 2012b) such that there are, in fact, 1.9 million people 
affected (IDF, 2012b).  Furthermore, Australia’s diabetes prevalence has increased by more 
than double from 1.5% of the population in 1989-90 to 4.1% in 2007-08 (ABS, 2011b), from 
which point it has not declined (ABS, 2013).  This trend is a likely reflection of the increased 
public recognition and screening of Type 2 diabetes from the early 1990’s; increases in the 
survival rates of those affected due to advances in treatment strategies; and/ or an increase in 
the number of cases (Magliano et al., 2009).  Diabetes is most prevalent in those aged 65 – 74 
years.  Therefore, its prevalence is expected to continue rising as Australia’s population 
distribution becomes primarily concentrated in the middle to older age cohorts, and due to 
increases in life expectancy over time (Magliano et al., 2008).   
Diabetes is an Australian National Health Priority Area (NHPA) due to the high rates 
of diabetes-related morbidity and mortality.  Diabetes is responsible for the Australia’s 
fourth-highest burden of disease, comprising 8.2% of the total burden (Australian Institute of 
Health & Welfare, AIHW, 2012a).  Diabetes and related causes were responsible for 5.4% of 
deaths in 2007 (AIHW, 2010a).  Diabetes remains the leading cause of blindness in those 
aged 30 – 69 years, non-trauma-related lower limb amputations, end-stage kidney disease, 
and cardiovascular disease (primarily heart disease and stroke) (WHO, 2011a).   In 2007 – 
08, over ½ of Australians with diabetes reported having a physical disability or impairment.  
Almost ¼ of these individuals stated that diabetes was the condition that was primarily 
responsible for their disability (AIHW, 2010a).  Further, diabetes-related disabilities tended 
to increase with age (ABS, 2011b).  Diabetes-related costs to the Australian government 
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comprised 2% of total disease expenditure, at approximately $990 million in 2011 – 2012, 
excluding out of pocket expenses and National Diabetes Services Scheme subsidies (AIHW, 
2012a).  Further excluded from this costing were intangible losses to individuals, their 
families and society.  Specifically, the significant losses to work productivity, functioning 
and quality of life (Schram, Baan, & Pouwer, 2009) that inevitably result from diabetes-
related psychological and emotional impacts were not accounted for in these cost estimates.     
1.2.1 Prevalence of Affective and Mood Disorders in Diabetes 
 Mental health disorders are another key Australian NHPA, with anxiety disorders 
affecting an estimated 14% of Australians and affective disorders affecting 6% over a 12-
month point-prevalence, and accounting for the leading cause of Australia’s disability burden 
(Begg et al., 2007).  Government health expenditure on mental health services was in excess 
of $6.3 billion in 2009 – 10 (AIHW, 2012b).  Mental health disorders were found to be 
significantly more common in those with, compared to those without, comorbid physical 
health conditions (AIHW, 2011).  Depression and anxiety are considered to be causal 
(Wulsin, Vaillant, & Wells, 1999) and consequential (Wilhelm, Mitchell, Slade, Brownhill, & 
Andrews, 2003) factors of physical health conditions.   
In 2007 – 08, an estimated 17.4% of people with diabetes aged 16 – 85 years had a 
comorbid lifetime mental health disorder (anxiety, affective disorder, or substance use 
disorder) with active symptoms in the past 12 months [National Health Survey (NHS): 
Summary of Results, 2007-2008].  Anxiety disorders were the most prevalent specific mental 
disorders within this group. Further, the 2007 – 08 NHS indicated that a significantly greater 
proportion (41.6%) of adults with diabetes reported experiencing medium to very high levels 
of psychological distress compared with the 32.2% of the non-diabetic population that was 
affected.  Mental disorders and psychological distress were significantly more common in 
females than males, both in the diabetic and non-diabetic populations.   
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There is currently a paucity of high quality data on the prevalence of mood 
comorbidities in the diabetic population, with the most recent figures becoming outdated.  
Furthermore, psychological distress and comorbid mood disorders are frequently under-
reported and often remain undiagnosed in people with diabetes due to factors including lack 
of regular screening by health care professionals and patients’ poor treatment-seeking 
behaviours (Chen et al., 2011).  Additionally, comorbid mood disorders may go unrecognised 
in patients, as dysphoric symptoms including tiredness, withdrawal from social events, 
excessive worry and lack of motivation may be confused with symptoms of Type 2 diabetes 
(Alberti, 2002).  Therefore, available data on the current prevalence, morbidity and mortality 
rates associated with comorbid diabetes and mental health disorders present conservative 
estimates.  Overall, the evidence indicates that diabetes and comorbid mood disorders present 
significant challenges to individuals’ well-being and pose particular challenges to health 
systems globally. 
1.2.2 Type 2 Diabetes Aetiology 
 Type 2 diabetes is defined by progressive impairment of the body’s sensitivity to 
insulin due to insulin resistance, and/ or deficiency in insulin secretion, with one or both of 
these effects being present at diagnosis (WHO, 2006).  Inadequacies in glucose metabolism 
result, causing elevated plasma glucose levels.  The initial onset of Type 2 diabetes is 
preceded by a phase between normal glycaemia and diabetes; a condition termed 
‘prediabetes’, which is characterised by Impaired Glucose Tolerance (IGT) and/ or Impaired 
Fasting Glucose (IFG; WHO, 2006).  The presence of abnormalities in glucose metabolism is 
identified by an oral glucose tolerance test (OGTT).  This involves testing 8-hour fasting 
plasma glucose level prior to, and 2 hours following, ingestion of a 75 g oral glucose load.   
IGT is indicated by a fasting plasma glucose level <7.0 mmol/l (126 mg/dl) and a 2-
hour plasma glucose ≥7.8 and <11.1 mmol/l (140 mg/ dl & 200 mg/ dl; WHO, 2006), in 
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which case fasting blood glucose levels are elevated above normal but lower than the level at 
which a Type 2 diabetes diagnosis is made (Dixon & Webbie, 2006).  IFG is represented by a 
fasting plasma glucose level of 6.1 to 6.9 mmol/ l (100 mg/ dl to 125 mg/ dl) and a 2-hour 
plasma glucose level <7.8 mmol/l (140 mg/ dl; WHO, 2006).  In IFG, fasting blood glucose 
levels are normal but blood glucose levels following food consumption remain raised for 
longer than normal (Dixon & Webbie, 2006).  Individuals with prediabetes are 10 – 20 times 
more likely to develop Type 2 diabetes than those with normal glucose tolerance (Barr et al., 
2006).  A Type 2 diabetes diagnosis is determined by fasting plasma glucose of ≥7.0 mmol/l 
(126 mg/ dl) or 2-hour plasma glucose ≥ 11.1 mmol/l (200 mg/ dl; WHO, 2006).  
Alternatively, glycosylated haemoglobin (HbA1c) assay level, which is a marker of the 
integrated average glucose level for the past 8 – 12 weeks (Nathan, Turgeon, & Regan, 
2007), is used as a diagnostic indicator, with the cut-point for Type 2 diabetes diagnosis 
being ≥ 6.5%. 
Wide-scale efforts have been made to implement early diagnostic strategies for Type 
2 diabetes, including screening using the Australian Type 2 Diabetes Risk Assessment Tool 
(AUSDRISK; Chen et al., 2011).  However, diagnosis is commonly delayed for some time 
following the condition’s onset due to its typically asymptomatic nature in the early stages 
(IDF, 2012b). Therefore, plasma glucose levels are often elevated for substantial duration by 
the time hyperglycaemia symptoms become apparent.  Consequently, approximately 50% of 
patients present with at least one diabetes complication at diagnosis (IDF, 2009a).     
The aetiology of Type 2 diabetes is linked to a genetic predisposition in some 
individuals as it is 50% heritable (WHO, 2006).  However, modifiable lifestyle risk factors, 
which primarily include overweight or obesity, insufficient physical activity, and unhealthy 
dietary intake, have an established causal role in Type 2 diabetes aetiology (Shaw & 
Chisholm, 2003).  Furthermore, these risk factors can exacerbate progression to Type 2 
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diabetes from impaired fasting glucose (IFG) or impaired glucose tolerance (IGT).  
Australian health data from 2007 – 08 indicated that Type 2 diabetes risk increases 
proportionally with the extent of excess weight.  For example, obese men were twice more 
likely to have had Type 2 diabetes (12%) than overweight men (6%), or men whose weight 
was in the normal or underweight range (5%).  Women in this study demonstrated the same 
pattern (AIHW, 2010a).   
In 2011 – 2012, 63.4% of Australians were overweight or obese, and 66.9% were 
sedentary or had low levels of exercise in the week prior to the interview, with physical 
activity levels declining with age (ABS, 2013).  Furthermore, these risk factors are implicated 
in the development and progression of diabetes-related complications and other medical 
comorbidities due to their strong associations with glycaemic control and additional risk 
factors, including hyperlipidaemia and hypertension (Barr et al., 2006).  Clustering of 
particular risk factors, including hypertension, dyslipidaemia, IGT or IFG, and abdominal 
obesity, has been termed the metabolic syndrome, and is associated with a two- to three-fold 
increased risk of developing Type 2 diabetes (Barr et al., 2006; Chew, Gan, & Watts, 2006).   
Type 2 diabetes is typically diagnosed in individuals aged 40 years and over.  Risk 
factor trends for Australians between 1995 and 2007–08 demonstrated an increase in 
overweight and obesity in all age groups, and the proportion of physically inactive adults 
remained over 50% (AIHW, 2012c).  Consequently, large proportions of Australians risk 
developing Type 2 diabetes.  Although it is most commonly seen in adults, Type 2 diabetes 
also occurs in children, and its incidence in the younger population is also rising (WHO, 
2011b).   
A further risk factor for Type 2 diabetes is depression, which has been shown to 
precede Type 2 diabetes diagnosis in 60% of cases (Black, 2006).  Depression has been 
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shown to have bi-directional associations with both Type 2 diabetes and cardiovascular 
disease (Clarke & Currie, 2009), with the effects of their relationship being as strong as that 
for other standard risk factors, including high cholesterol (Bunker, Colquhoun, Esler, & al, 
2003).  Risk factors typically occur in a cluster and lead to multiple comorbidities.  For 
example, Type 2 diabetes, cardiovascular disease and chronic kidney disease are risk factors 
for each other (AIHW, 2009), largely due to their common causal factors.  While efforts are 
at large in Australia to reduce these risks they are typically resistant to change.  Thus 
reducing the incidence of Type 2 diabetes and its deleterious health outcomes remains a 
challenge.      
1.2.3 Projections for Diabetes Prevalence 
Diabetes prevalence has risen substantially above previously projected estimates for 
the present time.  In Australia, diabetes prevalence has trebled in under 20 years, escalating 
from an estimated 193 000 diagnoses, or 1.3% of the population in 1989 – 90 to 818 200, or 
3.9% of Australians in 2007 – 08 (AIHW, 2010a), at which point it has remained stable 
(AIHW, 2012a).  Major causes for this increase include the ageing Australian population, 
reduced mortality for those living with diabetes, greater awareness and screening, and 
increased incidence due to lifestyle factors including the rising obesity “epidemic” (Colagiuri, 
Colagiuri, Yach, & Pramming, 2006; Wild, Roglic, Green, Sicree, & King, 2004; Zimmet, 
Alberti, & Shaw, 2001).  In 1999 – 2000, IGT or IFG was estimated to affect 16.3% of 
Australians (Dunstan et al., 2002).  Projections predict an increase in the proportion of those 
with prediabetes (Barr et al., 2006) along with an increase in modifiable lifestyle risk 
factors(Begg et al., 2007), and hence estimate a continual rise in Type 2 diabetes prevalence.   
 Diabetes’ prevalence is predicted to increase in every country around the world (IDF, 
2012b).  Predictions indicate that in 2030 diabetes’ world-wide prevalence will have risen to 
438 million (IDF, 2009a), or will be two-thirds greater than the 2008 prevalence (WHO, 
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2012).  Further, projections indicate that Australia’s diabetes prevalence will increase by 
221% from the 2003 estimate of 1.073 million cases, to 3.449 million cases in 2033 (Begg et 
al., 2007; Magliano et al., 2009).  Continuation of 2000 – 2005 trends in diabetes prevalence 
through to the year 2025 would result in 38% of Australians aged 25 years developing 
diabetes in their lifetime (Magliano et al., 2008).  The number of daily adjusted life years for 
those with diabetes is also expected to increase by 1.8% each year until 2023 (Begg, Vos, 
Barker, Stanley, & Lopez, 2008), presenting Australia’s health system with an increasingly 
dire challenge.  By 2023 Type 2 diabetes is predicted to become the leading cause of disease 
burden for males and the second leading cause for females (Begg et al., 2007).  Diabetes is 
projected to incur the highest associated rise in economic burden on Australia’s health care 
budget, with an estimated increase of 401% from $1.4 billion in 2002 – 03 to $7 billion in 
2032 – 2033 (Vos, Goss, Begg, & Mann, 2007).   
1.2.4 Type 2 Diabetes Management 
International standards recommend the use of glycosylated haemoglobin assay 
(HbA1c) level as an indicator of glycaemic control (WHO, 2006).  Long-term glycaemic 
control is strongly associated with the incidence and progression of diabetes complications 
(Stratton et al., 2000), as is the control of risk factors including dyslipidaemia and 
hypertension.  Maintaining or improving glycaemic control to be at the recommended HbA1c 
level of ≤ 7.0% (Colagiuri, Dickinson, Girgis, & Colagiuri, 2009) has been shown to prevent 
or delay the incidence of microvascular (Stratton et al., 2000) and macrovascular (The 
ADVANCE Collaborative Group, 2008) complications.  Each 1% decline in HbA1c level has 
been shown to produce a 21% overall risk reduction in complications (DCCT Research 
Group, 1993).  The uptake and maintenance of regular physical activity, balanced nutritional 
intake, medication adherence, and blood glucose self-monitoring are strongly associated with 
adequate glycaemic control.  Therefore guidelines on the management of Type 2 diabetes 
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refer to these behaviours as essential treatment components of the Type 2 diabetes treatment 
regime (Colagiuri et al., 2009; IDF, 2012a; WHO, 2012).   
 Accordingly, the ultimate goals of Type 2 diabetes management are to achieve and 
maintain adequate glycaemic control (HbA1c level < 7%), lipid levels, and hypertension (Del 
Prato et al., 2005).  A generic, step-wise treatment approach is recommended to normalise 
and maintain glycaemic control, with the stage at which Type 2 diabetes is diagnosed and its 
progression typically determining the prescribed treatment (IDF, 2012c).  Most patients are 
initially advised to undertake lifestyle management alone, including regular physical activity 
and a healthy diet, provided that there is sufficient insulin production and insulin sensitivity 
to maintain adequate glycaemic control.  Over time patients are often required to take anti-
hyperglycaemic agents which are continued until up-titration to maximum dosage is reached, 
at which point additional anti-hyperglycaemic tablets are prescribed.  Pancreatic insulin 
production typically continues to diminish and insulin resistance increases over time until the 
body is unable to produce and/ or utilise insulin sufficiently even with anti-hyperglycaemic 
tablets.  Patients are then required to undertake insulin therapy to achieve recommended 
targets for glycaemic control [UK Prospective Diabetes Study (UKPDS) Group, 1998].  
Whilst regular blood glucose self-monitoring may facilitate Type 2 diabetes management 
during its early stages, it becomes essential when patients are on insulin therapy (Colagiuri et 
al., 2009).  Efforts to improve the long-term prognosis of Type 2 diabetes patients have 
involved physicians being urged to prescribe diabetes medications relatively promptly 
following diagnosis (Del Prato, 2005).   
1.2.5 Type 2 Diabetes Treatment Adherence 
 At least 95% of the responsibility for diabetes management is up to the patient 
(Anderson, 1985).  Effective Type 2 diabetes self-management is fundamental to patients’ 
short- and long-term physical and mental health prognoses.  However, long-term difficulties 
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maintaining healthy lifestyle behaviours tend to remain problematic following Type 2 
diabetes diagnosis.  Conventionally, the term “adherence” is preferred to “compliance”, as 
the latter denotes that patients have a choice in following recommendations made by health 
professionals, rather than simply being required to follow orders (Haynes, Taylor, & Sackett, 
1979).  This change in terminology reflects the shift toward valuing chronic disease patients 
as active decision-makers in the treatment process, and the encouragement of health 
professionals to consult with them as such.  The doctor-patient relationship is now commonly 
encouraged to promote patient concordance which involves pooling the patient’s and health 
care provider’s expertise and engaging in shared decision-making (Suraci, Mulas, Rossi, 
Gentile, & Giorda, 2012).   
Non-adherence to recommended self-care regimens is as high as 38 – 75% in diabetes 
patients (Helmer & Harrington, 2004).  Although non-adherence may occur in lapses rather 
than being continuous (Kirkley & Fisher, 1988), the accumulative risk of diabetes 
complications with hyperglycaemic episodes over time warrants concern (Stratton et al., 
2000) and urgent intervention.  In response to this need, numerous studies have attempted to 
uncover the reasons for patient non-adherence to prescribed treatments.  A commonly 
identified factor that threatens adherence is the complexity of the Type 2 diabetes treatment 
regimen (Ingersoll & Cohen, 2008).   
Behavioural changes are difficult to motivate in Type 2 diabetes patients, particularly 
due to this population’s typically inadequate practise of self-care prior to diagnosis.  In 
Australia, 61.3% of the population has a body mass index in the overweight/ obese range; 
71.6% has sedentary or low activity levels; and 93.8% has inadequate fruit and/ or vegetable 
consumption (NHS: Summary of Results, 2007-2008).  Accordingly, behavioural risk factors 
common to Type 2 diabetes and mood disorders, including overweight/ obesity, physical 
inactivity and poor nutrition occur in a large proportion of Type 2 diabetes patients (AIHW, 
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2009).  Difficulties changing lifestyle habits result in continued exposure to risk factors that 
lead to poor diabetes-related outcomes.  Concordantly, a review of coaching strategies for 
improving the health outcomes of people with Type 2 diabetes concluded that motivating 
patients to make positive health behaviour changes was potentially the most challenging 
aspect of managing the condition (Cherrington, Wallston, & Rothman, 2010).  However, the 
need for health professionals to modify their behaviour toward patients to facilitate change 
was also asserted, indicating that behavioural change at the patient level depends heavily on 
external factors, including the doctor-patient relationship, as well as personal factors.   
 A number of quantitative studies that have investigated barriers to effective diabetes 
self-management have revealed a range of issues.  Chronic disease patients typically 
experience non-adherence to their treatment regimen due to motivational difficulties 
maintaining behavioural self-management, effects of emotional comorbidities at various 
periods, and disease non-acceptance (Fisher, Thorpe, DeVellis, & DeVellis, 2007).  Whilst 
qualitative exploration of this issue has the advantage of obtaining an unbiased account of 
patients’ views, a quantitative approach is often applied.  Barriers reported in studies 
exclusively on diabetes self-management have frequently included medication costs, 
forgetting to take medications (Odegard & Gray, 2008), patient health beliefs causing 
reluctance to take prescribed medications (Mann, Ponieman, Leventhal, & Halm, 2009), low 
self-efficacy for medication-taking (Chao, Nau, Aikens, & Taylor, 2005; Sacco & Bykowski, 
2010), treatment regime complexity (Fisher, Glasgow, Mullan, Skaff, & Polonsky, 2008), 
fear of hypoglycaemia (Barnett et al., 2010), and reduced social motivation for self-care 
(Egede & Osborn, 2010).   
Quantitative studies provide a relatively broad perspective on adherence issues that 
may be addressed in standardised treatment interventions.  However, these studies appear to 
be less rich sources of information on which to base personalised self-management 
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interventions.  Alternatively, a qualitative exploration of patients’ needs and preferences for 
self-management support may be more appropriate for this purpose.  Using a qualitative 
approach enables the achievement of an in-depth understanding of patients’ lived experiences 
in managing Type 2 diabetes, which concedes with the essential aspect of patient 
empowerment in diabetes management (Anderson et al., 1995; Williams, McGregor, 
Freedman, & Deci, 2004).   
1.2.6 Quality of Life and Type 2 Diabetes 
 Quality of life is an important marker of self-perceived physical and social 
functioning and mental health (Commonwealth of Australia, 1999).  Improving quality of life 
in people with Type 2 diabetes is a cornerstone of diabetes management (Del Prato et al., 
2005) with significant implications including improved treatment adherence (Mukherjee et 
al., 2009) and reduced mortality risk (Kleefstra et al., 2008).  The self-perceived health status 
of Australians with Type 2 diabetes is significantly lower than that of the general population.  
Latest figures indicated that 42% rated their health status as fair or poor, with this proportion 
being identical for people with cancer who rated themselves in the same category, and second 
only to those with a profound or severe disability (ABS, 2008).   
Results from the most recent National Survey of Mental Health and Well-being (2007 – 08) 
showed that quality of life declined as a function of increased disability (ABS, 2008).  
Concurrently, empirical research has indicated a significant, inverse relationship between 
diabetes complications and quality of life (UKPDS, 1999).  Significant reductions in quality 
of life have also been found as glycaemic control worsens (Imran, Ismail, Naing, & Wan 
Mohamad, 2010; Tapp et al., 2006).  In addition, factors associated with Type 2 diabetes self-
management, which include treatment regime complexity (Franciosi et al., 2001; Lau, 
Qureshi, & Scott, 2004; Stack & al., 2011), hypoglycaemic events (Barnett et al., 2010) and 
weight gain, have demonstrated significant negative impacts on quality of life (Herman, 
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1999; Tapp et al., 2006).  The maintenance of such factors may confound the association 
between improvements in glycaemic control and quality of life that have been reported in 
some studies (Ahroni, Boyko, Davignon, & Pecoraro, 1994; Kleefstra et al., 2005).  
Therefore, reduced quality of life as a function of diabetes management tends to impact 
individuals at both ends of the glycaemic spectrum.  These findings suggest that improved 
glycaemic control alone may not suffice to produce improvements in individuals’ perceived 
experience of living, and accordingly that ongoing support for diabetes self-management and 
additional factors, such as mood, is most likely necessary (Fisher, Brownson, O'Toole, & 
Anwuri, 2007). 
 Deteriorations in quality of life, particularly in terms of self-perceived physical 
functioning, have been shown to occur during impaired glycaemic control (IFG or IGT), 
when hyperglycaemia is generally asymptomatic.  Furthermore, these declines tend to 
progress following Type 2 diabetes diagnosis (Tapp et al., 2006).  In people with known Type 
2 diabetes, subjective hyperglycaemia symptoms have shown associations with health-related 
quality of life independently of HbA1c levels (Kleefstra et al., 2005).  Furthermore, increases 
in treatment regimen demands, including increased blood glucose self-monitoring and 
intensive insulin therapy, have been shown not to improve patients’ quality of life 
(Commonwealth of Australia, 1999; DCCT Research Group, 1993; de Grauw, van de 
Lisdonk, van Gerwen, van den Hoogen, & van Weel, 2001; Goddijn et al., 1999; UKPDS, 
1999).  Together, this evidence suggests that lifestyle and psychological factors, including 
self-perceptions of Type 2 diabetes rather than the presence of the condition itself, can 
negatively impact on quality of life (Arcega-DomÃ-nguez, Lara-MuÃ±oz, & Ponce-De-
LeÃ³n-Rosales, 2005).  Therefore, targeting these factors in interventions aimed to improve 
quality of life in people with Type 2 diabetes would appear to be important.   
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Comorbid mental health disorders present substantial barriers to the achievement of 
satisfactory quality of life in people with diabetes.  Recent survey data revealed that 
individuals suffering from comorbid physical and mental health conditions reported feeling 
significantly less pleased with their quality of life compared with individuals affected by a 
physical condition or mental disorder alone (ABS, 2008), and were approximately twice as 
likely to report being ‘out of role’ for more than 7 of the past 30 days (ABS, 2008).  
Together, the evidence conveys that taking a holistic approach to individuals’ experiences in 
living with Type 2 diabetes might most effectively assist with improving quality of life in this 
population. 
1.2.7 Health Care for Australians with Type 2 Diabetes 
Type 2 diabetes and dysphoria constitute two of the highest burdens to the Australian 
health care system at present (AIHW, 2012a).  First-world countries such as Australia 
characteristically have the facilities, services, personnel and financial resources to meet the 
IDF Global Guidelines recommended standards of care (IDF, 2012a).  However, there 
remains limited diabetes self-management support, particularly for those with comorbid 
dysphoria, due to the rising extent of diabetes-related disease burden.  In 2010 – 11 Type 2 
diabetes was the primary cause for major hospital admissions, with more than half of all in-
patient hospital admissions being for diabetes-related eye complications.  Other Type 2 
diabetes-related primary causes of in-patient admissions included multiple complications, 
kidney disease, circulatory problems, poor diabetes control and hypoglycaemia (AIHW, 
2012a).  In 2007 – 08 individuals who were hospitalised for diabetes were more likely to 
have a comorbid mental health condition on their records (8.4%) than patients who were 
hospitalised for other conditions (7.5%) (AIHW, 2011).  Individuals hospitalised with 
diabetes were primarily from the most and least advantaged socioeconomic quintiles (AIHW, 
2011). 
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The 2009 – 2010 Bettering the Evaluation and Care of Health (BEACH) survey 
results revealed that diabetes was the fourth-most common chronic condition seen by general 
practitioners (GPs).  Diabetes had accounted for 2.4% of all problems managed that year, 
which comprised 3.7 per 100 patient encounters, which represents a significant increase from 
the rate in 2000 – 01 of 2.8 per 100 encounters (Britt et al., 2011).  Further, individuals with 
mental health conditions most commonly consulted a GP for initial help for their symptoms 
(Britt et al., 2011).  In 2010 – 11, there were an estimated 13.9 million mental health-related 
encounters with GPs, which represented an increase of 4.8% from 2006 – 07 (Britt et al., 
2011).  Depression and anxiety were the two mental-health problems most frequently 
managed by GPs in 2010 – 11.  The first-line treatment for mental health problems by GPs 
was prescribed or recommended medications.  Psychological counselling and advice were the 
second-most common mental health-related treatments that GPs provided, and referrals to 
psychologists and other specialised mental health care were the third-most common 
approach.  Mental health problems in diabetes patients often remain unaddressed due to 
practical constraints such as time limitations (Presseau, Sniehotta, Francis, & Campbell, 
2009), and GPs’ difficulties in knowing how to approach patients’ psychological issues 
(Hajos, Polonsky, Twisk, Dain, & Snoek, 2011; Peyrot et al., 2005; Sturk et al., 2007).  
Therefore, additional patient support is needed.   
Health system initiatives are aimed to improve access to and the affordability of 
specialist health services for chronic disease and mental health patients.  The Better Access 
Initiative, which provides patients with a Medicare subsidy for allied health consultations 
(Medicare program: expanded coverage for outpatient diabetes self-management training and 
diabetes outcome measurements) was launched by the Australian Government in 2006.  
Accordingly, the average number of mental health-related services that were accessed 
showed a 34% increase between 2005 – 06 and 2009 – 10 (AIHW, 2012a).  Patients with 
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diabetes are encouraged to access a GP annual cycle of care, which includes a sequence of 
steps that includes regular screening and thus the early detection of complications (AIHW, 
2012a).   
While the need for emotional and psychological support for diabetes patients is well 
recognised (Adriaanse et al., 2008; Fisher, Thorpe, et al., 2007; Peyrot et al., 2005), 
significant improvements are needed to achieve the provision of adequate care.  Current 
allowances of up to 10 Medicare-subsidised visits to a mental health professional each year 
are unlikely to be sufficient to treat ongoing emotional difficulties, particularly for those 
facing significant behavioural and psychological problems.  The lower socioeconomic 
bracket represents a disproportionately large proportion of the Australian Type 2 diabetic 
population, and is somewhat disadvantaged in the Australian health care system.  
Furthermore, current government initiatives commonly remain unutilised by target 
populations.  For example, in 2010 – 11 just 18% of people with diabetes completed a cycle 
of annual care, despite the fact that GPs are the commonest diabetes management primary 
care providers (Britt et al., 2011).  Furthermore, during that year just 1 in 5 patients with a 
mental health condition were recorded as having a GP mental health treatment plan.   
Patients’ reluctance to access mental health services in the primary care setting may 
prevent them from receiving needed support.  For example, the majority (86%) of people 
with a diagnosed mental disorder reported that in 2007 – 08 they had not used services for 
their mental health problem in the previous 12 months (AIHW, 2010b).  Of those who did 
access mental health services during this time, 26% reported feeling that their need for 
counselling was, at best, only partially met, and a further 29% indicated feeling that their 
need for information was, at best, partially met (ABS, 2011a).  More regular and ongoing 
forms of support may assist with better meeting the self-management and mental health needs 
of people with diabetes.  Whilst ecological and service-based initiatives to provide extra 
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support to diabetes patients are important, this data indicates that additional patient-level 
support is required. 
1.2.8 Rural and Regional Health in Australia 
Geographic remoteness is a significant and widely recognised ecological barrier to 
those with Type 2 diabetes receiving adequate self-management, emotional and 
psychological support.  Rural and regional areas are hereby referred to according with the 
ABS Australian Geographical Classification (ASGC; 2010), as areas outside of Major cities 
(ABS, 2010).  In 2003, females living in rural and remote areas were 1.3 times more likely to 
report having diabetes than those living in Major cities (AIHW, 2008).  Rates of death due to 
diabetes were higher in non-urban than within metropolitan populations (AIHW, 2012a), and 
Standardised Mortality Ratios (SMRs) indicated a positive relationship between increasing 
geographic remoteness from city regions and death rates from diabetes (Dunn, Sadkowsky, & 
Brockway, 2006).  In 2002 – 04, diabetes caused 6% of ‘excess’ deaths in rural and regional 
areas (AIHW, 2007).      
Australians residing in non-urban areas were more likely to exhibit multiple lifestyle 
risk factors for chronic disease, with higher proportions more commonly having reported four 
or more risk factors than those living in Major cities (AIHW, 2012a).  In particular, higher 
levels of saturated fat intake (as indicated by measures of whole milk consumption), 
insufficient physical activity, tobacco smoking (AIHW, 2012a), and risky levels of alcohol 
consumption have been found in Australians living in Remote or Very remote areas 
compared with those in Major cities.  Concurrently, diabetes complications have shown 
higher prevalence and severity in non-urban populations, in which hospitalisations for lower-
limb amputations, rates of long-term vision loss and cardiovascular disease have been shown 
as substantially higher than in metropolitan populations (AIHW, 2012a).  Furthermore, levels 
of health literacy are lower in people living outside Major cities (AIHW, 2012a), which is 
34 
 
 
 
associated with poorer self-assessed health status and which has significant implications for 
effective diabetes self-management.     
Rural and remote dwellers face significant barriers to receiving adequate health care 
due to factors typically associated with rurality (AIHW, 2008).  Specifically, factors include 
geographic isolation and limitations to the availability of health services and health care 
providers; access issues presented by transport and communication restrictions; and higher 
rates of socioeconomic disadvantage (AIHW, 2008).  An estimated 20% of all primary health 
care providers across Australia service the 29% of the population that resides in non-urban 
areas (Catanzariti, Faulks, & Water, 2007), which seriously limits the likelihood that patients 
can receive the regular and ongoing support that they need.  Access and availability issues 
exacerbate the inherent challenges associated with Type 2 diabetes self-management and 
psychological intervention.  Further, they suggest that effective intervention requires going 
beyond the scope of traditional services and rather looking to provide a support system that 
offers greater availability and access, as well as wider outreach to this population. 
1.2.9 Section Summary and Conclusions 
This section discussed the escalating impact of diabetes on a global and national scale.  
The latest statistics on diabetes prevalence and impacts were used to demonstrate the urgent 
need for effective, wide-spread intervention.
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1.3 Depression, Anxiety, Distress and Type 2 Diabetes 
 
 ‘Mental health’ refers to having proficient wellbeing to enable the realisation of one’s 
potential, ability to cope with life stressors, satisfactory work productivity, and to make 
community contributions (WHO, 2010).  The International Classification of Disease (ICD) – 
10th revision classification of mental and behavioural disorders defines a mental disorder as 
“the existence of a clinically recognisable set of symptoms or behaviour associated in most 
cases with distress and with interference with personal function” (WHO, 1992, p. 5).  The 
prevalence of mental health problems is substantially higher in people with, than those 
without diabetes, which supports the bidirectional nature of the diabetes/depression 
relationship.  Mental health problems and diabetes have common risk factors and outcomes.  
In particular, both have been shown to significantly undermine physical and mental 
wellbeing, and further to debilitate quality of life (AIHW, 2011). 
1.3.1 Psychological Distress and Type 2 Diabetes 
 Severe psychological distress, referring to high or very high levels of overall 
psychological strain or pain (ABS, 2001), is more prevalent in people with, than in those 
without diabetes (ABS, 2004-05).  Levels of psychological distress tend to increase as a 
function of physical disability.  In the 2007 National Survey of Mental Health and Wellbeing, 
23.8% of Australians with diabetes reported having some form of restriction or disability 
compared with 36.1% of the general population (ABS, 2008).  Higher levels of physical 
disability are associated with increased stress in the face of personal stressors than lower 
levels of physical disability (ABS, 2011a).  People with diabetes commonly reported having 
poor self-perceived physical and mental health status, which can exacerbate psychological 
distress (AIHW, 2010a).  Additional risk factors for distress in people with Type 2 diabetes 
included lower educational status (Peyrot & Rubin, 1997), being female (Lustman, Griffith, 
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Clouse, & Cryer, 1986; Peyrot & Rubin, 1997), lack of social support (Whittemore, D'Eramo 
Melkus, & Grey, 2005), being unmarried (August & Sorkin, 2010), and being from an ethnic 
minority group (Manderson & Kokanovic, 2009). 
1.3.2 Dysphoria and Type 2 Diabetes 
 Dysphoria hereby refers to psychological and emotional problems that are 
characterised by symptoms of an affective or anxiety disorder and/ or psychological distress.  
Depression is characterised by, “a state of gloom, despondency or sadness lasting at least two 
weeks.  The person usually suffers from low mood, loss of interest and enjoyment, and 
reduced energy.  Their sleep, appetite and concentration may be affected” (AIHW, 2011, 
p.32).  Anxiety disorders refer to, “...excessive feelings of apprehension, worry, nervousness, 
and stress” (AIHW, 2011, p.36) and include the Diagnostic and Statistical Manual of Mental 
Disorders Fourth Edition (DSM-IV-TR) classification of Generalised Anxiety Disorder 
(GAD; American Psychiatric Association, 2000).   
Comorbid diabetes and dysphoria represents one of Australia’s most dire health 
challenges to date.  In 2007, 6.2% of Australians aged 16 – 85 years reported having 
experienced an affective disorder, and 14.4% reported experiencing an anxiety disorder in the 
previous 12 months (ABS, 2008).  In 2010, mental disorders were the third-leading 
contributors to Australia’s total burden of disease (AIHW, 2010a).  Similarly, to diabetes, 
non-fatal burden comprised the majority of disease burden attributable to anxiety and 
depression (AIHW, 2010a).  Specifically, they accounted for the loss of an estimated 203 000 
daily adjusted life years (DALYs), or 7.1% of total DALYs for Australians per annum (Begg 
et al., 2007).  Projections for 2023 predicted that anxiety and depression will remain within 
the top five conditions responsible for Australia’s disease burden.  Australian health system 
expenditure on mental health services has increased by an average of 5.2% per annum 
between the years 2000 – 01 and 2005 – 06, to an estimated $2.7 billion (ABS, 2009a).  
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Depression and anxiety accounted for the top two mental health-related problems managed in 
the Australian health care system, and hence were responsible for the majority of this 
expenditure. 
 Depression and anxiety have shown a two- to three-fold prevalence in individuals 
with Type 2 diabetes compared with those in the general population (Ali, Stone, Peters, 
Davies, & Khunti, 2006; Anderson, Freedland, Clouse, & Lustman, 2001).  Depression 
occurs in 27% of people with Type 2 diabetes according to self-report scales and 9% based 
on clinical diagnostic interviews, and is more prevalent in women than in men (Anderson et 
al., 2001).  GAD has been reported to affect 14% of people with diabetes (Grigsby, 
Anderson, Freedland, Clouse, & Lustman, 2002).   
Subsyndromal depression and anxiety symptoms are substantially more prevalent than 
clinical presentations of these disorders.  For example, findings of a longitudinal study 
indicated that depressive symptoms and distress were each 60 – 73% times more prevalent 
than clinical affective and anxiety disorders (Fisher et al., 2008).  A meta-analysis of anxiety 
disorders prevalence in people with diabetes indicated that 40% of participants in the 
included studies had elevated anxiety levels and 14% had GAD (Grigsby et al., 2002).  
Another study that measured depression and diabetes-specific distress in a sample of Type 2 
diabetes patients reported that 24% had subclinical depression symptoms compared with 11% 
who were clinically depressed (Kokoszka, Pouwer, Jodko, Radzio, Mućko et al., 2009).   
In up to 50 – 75% of cases depression remains undiagnosed in people with diabetes 
even at clinical levels (Leppävuori, 2010; Pouwer, Beekman, Lubach, & Snoek, 2006).  A 
study conducted in the United States found that failure to diagnose depression was 
significantly higher in Type 2 diabetes patients than in people without diabetes (Li et al., 
2009).  Reasons may include that symptoms of dysphoria are mistakeable for those of 
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hyperglycaemia, such as fatigue, and/ or that sadness, hopelessness, or anxiety may be 
confused for natural consequences of diabetes.  Therefore, dysphoria and associated negative 
outcomes are likely to persist in people who have Type 2 diabetes long before intervention is 
sought. 
 Dysphoria symptoms have more serious health and psychological outcomes for 
people with diabetes than for those without diabetes (Lustman, Griffith, & Clouse, 1988).  
Comorbid depression/ anxiety with diabetes is significantly related to substantially reduced 
engagement in diabetes self-care (Bell et al., 2000; Ciechanowski, Katon, & Russo, 2000; 
Gonzalez, Safren, et al., 2008), including medication adherence (Gonzalez et al., 2007), foot 
care (Scollan-Koliopoulos, Walker, & Bleich, 2010), and participation in physical activity 
and dietary adherence (Katon et al., 2010).  Associated consequences include poor glycaemic 
control (Anderson et al., 2002; Lustman et al., 2000; Pouwer et al., 2010; Pouwer & Snoek, 
2001), increased risk of diabetes complications (Black, Markides, & Ray, 2003; de Groot, 
Anderson, Freedland, Clouse, & Lustman, 2001; Williams et al., 2010), impaired 
functionality (Pawaskar, Anderson, & Balkrishnan, 2007), reduced quality of life (Ali et al., 
2010; Chyun et al., 2006; Papelbaum et al., 2010; Schram et al., 2009), cardiovascular 
disease (Katon et al., 2004) (particularly in women; Clouse et al., 2003; Pan et al., 2011), and 
a higher risk of mortality (Egede, Nietert, & Zheng, 2005; Zhang et al., 2005).  Even 
subclinical levels of anxiety and depression have been associated with such effects (Black et 
al., 2003; Gonzalez, Fisher, & Polonsky, 2011; Gonzalez et al., 2007).  Further, depression 
tends to inhibit the seeking of treatment and social support in Type 2 diabetes patients (Egede 
& Osborn, 2010), which increases the likelihood of its progression to clinical symptoms.  
United States research has estimated health care costs to patients with comorbid 
depression and diabetes being 4.5 times higher than those for patients with diabetes alone 
(Egede, Zheng, & Simpson, 2002).  Another study estimated the difference to be 70% (Simon 
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et al., 2005).  Subclinical dysphoria severely impacts the health and functioning of diabetes 
patients (Cuijpers, Smit, & Willemse, 2005; Kokoszka, Pouwer, Jodko, Radzio, MuÄ‡ko et 
al., 2009) and thus exerts substantial financial strains on health care systems.  Therefore, 
intervention is warranted even at subclinical levels. 
 The precise causal mechanisms involved in the association between dysphoria and 
Type 2 diabetes remain unclear (Musselman, Betan, Larsen, & Phillips, 2003).  However, 
diabetes and mood disorders (referring to depression and anxiety) are commonly reported to 
have a bidirectional relationship (Knol et al., 2006).  The Consequence Model portrays 
dysphoria in diabetes patients as resulting from negative self-relevant cognitions, including 
low self-efficacy, that arise from failure to meet self- or other-imposed standards for 
treatment goals (Sacco et al., 2005).  Further, the model proposes that physiological 
symptoms caused by poor adherence and inadequate glycaemic control play a role in 
affective pathology (Sacco et al., 2007).  The relationship between Type 2 diabetes treatment 
adherence and dysphoria is proposed to be mediated by low levels of self-efficacy and 
physiological diabetes-related symptoms, such as diabetes complications and 
hyperglycaemia.   
Factors believed to be implicated in successful diabetes management are thought to be 
associated with self-efficacy.  With Type 2 diabetes, these factors may include physical 
activity, dietary and health regime adherence, and weight loss or maintenance.  Poor 
adherence resulting in failure to meet a desired treatment target is proposed to result in low 
self-efficacy and depression (Sacco et al., 2005).  This model is supported by research that 
reported positive associations between diabetes complications or demands of the treatment 
regimen and dysphoric mood (Chyun et al., 2006; de Groot et al., 2001; Peyrot & Rubin, 
1997).  Studies in which affective symptom severity has shown a significant negative 
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relationship with glycaemic control (Anderson et al., 2002; Lustman et al., 2000) also support 
the Consequence model.   
 The Antecedent Model suggests that dysphoria is present prior to the onset of Type 2 
diabetes.  This model proposes that activation of the hypothalamic-pituitary-adrenal axis in 
response to dysphoria stimulates the sympathetic nervous system (Black, 2006) and thereby 
leads to alterations in glucose transport functions; increases in the activation of immune-
inflammatory responses, and the release of counter-regulatory hormones.  These processes 
are proposed to contribute to insulin resistance in bodily cells and/ or to pancreatic β-islet cell 
dysfunction (Black, 2006).  In obese individuals, depressive behaviour may also be induced 
by the expression of excess TNF-α in the adipose and muscle tissue, leading to insulin 
resistance (Wing, Phelan, & Tate, 2002). Thus, depression is proposed to increase the 
physiological risks for developing impaired glucose tolerance and hence, in many cases, leads 
to Type 2 diabetes. 
 The Antecedent Model further proposes that stress is implicated in Type 2 diabetes 
etiology.  Stress is associated with the release of counter-regulatory hormones in the brain, 
including glucagon, glucocorticosteroids, growth hormones and catecholamines, which 
counteract the processes by which insulin reduces blood glucose levels (Sapolsky, Romero, & 
Munck, 2000).  Further, stress causes blood glucose levels to rise rapidly due to the release of 
epinephrine and glucagon following which blood glucose levels remain elevated for hours 
due to glucocorticoid and GH action (Munck & et al., 1990).  The antecedent model suggests 
that Type 2 diabetes and depression have common biochemical risk factors.  Further, it is 
proposed that as well as reducing the individual’s tendency to participate in essential self-care 
behaviours, affective disturbance in individuals with Type 2 diabetes impairs the body’s 
effective utilisation of insulin via these physiological processes, resulting in hyperglycaemia 
(Sapolsky et al., 2000).   
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Scientific literature supporting this view includes a meta-analysis which revealed that 
in people with Type 2 diabetes the risk of developing depression was 15%, and people with 
Type 2 diabetes had a 60% increased risk of depression (Mezuk, Eaton, Albrecht, & Golden, 
2008).  Concurrently, depressive symptoms have been shown to persist despite improvements 
in glycaemic control (Ciechanowski, 2003; Lustman, Griffith, Clouse et al., 1997) or the 
onset of diabetes complications (Lustman et al., 1988; Paschalides et al., 2004), which 
suggests that rather than simply being a consequence of diabetes control, depressive 
symptoms can exist independently.  These findings demonstrate that in interventions that are 
aimed to improve diabetes self-management it is essential to address dysphoria symptoms. 
 Dysphoria has demonstrated impairing Type 2 diabetes self-management and 
glycaemic control via interactive cognitive and physiological effects.  Therefore, while stress 
management may help to prevent Type 2 diabetes, urgent intervention that incorporates long-
term dysphoria symptom management is crucial for those who already have diabetes (Egede 
& Ellis, 2010).  Evidence indicates that in many cases dysphoria symptoms preceded and 
possibly were implicated in the development of Type 2 diabetes, and hence that people with 
diabetes have a long-standing predisposition to poor mental and physical health outcomes.  
Furthermore, it is foreseeable that diabetes-specific stressors are highly likely to incur an 
additional burden in this vulnerable population. 
There may be differential associations between the various forms of dysphoria 
(depression, anxiety and psychological distress) and physiological and psychological 
outcomes (Fisher et al., 2009; Fisher et al., 2007; Gonzalez et al., 2011).  For example, the 
Edinburgh Type 2 Diabetes Study demonstrated that symptoms of depression were related to 
abdominal obesity and cardiovascular disease, whilst anxiety was not significantly related to 
these outcomes (Labad et al., 2009).  Despite differences in the effects of various types of 
dysphoric mood on well-being, each psychological and emotional symptom presentation 
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tends to significantly impact the wellbeing of people with diabetes, albeit in various ways.  
Furthermore, psychological, psychosocial and ecological diversity between individuals is 
likely to influence the impacts of psychological and emotional symptoms on outcomes.  In 
turn, these effects are likely to differ over time as a function of changes in the point-
prevalence of symptoms.  Therefore, it is essential that personalised psychological and 
emotional support that caters for individual diversities on an ongoing basis is provided to the 
highest possible degree (Fisher et al., 2007).  
1.3.3 Diabetes-Specific Distress and Type 2 Diabetes 
Diabetes-specific distress refers to stress that is specifically related to the emotional, 
physical, and psychological burden associated with diabetes and its management (Fisher et 
al., 2008).  Diabetes distress involves issues including fear of diabetes complications 
(Scollan-Koliopoulos et al., 2010), anger related or unrelated to conflict with family and 
health professionals (Fisher et al., 2007; Polonsky et al., 1995), which has been shown to 
negatively impact on diabetes self-care (Scollan-Koliopoulos et al., 2010), and poor 
glycaemic control (Adriaanse et al., 2008; Fisher, Glasgow, & Strycker, 2010; Fisher, Mullan 
et al., 2010; Fisher et al., 2008).   
Distinctions between the effects of depression and diabetes-specific distress on 
wellbeing have in particular attracted much empirical interest (Fisher et al., 2009; Fisher et 
al., 2007; Gonzalez et al., 2011).  Identifying these differences has been popularised as a 
means of seeking to provide symptom-specific, and hence optimally effective, intervention 
(Gonzalez, Delahanty, Safren, Meigs, & Grant, 2008).  Research findings have indicated that 
the point-prevalence of diabetes distress (18%) is significantly higher than that of major 
depressive disorder (10.7%; Fisher, Glasgow et al., 2010).  Furthermore, diabetes-specific 
distress has shown significant relationships with glycaemic control and diabetes self-care, 
whilst Major Depressive Disorder (MDD) and dysphoria did not (Fisher, Glasgow et al., 
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2010; Fisher et al., 2008; Fisher et al., 2007).  However, other research has reported a 
significant relationship between diabetes-specific distress and depression such that diabetes-
specific distress was more prevalent in those with a history of MDD (Fisher et al., 2009) and 
those with current clinical or subclinical depression (Adriaanse et al., 2005; Kokoszka et al., 
2009).  This relationship may be understood in the context of research that has demonstrated 
a mediation effect of diabetes-specific distress on the relationship between depression and 
glycaemic control (van Bastelaar et al., 2010).  Overall, findings emphasise the importance of 
targeting diabetes-specific distress, particularly in patients who exhibit depressive symptoms. 
Symptom amplification, which is characteristic of depression (Ludman et al., 2004), 
has been shown to heighten emotional vulnerability in the face of diabetes-related issues, and 
to thereby increase the likelihood of experiencing distress.  Personal stressors including 
negative life events and non-chronic stressors can significantly impair optimum diabetes self-
management (Albright, Parchman, & Burge, 2001; Fisher et al., 2009; Goetsch, Abel, & 
Pope, 1994) and glycaemic control (Fisher et al., 2009; Skaff et al., 2009).  Similarly to 
depression, general life stressors are likely to increase vulnerability to the effects of diabetes-
specific stressors.  External stressors are likely to compound the effects of diabetes-specific 
distress on glycaemic control and emotional well-being (Fisher et al., 2009).  Indeed, 
relaxation and stress management training in diabetes patients has demonstrated producing 
significant positive effects on blood glucose control (Attari, Sartippour, Amini et al., 2006; 
Surwit, 2002) and mood (Stenstrom, Goth, Carlsson et al., 2003).  Given the inter-related 
effects of diabetes-specific and external stressors, diabetes self-management interventions 
should ideally utilise a holistic approach that targets the discussed psychological and 
emotional issues.
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1.3.4 Section Summary and Conclusions 
This section reported the high prevalence of dysphoria in people with Type 2 diabetes 
and the deleterious impacts on individuals’ physical and mental health that are linked to 
comorbid mood disorders.  Numerous empirical studies have investigated the differential 
effects of various types of emotional dysregulation, including depression, anxiety and 
diabetes-specific distress, in people with diabetes.  However, conventional intervention 
approaches would ideally aim to improve the identification and management of all types and 
severities of dysphoria in this population. 
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1.4 A Qualitative Overview of Patients’ Perspectives on Type 2 Diabetes Self-
Management 
 
The issue of diabetes treatment non-adherence is universal (Vermeire et al., 2005), 
with significant influences including personal beliefs, motivations, psychological strengths 
and weaknesses, and various external factors (Peyrot et al., 2005).  Once typically seen to 
affect the upper class due to over-indulgence in unhealthy foods and leading a leisurely 
lifestyle, Type 2 diabetes now more commonly affects the lower socioeconomic bracket of 
society.  This class typically experiences significant external barriers to effective disease self-
management which include financial difficulties making it difficult to afford mediations and 
healthy food, poor access to fitness facilities, and infrequent allied health support (IDF, 
2012b).  Further challenges for this group include educational limitations, which increase the 
risk of poor health literacy (Forbes, While, Griffiths, Ismail, & Heller, 2011), unemployment, 
reduced social support, and mental health issues (AIHW, 2012a); all of which are 
significantly associated with poor diabetes self-care and outcomes (Nam, Chesla, Stotts, 
Kroon, & Janson, 2011; Yamashita & Kart, 2011).      
Interpersonal barriers, including psychological issues (Adili, Larijani, & 
Haghighatpanah, 2006), health beliefs (Alderson, Foy, Glidewell, McLintock, & House, 
2012; Klok, Sulkers, Kaptein, Duiverman, & Brand, 2009), and diabetes-related attitudes and 
perceptions (Siminerio, 2008; Vermeire et al., 2007), can also impair adequate diabetes self-
care.  Qualitative research has revealed that Type 2 diabetes patients are commonly confused 
about the purpose of their prescribed treatment (Hayes, Bowman, Monahan, Marrero, & 
McHorney, 2006; Nair, Levine, Lohfeld, & Gerstein, 2007).  Patients’ health beliefs represent 
a further barrier to treatment adherence, and in particular underlie attitudes towards following 
prescribed medication regimes (Mann et al., 2009).  Additional, self-reported reasons for 
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medication non-adherence in Type 2 diabetes patients include their refusal to commence anti-
hyperglycaemic agents or insulin, and medication side-effects (Khan, Lasker, & Chowdhury, 
2011).  Fear of hypoglycaemia has also been shown to significantly undermine patients’ 
adherence to diabetes medications, and has an increasing effect as the treatment regime 
becomes more complex (UKPDS Group, 1998).  Weight gain is another deterrent to 
medication adherence which longitudinal research indicates is a typical consequence of 
sulfonylurea and insulin therapy (UKPDS Group, 1998).  A further issue is forgetting to take 
medications (Odegard & Gray, 2008).  Often these issues are overlapping in the same 
individual, and combined these factors present substantial difficulties for medication 
adherence. 
Patients’ perceived treatment burden is another factor that commonly affects 
adherence to pharmacological treatment (Cobden, Niessen, Barr, Rutten, & Redekop, 2010; 
Odegard & Capoccia, 2007; Vermeire, Van Royen, Coenen, Wens, & Denekens, 2003).  A 
systematic review of studies on medication adherence in patients with chronic illnesses found 
a negative relationship between Type 2 diabetes medication adherence and the number of 
medications in the treatment regimen (Penfornis, 2003), which is supported by other, 
diabetes-specific empirical studies (Rubin, 2005).  A study of 446 diabetes patients in the 
United States reported that many considered the burden of following a healthy diet to equate 
to that of taking anti-hyperglycaemic tablets.  Further, when weight loss was required, 
following a diet was equated to the burden of taking insulin (Vijan et al., 2005).  Wide 
variation in patients’ perceptions of diabetes treatment burden suggest it is important to 
explore the variety of experiences related to managing diabetes to understand the range of 
potential effects on treatment adherence.   
A further significant barrier to effective self-management is lifestyle inflexibility 
resulting from strict adherence to the Type 2 diabetes treatment regime.  A particular caveat 
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in this domain occurs when patients are unable to take medications on time or eat to routine.  
An international study that enrolled 123 people with Type 2 diabetes from four European 
countries and the United States found that difficulties with adhering to a routine in addition to 
problems with modifying alcohol intake and diet were common across countries (Frandsen & 
Kristensen, 2002).  Even after lifestyle changes were successfully implemented, patients 
typically resumed past patterns of behaviour in the long-term.  The presence of common risk 
factors such as overweight/ obesity (Mier, Medina, & Ory, 2007; Schultz, Sprague, Branen, 
& Lambeth, 2001; Wycherley et al., 2010) and physical comorbidities (Ahroni et al., 1994) 
presents further self-management limitations, particularly in terms of physical activity 
adherence.  Psychosocial resources have been shown to promote the maintenance of 
recommended lifestyle behaviours, which indicates that implementing social and systemic 
intervention can support patients in overcoming barriers to change (Barrera, MacKinnon, 
Strycker, & Toobert, 2008; Beverly, Miller, & Wray, 2008; Fisher et al., 2012; Kirk & Leese, 
2009). 
Furthermore, cultural affiliation can significantly impact on engagement in Type 2 
diabetes self-management.  This is particularly due to the impact of culture on the way that 
individuals make sense of Type 2 diabetes, which influences their approach to accepting and 
managing the condition (Khan et al., 2011).  Cultural minority groups are less likely to have 
the ability and skills necessary to undertake a prescribed treatment regimen (Nam et al., 
2011).  For example, in a U.S.-based study, American non-immigrant women reported using 
more complex self-management techniques compared with Slavic immigrant women, with 
differences in hypoglycaemia awareness and education having disadvantaged the Slavic 
women in their self-management efforts (Barko, Corbett, Allen, & Shultz, 2011).   
Individuals from ethnic minority groups have been found to experience less self-
perceived control over their Type 2 diabetes than those in major cultural groups due to their 
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generally poorer understanding of the condition and its management (Chlebowy, Hood, & 
LaJoie, 2010; Song, Lee, & Shim, 2010).  Furthermore, there is often a mismatch between the 
usual diet of ethnic patients and the dietary guidelines they are recommended (Kochinor, 
Stronks, Nicolaou, & Haafkens, 2011).  Frustration and emotional distress associated with 
failing to achieve treatment targets may be piqued in patients who also face pressure to adapt 
to a foreign lifestyle.  Overall, there is a range of precluding factors that sabotage adherence 
to the diabetes treatment regime and individuals’ holistic well-being, with cultural diversity 
often serving to exacerbate the inherent challenges.      
The doctor-patient relationship has demonstrated bearing a fundamental impact on 
adherence to the Type 2 diabetes treatment regime (Nam et al., 2011; Vermeire et al., 2007).  
Qualitative studies on patients’ perspectives on self-management have indicated that doctors 
provided insufficient information and/ or explanation of the diabetic treatment regime.  This 
resulted in confusion about putting treatment recommendations into practise, and 
subsequently treatment non-adherence (Vermeire et al., 2003).  Patients consequently used 
their own judgements to manage their diabetes, which often resulted in inadequate self-
management.  Another study indicated that patients who felt they had a poor understanding of 
required self-management tasks and their purposes reported experimenting with prescribed 
treatments to personally assess the risks and benefits (Nair et al., 2007).   
Furthermore, patients have reported that their doctors failed to acknowledge their 
difficulties with understanding diabetes and their self-management efforts (Bissell, May, & 
Noyce, 2004; Wellard, Rennie, & King, 2008).  Consequences may include treatment non-
adherence (Ciechanowski, Katon, Russo, & Walker, 2001; Schillinger, Bindman, Wang, 
Stewart, & Piette, 2004), and the augmentation of diabetes-related emotional difficulties.  
Accordingly, patients have reported valuing collaborative communication with their primary 
care physician, and that this tends to enhance their diabetes treatment adherence (Nagelkerk, 
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Reick, & Meengs, 2006; Schillinger et al., 2003).  Evidence from these studies indicates that 
improvements in understanding between primary care providers and people with diabetes are 
needed to limit the adverse consequences of current inadequacies on diabetes self-
management.  Overall, diabetes patients have reported their acceptance of physicians’ 
primarily task-oriented approach in consultations.  However, they indicated that physicians’ 
acknowledgement of their patients’ psychosocial and emotional challenges and incorporation 
of this into their communication with them would facilitate their self-management (Alberti, 
2002).   
Qualitative research into physicians’ perspectives on Type 2 diabetes self-
management has revealed that physicians were commonly attuned to patients’ difficulties 
with treatment adherence.  Physicians appeared to understand the difficulties associated with 
adhering to a complex treatment regime; issues with motivation to maintain diabetes self-care 
into the long-term; and the frequency and effects of emotional and psychological problems on 
diabetes self-care (Belle Brown et al., 2002).  General Practitioners (GPs) have reported 
experiencing problems with their Type 2 diabetes patients’ knowledge deficits regarding the 
condition and patients’ minimisation of the risk of diabetes complications.  Further, GPs have 
reported becoming frustrated when patients failed to meet targets for health behaviour and 
metabolic control (Wens, Vermeire, Royen, Sabbe, & Denekens, 2005).   
Further qualitative studies on physicians’ views of patients’ reluctance to initiate 
insulin therapy have revealed that physicians were generally unaware of patients’ common 
experience of fear about being on insulin and their diabetes progression (Ratanawongsa et al., 
2012; Tan et al., 2011).  In addition, patients’ perceptions of being a failure for needing 
insulin therapy (Tan et al., 2011) along with psychological insulin resistance, which refers to 
patients’ emotional and psychological difficulties accepting their need for insulin (Brod, 
Kongsø, Lessard, & Christensen, 2009), were commonly unrecognised by physicians in the 
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study.  Cultural diversity was seen by physicians to enhance typical barriers to insulin 
administration and adherence in general (Patel, Stone, Chauhan, Davies, & Khunti, 2012).   
Difficulties in Type 2 diabetes self-management stem from the effects of dynamic, 
interactive factors related to the patient, physician, and system (Belle Brown et al., 2002).  
The doctor-patient relationship significantly impacts on diabetes self-management, as the 
attitudes, beliefs and treatment decisions of physicians have been shown to elicit or 
accentuate barriers to appropriate self-care (Puder & Keller, 2003).  The phenomenon of 
clinical inertia, which relates to physicians forestalling the recommendation of particular 
treatments, is common in Type 2 diabetes patients, particularly with regards to insulin 
initiation (Suraci et al., 2012; Zafar, Davies, Azhar, & Khunti, 2010).  Physicians have 
reported making personalised treatment decisions for their patients based on factors including 
financial status, perceived likelihood of adherence, demographics, and the presence of 
diabetes complications (Grant et al., 2009).  Physicians are required to interpret patients’ 
psychosocial and psychological readiness for therapy in making these judgements, which 
patients may not clearly communicate (Nam, Chesla, Stotts, Kroon, & Janson, 2011).  
Globally, patients have reported that effects of the doctor-patient relationship exceed those of 
health system limitations on their self-management (Vermeire et al., 2007).   
Additionally, patients have reported that attempts by their physicians to motivate 
diabetes self-management were perceived as poorly construed and/ or purely unhelpful.  
Examples included the use of “shock tactics” to scare patients into improved self-care, 
placing pressure on patients to better self-manage, and threats to refer patients to hospital or 
increase their treatment intensity (Wens et al., 2005).  Further, some physicians have reported 
interpreting patients’ desire for autonomy as non-compliance (Matthews, Peden, & Rowles, 
2009).  A study that explored physicians’ and patients’ views on diabetes self-management 
revealed that both groups experienced self-blame when treatment targets were not achieved 
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(Beverly et al., 2012).  However, patients were uncertain about how their physicians felt, and 
both samples reported communication difficulties in the doctor-patient relationship.   
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1.4.1 Section Summary and Conclusions 
Overall, although miscommunication between patients and physicians has commonly 
been acknowledged, there remains a need for a better understanding of the dynamics of the 
patient-physician relationship.  Furthermore, the apparent divergence in the perspectives of 
patients and physicians indicates the need to explore the views of both to gain a 
comprehensive picture of self-management successes and shortcomings.  Therefore, 
interventions to complement physician care that are based on both patients’ and physicians’ 
accounts are most likely to meet the range of needs for additional Type 2 diabetes self-
management support.
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1.5 An Overview of Type 2 Diabetes Self-Management Interventions 
 
Chronic disease patients are required to implement consistent, long-term disease self-
management to achieve optimum well-being (Bodenheimer, Lorig, Holman, & Grumbach, 
2002), and Type 2 diabetes patients face the burden of implementing a multi-faceted 
treatment regime each day.  Concurrently, reports of people living with chronic diseases have 
indicated that they find maintaining effective self-management to be the most difficult aspect 
of living with a chronic disease (Harris et al., 2007).  Current Australian guidelines that 
specify standards of diabetes care recommend adhering to a self-care routine comprised of 
four major components that each influence glycaemic control (Colagiuri et al., 2009).   
Recommended components are associated with significant improvements in 
glycaemic control and other metabolic outcomes, and include regular participation in: blood 
glucose monitoring (Bond, 2006; IDF, 2009b; Liebreich, Plotnikoff, Courneya, & Boule, 
2009; Meigs et al., 2003), physical activity (Balducci et al., 2012; Iijima et al., 2012; 
Kadoglou et al., 2012; Richert, Webb, Morse, O'Toole, & Brownson, 2007; Sigal, Kenny, 
Wasserman, & Castaneda-Sceppa, 2004; Trenell, Hollingsworth, Lim, & Taylor, 2008; 
Zisser, Sueyoshi, Krigstein, Szigiato, & Riddell, 2012), healthy nutritional intake (Adam, 
Evans, & Koopmanschap, 2003; Al Mazroui et al., 2009; Barclay, Gilbertson, Marsh, & 
Smart, 2010; Dämon, Schätzer, Höfler, Tomasec, & Hoppichler, 2011; Josephine, Frans, & 
Warren, 2003), and medication adherence (Mazroui et al., 2009; Haynes, Ackloo, Sahota, 
McDonald Heather, & Yao, 2008; Lawrence, Allison, Chen, & Demand, 2008).  Results from 
randomised controlled lifestyle intervention studies with Type 2 diabetes patients have 
indicated that addressing these components is cost effective, at least partly due to reduced 
medication requirements (Redmon et al., 2010).  Further, economic cost-benefit analyses 
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conducted in 2010 revealed that the economic burden of diabetes will be significantly 
reduced in the U.S. within the next 20 years with significant improvements in Type 2 
diabetes self-management (Fitch, Iwasaki, & Pyenson, 2010).  Therefore, Type 2 diabetes 
self-management intervention entails numerous patient- and system-related advantages.    
1.5.1 Intervention Issues with Dysphoria and Type 2 Diabetes 
The extreme prevalence and impact of dysphoria in Type 2 diabetes patients has 
prompted the requirement of regular, ongoing symptom screening in order that adequate 
intervention be provided as early as possible (Fisher et al., 2008; Pelletier, Jethwani, Bello, 
Kvedar, & Grant, 2011; Pouwer, 2009).  Pharmacotherapy for depression and anxiety has 
demonstrated efficacy in improving affective symptoms.  However certain antidepressants 
cause hyperglycaemia [e.g. nortriptylene (Lustman, Griffith, Clouse et al., 1997)], whilst 
others have hypoglycaemic effects (Goodnick, Henry, & Buki, 1995), which may induce 
diabetes-related distress (Barnett et al., 2010).  Poor metabolic control may worsen dysphoria 
and reduce responses to pharmacotherapy for depression/anxiety (Lustman & Clouse, 2005).  
In addition, increasing patients’ treatment regime complexity inevitably exacerbates 
adherence issues (Ingersoll & Cohen, 2008).  Furthermore, over time the risk of dysphoria 
tends to increase with the complexity of the Type 2 diabetes treatment regimen (IDF, 2012c) 
and is more persistent and recurrent in people with than in those without diabetes (Lustman, 
Griffith, Freedland, & Clouse, 1997).  The bidirectional relationship between dysphoria and 
diabetes urges the need for early symptom intervention and ongoing support.      
A recent meta-analysis on the efficacy of various interventions for depression 
compared pharmacotherapy, psychotherapy and both approaches combined.  Moderate 
combined effect sizes were found for improvements in glycaemic control and depressive 
symptoms (van der Feltz-Cornelis et al., 2010).  Psychotherapy demonstrated the largest 
effect size, which may be reflective of its common incorporation of diabetes self-
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management intervention.  Collaborative care, comprising a stepped-care intervention 
combined with pharmacotherapy, was successful in reducing depressive symptoms but did 
not significantly improve glycaemic control.  Similarly, a systematic review that included 
three randomised controlled trials (RCTs) on depression and glycaemic control in people with 
Type 2 diabetes concluded that while CBT produced improvements in depressive symptoms, 
there were no improvements in glycaemia (Wang, Tsai, Chou, & Chen, 2008).   
A further systematic review on the effectiveness of combined depression and diabetes 
self-management interventions indicated that both diabetes and depression must be addressed 
in order to achieve optimum improvements in physiological and psychological outcomes 
(Wang, Tsai, Chou, & Chen, 2008).  However, a review of treatments for depression in 
people with diabetes indicated that no interventions focused on targeting both diabetes self-
management and dysphoria (Markowitz, Gonzalez, Wilkinson, & Safren, 2011).  Targeting 
both issues may be required to produce optimum impacts on glycaemic control and mood, 
and hence for the most positive long-term outcomes.   
 Physical activity interventions appear to offer a promising alternative solution to the 
shortcomings associated with pharmacotherapy for dysphoria.  Physical inactivity is linked to 
depressed mood in people with diabetes (Lysy, Da Costa, & Dasgupta, 2008), and regular 
exercise has demonstrated producing positive effects on depression (Aylin, Arzu, Sabri, 
Handan, & Ridvan, 2009), anxiety (Reddy et al., 2011) and self-efficacy (Netz, Wu, Becker, 
& Tenenbaum, 2005), as well as improving glycaemic control by its effects on glucose 
metabolism and insulin resistance (Cauza et al., 2005; Thomas, Elliott, & Naughton, 2006).  
Physical activity may also promote increased circulation to small and large blood vessels and 
thereby reduce the risk of diabetes complications (Praet & van Loon, 2009).  Further, 
physical activity reduces common risk factors for both dysphoria and Type 2 diabetes, which 
include overweight/obesity (Ackermann, Finch, Brizendine, Zhou, & Marrero, 2008; Hills et 
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al., 2010) and cardiovascular risk (Djousse, Driver, & Gaziano, 2009; Hordern et al., 2008; 
Marwick et al., 2009; Warburton, Nicol, & Bredin, 2006).   
Although there are associations between poor nutritional intake and dysphoria, there 
is no known evidence on the effects of specific dietary interventions on dysphoria in people 
with Type 2 diabetes (ABS 2009; Bell et al., 2012).  Multi-faceted diabetes self-management 
interventions are commonly applied, which make it difficult to identify the independent 
effects of the intervention’s individual components. 
1.5.2 Non-Web-Based Type 2 Diabetes Self-Management Interventions 
A wide range of interventions aimed to improve Type 2 diabetes self-management 
and clinical, physical, and quality of life outcomes have been trialled.  Interventions have 
ranged from targeting a single aspect of diabetes self-management (e.g. Hudon et al., 2008) 
(Kim, 2005) to multi-faceted treatments that targeted lifestyle behaviours and health routine 
adherence (Bird et al., 2010).  
Diabetes education is widely recognised as an essential component of diabetes self-
management in Australian and global guidelines (Colagiuri, Girgis, Eigenmann, Gomez, & 
Griffiths, 2009; IDF, 2012a).  Patients must have the information to enable their proficiency 
in skill development for effective self-management (Bodenheimer et al., 2002; Fisher, Kohut, 
Schachner, & Stenger, 2011; Hicks, 2010).  Diabetes education has demonstrated 
empowering patients by facilitating their understanding of the importance of adequate self-
management and methods to achieve it (Anderson et al., 1995; Williams et al., 2004).  
However, presenting information about risk factors (Edwards et al., 2006), clinical 
parameters and diabetes treatment targets without concomitant behavioural intervention has 
shown to be ineffective (Stark Casagrande et al., 2012).  Diabetes education alone has rarely 
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produced significant improvements in diabetes self-care (Duke, Colagiuri, & Colagiuri, 2009; 
Glasgow & Osteen, 1992; Verheijden et al., 2004).   
Where diabetes education has produced significant improvements on clinical 
outcomes, structured education programs such as the Diabetes X-PERT program have 
typically been used.  Diabetes X-PERT was a patient-centred, group program that 
incorporated empowerment principles and discovery learning (Deakin & Whitham, 2009).  
When the effects of participating in six, 2-hour group sessions of diabetes self-management 
education were compared with usual care, significant improvements were found on HbA1c, 
weight, cholesterol, self-empowerment, foot care, and dietary intake in the intervention 
group.  The inclusion of ongoing guidance and peer support and the structured nature of this 
intervention probably contributed to these effects.  There is substantial evidence that supports 
the promotion of self-determination in people with Type 2 diabetes to facilitate self-
management (Anderson et al., 1995; Deakin, Cade, Williams, & Greenwood, 2003; Howorka 
et al., 2000; Williams et al., 2004).  Hence, a number of current interventions incorporate 
interactive features to improve users’ sense of autonomy and responsibility for self-care 
(Couper, 1996; Zoffmann & Lauritzen, 2006).   
Psychological and emotional support is a further fundamental component of diabetes 
self-management intervention (Fisher, Delamater, Bertelson, & Kirkley, 1982).  The 
interactive effects of psychological, emotional and behavioural factors on disease self-
management must be considered when designing treatment interventions and particularly 
when targeting populations at increased risk for dysphoria (Fisher, Thorpe, McEvoy 
DeVellis, & DeVellis, 2007).  Accordingly, whilst behavioural interventions have a positive 
impact on diabetic outcomes, physical activity and nutrition (Concha et al., 2009; Fisher et 
al., 2007; Ismail, Winkley, & Babe-Hesketh, 2004), they are unlikely to remediate 
psychological and emotional issues.  A systematic review of behavioural medicine 
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interventions in diabetes found that they produced significant improvements in glycaemic 
control, diabetes distress, self-efficacy, self-management, proactive coping, and 
psychological symptoms (Plack, Herpertz, & Petrak, 2010).  Seven of the 10 RCTs in the 
review included cognitive-emotive components, which included motivational interviewing, 
self-efficacy skills training, and coping skills training.  A further five of the 15 included 
studies were categorised as purely “psychological interventions”, which demonstrates the 
significance of addressing psychological/ emotional factors in self-management 
interventions, even if they are primarily behaviourally-based.   
Further, even physical activity interventions that have demonstrated short-term 
success in improving emotional regulation and diabetes self-care behaviours (Colley et al., 
2008; Neumann & Frasch, 2009), failed to maintain effects into the long-term without the 
inclusion of psychological or emotional support.  Motivation tends to wane over time as 
depressive symptoms increase, in which case physical activity participation is unlikely.  In 
these cases, patients would potentially be left without required mood support or intervention.  
Multi-faceted lifestyle interventions aimed to improve behavioural self-management 
and glycaemia in people with Type 2 diabetes have demonstrated efficacy (Eakin et al., 2010; 
Toobert et al., 2003).  The Mediterranean Lifestyle Program trial, which involved a weekend 
retreat followed by 24 months of regular meetings for post-menopausal women with Type 2 
diabetes, has had the longest-lasting positive effects on lifestyle behaviours to date.  
Improvements in nutrition and stress management lasted 5 years post-intervention and 
physical activity changes lasted for up to 1 year (Toobert, Strycker, Barrera, & Glasgow, 
2010).  Difficulties providing long-term, ongoing, cost-effective lifestyle interventions have 
resulted in the use of advances in telecommunications technology, including mobile phones, 
smart phones, tablets and the internet.   
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In the past decade telehealth services have increasingly been used as a means of 
lifestyle intervention delivery, including for people with diabetes (Earle, Istepanian, Zitouni, 
Sungoor, & Tang, 2010).  Telehealth interventions have shown cost-effectiveness (Noel, 
Vogel, Erdos, Cornwall, & Levin, 2004) and can assist with reducing strains on the health 
care system while offering regular, convenient and ongoing delivery.  Popular interventions 
delivered by phone have included motivational counselling by trained health coaches or 
nurses  (Eakin et al., 2010; Orr et al., 2006; Sacco, Malone, Morrison, Friedman, & Wells, 
2009), peer support telephone calls (Dale, Caramlau, Lindenmeyer, & Williams, 2008) and 
m-health (mobile phone applications) that provide feedback on goal attainment and/or 
reminders via short message service (SMS) texts (de Jongh, Gurol-Urganci, Vodopivec-
Jamsek, Car, & Atun, 2008; Morrow, Menard, Ridolfo, & Leirer, 2003; Upadhyay, Kokalj 
Kokot, Kokalj Kokot, Car, & Svab, 2007; Vodopivec-Jamsek, de Jongh, Gurol-Urganci, 
Atun, & Car, 2008).   
Studies have demonstrated that these interventions can improve diabetes self-care 
including healthcare appointment attendance (Morrow et al., 2003), exercise and foot care, 
diet, depression symptoms (Sacco et al., 2009), and HbA1c testing adherence (Orr et al., 
2006).  While telehealth can offer appropriate short-term intervention delivery, however, it 
requires the ongoing involvement of numerous trained staff, particularly in the case of 
nationwide implementation.  Additionally, patients may experience less autonomy in their 
decision-making and/or a reduced sense of control in the context of continuous telephone 
coaching that provides frequent follow-ups.  Rapid developments in web-based programs and 
applications have resulted in recent empirical attention on the web as an alternative means of 
intervention delivery.   
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1.5.3 Web-Based Diabetes Self-Management Interventions 
Evaluations of web-based interventions have demonstrated the effectiveness of a web-
based modality for Type 2 diabetes self-management intervention delivery (Ramadas, Quek, 
Chan, & Oldenburg, 2011).  A surge has occurred in the development and evaluation of web-
based diabetes self-management interventions particularly during the past decade, since 
McKay and colleagues’ (2002) randomised trial of the Diabetes Network (D-Net) self-
management and peer support intervention (McKay, Glasgow, Feil, Boles, & Barrera Jr, 
2002).  Nonetheless, further empirical studies on web-based chronic disease self-management 
programs are required, as inter-study heterogeneity has made it difficult to draw overall 
conclusions about their efficacy (Andersson, Ljotsson, & Weise, 2011), particularly given 
that intervention studies in this area to date are relatively short-term and have failed to 
investigate effects on  a range of emotional, psychological, and self-care outcomes.    
Australia has one of the largest proportions of computer and internet access per 
person in the world.  In 2008-09, 72% of Australian households had internet access, with its 
availability in regional areas rapidly improving (ABS, 2009b).  Online diabetes support 
programs may be more cost-effective (Brownson, Hoerger, Fisher, & Kilpatrick, 2009) than 
structured face-to-face and telehealth self-management programs, which incur substantial 
financial and time costs (Istepanian et al., 2009).  Furthermore, online support programs offer 
broader and more frequent long-term accessibility than face-to-face interventions, and thus 
are reasonably well suited to supporting individuals in rural and regional locations (Glasgow, 
Vogt, & Boles, 1999).  Finally, the regular, mostly reliable, ongoing and 24-hour accessible 
support that is possible via the web may be ideal for meeting the needs of people with Type 2 
diabetes (Fisher, Brownson, O'Toole, & Anwuri, 2007).  In this sense, the web may 
supersede the challenges that are inherent in other methods of self-management intervention 
delivery (Norris, Lau, Smith, Schmid, & Engelgau, 2002). 
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  Pilot trials of web-based diabetes self-management programs that included 
informational, educational, and/or social support have reported finding high user acceptance 
and usability (Armstrong & Powell, 2008; Eyombo, 2009; McTigue et al., 2009; Pagliari et 
al., 2003; Schroter et al., 2011; Thomas & Elliott, 2009).  In addition, novice computer users 
(McKay et al., 2002) as well as seniors (≥ 60 years; Wang, Balamurugan, Biddle, & Rollins, 
2011; Wantland, Portillo, Holzemer, Slaughter, & McGhee, 2004) have demonstrated their 
willingness to use a web-based program to support their diabetes self-management.  
Furthermore, web-based programs have shown to be effective in improving clinical and 
behavioural self-management outcomes in people with diabetes.  An example is a recent 
review of computerised patient education in chronic disease patients in which the 
independent effects of included interventions were specified.  Results indicated that online 
interactive interventions that were focused solely on educational and/or instructional content 
significantly improved daily blood glucose levels among participants with diabetes.  The 
authors concluded that face-to-face physician consultations should be complemented with 
interactive, online support to improve patient outcomes (Verhoeven, Tanja-Dijkstra, Nijland, 
Eysenbach, & van Gemert-Pijnen, 2010).  An online nutrition information program 
containing cooking ideas, instructions, and facts about healthy eating produced significant 
improvements in knowledge, health beliefs & self-reported eating behaviours in a middle 
aged cohort with Type 2 diabetes (Ritzwoller, Toobert, Sukhanova, & Glasgow, 2006).  As 
knowledge can heighten self-efficacy (Bandura, 1990), such an intervention may provide the 
impetus for initial mastery experiences related to nutrition self-care, which may be 
maintained with ongoing socio-cognitive support.  
Another study evaluated the implementation of a 10-week physical activity impact 
trial.  Experimental conditions included a condition that received a web-based, skill-building 
intervention; a condition that received exercise instruction in addition to three exercise labs 
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each week, and a control group that received only physical activity instructions.  Results 
indicated that significant improvements in self-regulation, vigorous activity, and outcome 
expectancies were equivalent for the first two (intervention) conditions, but no significant 
improvements were found in the control condition (Gougeon, Carrington, & Field, 2006).  
These results indicated that participation in an online SCT-based intervention can produce as 
much cognitive motivation as attending regular physical activity training sessions, and further 
that physical activity information alone has no such benefits.  Health information is most 
likely to be insufficient for the prevention or remediation of diabetes-related self-
management and affective challenges that patients commonly experience in the long-term 
(Fisher et al., 2007).  Rather, supplementing diabetes education with coping skills training 
and providing behavioural self-management enhancement strategies can have ongoing effects 
and increase user retention (Unick et al., 2011).  This issue is important, since drop-out rates 
for minimal therapist-assisted online psychological support programs can be as high as 82%, 
and have a weighted average of 31% (Melville, Casey, & Kavanagh, 2010).  
Web-based diabetes self-management support programs based on social cognitive 
theory (SCT) and cognitive behavioural therapy (CBT) have demonstrated that improvements 
in clinical outcomes can be reasonably well maintained.  A 2-year trial of a web-based 
intervention that featured SCT-based methods to modify illness attributions in seniors with 
diabetes showed that improvements in HbA1c level, weight and cholesterol level were 
maintained at 6 months post-intervention (Wantland et al., 2004).  Lorig and colleagues 
(2010) trialled a web-based, therapist-assisted intervention for Type 2 diabetes self-
management that was based on CBT  techniques to support diabetes education, skill building, 
and support for stress (Lorig et al., 2010).  The group that received e-mail feedback and 
reinforcement did not show differential clinical or behavioural improvements compared with 
the group that received the web-based program only.  Significant improvements in self-
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efficacy and patient activation were found in both groups at 6 months post-baseline while a 
control group that received neutral health information showed no significant changes in any 
outcome (Lorig et al., 2010).  Failure to produce or maintain significant improvements in 
clinical parameters including HbA1c level from directly post-intervention to 12 months post-
intervention indicated difficulties in producing long-term maintenance effects via web-based 
intervention.  Considering that web-based intervention delivery enables long-term 
implementation, further exploration of its propensity to do so warrants further exploration.   
A randomised trial of the effects of combined therapist and computer-based nutrition 
support for diabetes patients revealed promising results for dietary intake (Stevens, Glasgow, 
Toobert, Karanja, & Smith, 2003).  In the trial, 616 women were randomised to one of two 
experimental conditions.  The intervention condition received a moderate-intensity nutrition 
intervention that involved two, 45-minute counselling sessions and 20 minutes using an 
interactive, computer-based intervention followed by two, brief follow-up phone calls.  The 
control group received information that was unrelated to nutrition.  The intervention 
condition demonstrated significant improvements in fat, fruit and vegetable intake that were 
maintained at 1 year post-intervention (Stevens et al., 2003).  These studies indicated that 
web-based programs that include health education materials and skills training with ongoing 
support can significantly improve diabetes self-management.   
Social support is integral to effective diabetes self-management (Albright et al., 2001; 
Fisher et al., 2012; Fisher et al., 1998; Hunt et al., 2012; Weinger, 2007) and emotional and 
affective well-being (Kokoszka, Pouwer, Jodko, Radzio, MuÄ‡ko, et al., 2009; Snoek et al., 
2011).  Prior research indicated that people with diabetes reported that the inclusion of a web-
based community (Oh & Lee, 2012), peer support forum (Barrera, Glasgow, McKay, Boles, 
& Feil, 2002), or web-based interactions with a nurse (Bond, Burr, Wolf, & Feldt, 2010) in a 
web-based support program increased their perceived social support.  Peer social support via 
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online interventions has been included in recent web-based programs and typically involves 
the use of chat rooms, blogs, and forums (Lorig et al., 2010).   
A recent Korean study tested the effects of computer-mediated social support in web-
based communities on patient empowerment and doctor-patient communication (Oh & Lee, 
2012).  Following their interaction within the web-based community, patients reported 
significantly increased perceived social support from its members.  In addition, they reported 
an increased sense of empowerment, which they felt assisted with improvements in doctor-
patient communication.  Hence, improvements in social support and patient empowerment 
that are enhanced by web-based programs may have flow-on effects to the doctor-patient 
relationship.  However, social support that is viewed by patients as being inappropriate to 
their needs may exacerbate depression (Bond et al., 2006).  Web-based forums may also 
expose individuals to inaccurate health-related information, which necessitates constant 
monitoring by administrators.  Providing tools that motivate patients to increase their social 
support networks outside of the web program may be an effective alternative.   
No known trials to date have investigated the effects of web-based interventions on 
users’ development of and access to social support networks in the real world.  The 
importance of social support to physical and psychological wellbeing, particularly in chronic 
disease patients, indicates the requirement for trials that investigate this possibility.  Evidence 
of positive effects and the best way to go about implementing this feature would inform the 
incorporation of social support enhancement into future interventions (Toobert et al., 2010). 
1.5.4 Web-Based Diabetes and Dysphoria Interventions 
 Wide-spread acknowledgement of the need to address psychological and emotional 
issues in diabetes self-management interventions has prompted a rise in the number of 
interventions that include emotional support components.  Web-based treatments for 
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depression and anxiety have demonstrated producing significant improvements in symptoms, 
including in patients with diabetes (Andersson et al., 2005; Meeuwissen, Holleman, de Jong, 
Nuyen, & Cim, 2011).  In particular, web-delivered CBT has demonstrated equivalent 
efficacy to face-to-face CBT in treating depression (Hedman, Ljótsson, & Lindefors, 2012).  
Affective symptom severity has been shown not to modify the effectiveness of web-based 
CBT support in diabetes patients (van Bastelaar et al., 2012), which indicates that this form of 
intervention may be suitable to treat symptoms on a long-term basis.  Web-based intervention 
delivery has also demonstrated appropriateness for addressing diabetes-specific and mood-
related issues, and has shown high user acceptability in these contexts (van Bastelaar, 
Cuijpers, Pouwer, Riper, & Snoek, 2011).  
 In the Netherlands, a minimal-guidance, web-based CBT intervention both for people 
with type 1 and Type 2 diabetes and depression was adapted from a CBT intervention for 
depression (“coping with depression course”) by incorporating diabetes-specific topics (van 
Bastelaar et al., 2011).  The program included a mood self-monitoring tool and participants 
were encouraged to record their blood glucose levels to note any relationship between blood 
glucose control and mood.  There was also an online library from which participants could 
print out texts to create their own compilation of relevant materials.  The program provided a 
structured sequence of eight, weekly lessons that required the completion of homework tasks 
which involved watching brief videos of people living with diabetes.  Homework was 
reviewed by a specially trained “coach,” and automated email reminders were sent if 
participants failed to submit homework tasks within the week.  Following a 2-week period, 
participants received an email advising them that failure to submit homework within the 
following week would result in being regarded as having dropped out of the trial.  An RCT 
with a sample of 255 (n= 125 intervention; n= 130 wait-list control) indicated that at 1 month 
post-baseline there were significant improvements in the primary outcome of depressive 
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symptoms.  However, no statistically significant improvement was found for HbA1c level 
(van Bastelaar, Pouwer, Cuijpers, Riper, & Snoek, 2011). 
 A further RCT of a web-delivered, CBT-based diabetes self-management and 
depression intervention (nullDiabetergestemd.nlnull; DbG) is currently being implemented in 
the Netherlands (van Vugt, 2012).  This program also offers participants guided self-help, and 
preliminary implementation trial results indicated that patients reported satisfaction with the 
program’s availability and willingness to self-refer to it.  However, health professionals 
reported that it was important for professionals to refer patients to the program and also of 
their awareness of patients’ participation in the program.  
 A 6-month pilot RCT of a web-based program (mydiabetesliving.com) that is aimed 
to provide Type 2 diabetes self-management and mood intervention is in progress in Bristol, 
the UK (McKenzie, Montgomery, Bennert, Kessler, & Gregor, 2012).  Initially, the 
psychological needs of people with Type 2 diabetes were explored using qualitative focus 
groups and a design workshop.  The workshop revealed a theme that represented a complex 
relationship between patients’ objective physical body and how they experienced it 
subjectively.  Further, participants reported that they valued the anonymity provided by web-
based support.  Program development was built upon interview data.  As the trial is currently 
underway, data analyses remain in progress. 
 Empirical research on web-based interventions aimed to target both Type 2 diabetes 
self-management and psychological/ emotional health is currently limited.  Therefore, 
information about the efficacy of these interventions, their practicality for treating emotional 
issues, and the processes involved in their development and evaluation, are required.        
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1.5.5 Empirical Considerations in Developing Web-based Interventions 
Increasing developments in the area of electronic medical records to facilitate chronic 
disease management by providers and share health information with patients have prompted 
trials of their effectiveness.  In particular, trials of online interactive health application 
(IHCA) with health care provider interfaces for people with diabetes have yielded positive 
results in terms of their effectiveness and acceptability (Quinn et al., 2008; Venmans, Gorter, 
Hak, & Rutten, 2008).  A systematic review that included 24 studies on IHCAs for people 
with chronic diseases indicated that the applications significantly improved knowledge, social 
support, clinical and continuous behavioural outcomes, and positive influences on self-
efficacy (Murray, Burns, See Tai, Lai, & Nazareth, 2005).  Trials of patient portals have 
indicated that increasing patients’ awareness of their clinical status can motivate improved 
self-management.  However, in light of the evidence presented in Chapter 4 regarding the 
importance of the doctor-patient relationship to self-care, the increased contact with health 
care providers that these interventions involves is likely to contribute to their efficacy.  This 
indicates that integrating web-based diabetes management support programs into general 
practice is likely to be beneficial.    
Intervention complexity has been a source of debate in chronic disease self-
management.  A review of RCTs of interventions aimed to increase medication adherence in 
people with diabetes revealed that complex interventions produced the greatest long-term 
effects in diabetes self-management adherence and treatment outcomes (Haynes et al., 2008).  
Specifically, these interventions featured combinations of information, reminders, self-
monitoring, reinforcement, counselling, and family improvements.  It is plausible that an 
approach encompassing complex interrelationships between individual, psychosocial and 
environmental factors involved in Type 2 diabetes self-management would optimise efficacy.  
Consistent with this idea, Xu and colleagues (2008) recommended that diabetes self-
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management interventions be designed to influence the personal factors of knowledge, self-
efficacy and beliefs, as well as interpersonal areas of support for family members, and 
patient-provider communication skills (Xu, Toobert, Savage, Pan, & Whitmer, 2008).   
Alternatively, there is evidence that simple, low intensity approaches are efficacious 
(Glasgow et al., 2006).  In fact, comparisons between low- and high- intensity interventions 
have indicated that the two approaches have equivalent efficacy (Hansen et al., 2009).  
Furthermore, it is unclear whether adding components such as peer support (Glasgow, Boles, 
McKay, Feil, & Barrera, 2003) and/ or reinforcement e-mails for achieving self-care goals 
(Lorig et al., 2010) produces additional benefits for study outcomes over the effects of a web-
based intervention alone.   
Overwhelming people with multiple task demands may increase their risk of 
depression (Odegard & Capoccia, 2007).  Patients with Type 2 diabetes have commonly 
reported feeling that their treatment regimens are already onerous (Bailey & Kodack, 2011).  
Further increases to the treatment burden are likely to undermine treatment effects and 
increase participant attrition.  Aiming to improve one or two target behaviours may actually 
have a snowball effect on other behaviours, either by setting the occasion for implementing 
the new behaviours, or by bringing the individual into contact with influences that encourage 
behaviour change (Baer et al. 1876, as cited in Fisher et al. 1982).  Therefore, while using a 
multi-faceted approach to diabetes self-management intervention may seem logical, 
minimally invasive or low intensity interventions may offer similar benefits with the benefit 
of minimising participant burden. 
A further uncertainty regarding web-based intervention design is whether an 
individualised or standardised treatment approach should be used.  In a recent systematic 
review on the efficacy of personally tailored, web-based chronic disease self-management 
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interventions, tailored interventions were shown to be no more efficacious than the 
standardised ones (Radhakrishnan, 2012).  A standardised approach that offers users the 
opportunity to address personalised issues has potential to be an efficacious, acceptable and 
cost-effective option.
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1.5.6 Section Summary and Conclusions 
Overall, evidence on the efficacy of traditional treatment for Type 2 diabetes self-
management and dysphoria (e.g. psychotherapy, diabetes education, and self-management 
programs) remains mixed.  This uncertainty is congruous in the technological intervention 
arena, and particularly in the case of web-based interventions.  Further research is needed to 
illuminate the effects of web-based interventions, which have the potential to maximise 
outreach, accessibility and ongoing provision of support, while minimising costs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
 
 
1.6. Social Cognitive Theory as a Theoretical Foundation for the OnTrack Diabetes 
Project. 
 
Individuals do not exist in a vacuum, but rather are influenced and exert influence 
upon the social and ecological environments in which they exist.  Various theories focus 
primarily on interpersonal factors as determinants of chronic disease and behavioural self-
management in general (Ajzen, 1991; Ajzen & Fishbein, 1980).  However, evidence that 
wider ecological, psychosocial and personal influences have significant roles in health 
behaviours (Fisher et al., 2005; Harris, 2003; Peyrot et al., 2005) warrants taking a broader 
perspective of chronic disease self-management.  In particular, Type 2 diabetes has 
multifaceted implications for individuals’ lifestyles and social relationships (Akimoto et al., 
2004; Albright et al., 2001; Beverly et al., 2008), and environmental influences can derail 
self-management efforts (Barrera et al., 2008; De Greef, Van Dyck, Deforche, & De 
Bourdeaudhuij, 2011).  A holistic approach that encompasses these realities was considered 
to be most suited to this program of research.   
Social Cognitive Theory (SCT; Bandura, 1977) takes a socio-ecological approach to 
human behaviour that accounts for the complex, interactive nature of environmental, 
intrapersonal and interpersonal processes (Bandura, 1986).  SCT acknowledges the 
instrumental role of systemic and psychosocial interactions as potential facilitators and 
barriers to positive behavioural enactment, including in relation to health behaviours 
(Bandura, 2004b).  SCT provides an appropriate model for conceptualising issues involved in 
diabetes self-management, and is well supported by empirical research as an effective 
theoretical basis upon which to establish chronic disease self-management interventions 
(Dunn, Andersen, & Jakicic, 1998; Liebreich et al., 2009; Plotnikoff, Lippke, Courneya, 
Birkett, & Sigal, 2008; Strychar, Elisha, & Schmitz, 2012).  Therefore, SCT is the principle 
theoretical underpinning of this program of research.  The principle of patient empowerment 
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is seen as a potential facilitator of non-invasive disease self-management and improved 
quality of life, and hence this aspect of the empowerment model was also included. 
1.6.1 Social Cognitive Theory 
SCT is based on a model of triadic reciprocal determinism (Bandura, 1977), in which 
one’s behaviour, interpersonal factors including cognition, affect and biological processes, 
and environmental influences operate in dynamic, mutually interactive relationships.  SCT 
understands human functioning from an agentic perspective, wherein humans are purported 
to be both the products and the producers of their own environments (Bandura, 1989).  The 
uniqueness of humans is in their ability for self-reflective action, in which thoughts are acted 
upon, and reflection of the outcomes is then performed.  This process assists individuals to 
determine their thought accuracy by cognitive comparisons of the expected and actual 
outcomes (Bandura, 1986).  Hence, humans are denoted as proactive creators of their 
environments, rather than simply as exhibiting behavioural reactions in response to stimuli.  
SCT conceives of behaviour as a bidirectional, interactive determinant rather than as exerting 
a unidirectional influence on outcomes, or as solely produced from cognitive determinants.  
This conceptualisation of behaviour differentiates SCT from other health-related theories that 
refer to behaviour as the culmination of mental processes.   
SCT proposes that humans have a range of innate capabilities that assist in shaping 
their behaviour and choice of environment.  Forethought, or the ability for cognitive 
guidance, involves cognitively representing the predicted consequences of intended actions.  
These representations then serve the basis for deciding about whether or not to enact an 
intended behaviour (Bandura, 1986).  Self-reflection involves considering alternative courses 
of action, which involves weighing up the costs and benefits in terms of predicted 
consequences, and judging one’s own capabilities to perform the actions.  The potential for 
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differences between predicted and actual outcomes that result from environmental 
uncertainties exposes individuals to the risk of experiencing undesirable consequences.   
Self-reflective capability is a potential source of human motivation, as the anticipatory 
cognitive conceptualisation that guides intended actions can increase motivation for their 
performance (Bandura, 1986).  It is essential that forethought occurs close in timing to the 
behavioural event, as distantly temporal goals do not tend to produce current motivation.  
However, cognitive representations of short-term events can motivate current behaviour or 
self-regulation (Bandura, 1988).  This concept is referred to as the future- or expanded-time 
perspective, and is an important aspect of human survival, as it enables individuals to base 
their actions upon considerations of the longer-term consequences. 
Self-reflection is also purposeful in enabling associations to be made between actions 
and their outcomes, which is necessary for expected outcomes to have any self-regulatory or 
motivational function.  SCT proposes that a process of verification of thought accuracy forms 
the basis for guiding future actions (Bandura, 1977).  Enactive verification involves 
individuals directly experiencing the outcomes of their actions.  Vicarious verification 
involves observing the effects that someone else’s actions produce.  Persuasory verification 
entails using others’ judgements to come to conclusions about the accuracy of one’s thoughts; 
and logical verification involves using cognitive rules of self-reference to extract further 
knowledge from what is already known (Bandura, 1986).  In combination with its 
interactions with other capabilities in the self-system the process of self-reflection enables 
individuals to plan desired courses of action, set goals, and self-motivate.   
Self-regulation is based on the practice of forethought, which it translates into 
incentives and cognitive guidance to implement action.  Humans are considered to actively 
process and transform situations rather than simply to form reactions to them (Bandura, 
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1978).  Behavioural self-regulation involves setting personal incentives or goals; using self-
regulation to guide this process before taking action.  To do so, it is necessary that people 
have knowledge about what they are doing, and regularly self-observe and evaluate their 
behaviour according to internal personal standards.  Motivation, affect, and behaviour are 
essentially governed by these internal standards and evaluative self-reactions.  Therefore, 
goal-setting and self-monitoring are integral components of this process (Bandura, 1978).  
However, individuals must selectively activate the process of self-evaluation, and this 
tendency is subject to a range of situational influences (Bandura, 1978) that may instead 
result in self-evaluative disengagement.  For example, conceptions formed during self-
regulatory processes are in part the result of direct or socially mediated environmental 
transactions, which emphasises that two-way causal processes are implicated in the 
relationship between thought and action.  Consequently, social and environmental 
determinants are presented as possible caveats or enablers to both motivation and the 
performance of intended behaviours as a function of their interdependent effects with 
personal factors, including self-referent thoughts (Bandura, 1986).  However, through its 
deterministic effects on action, self-influence enables humans some freedom to act on their 
self-generated thoughts, which is the essence of self-regulation. 
Self-referent thoughts are critical to behavioural self-regulation.  SCT holds that the 
central and most pervasive of these thoughts is self-efficacy, which is defined as the belief in 
one’s capabilities to take control of circumstances that affect their life, including in their 
ability to implement desired courses of action (Bandura, 1977).  Belief in one’s personal 
capability to produce desired results is argued to be fundamental to the optimisation of 
performance attainments.  Rather than serving as an incentive, self-efficacy is conceptualised 
as a foundational constituent of personal achievements. 
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High self-efficacy is proposed to be an essential component of human 
accomplishment and wellbeing (Bandura, 1988).  Self-efficacy strongly influences the 
thoughts, feelings, and actions of individuals and concurrently, their self-motivation.  It has 
an essential role in the decisions that individuals make about how to act, how much effort 
they should invest in tasks, and how long they will endure in their performance before giving 
up in the face of challenges.  Rather than being a pervasive and unchanging trait, self-efficacy 
is characterised by situation and time specificity (Bandura, 1989) — that is, it varies across 
different occasions and contexts. This characteristic offers a potential for improvement via 
targeted intervention.  SCT acknowledges that knowledge and performance skills are also 
essential to successful performance accomplishments.  However, self-efficacy influences 
whether individuals make effective use of their skills (Bandura, 1998).   
SCT outlines four principal sources of information that influence the development and 
maintenance of self-efficacy (Bandura, 1977).  The first is mastery experiences, which are the 
achievement of desired performance accomplishments, or goals.  Experiencing success in 
one’s goal pursuit increases mastery expectations, but repeated failures typically lower them.  
However, repeated successes can reinforce efficacy strength to an extent that persistence in 
one’s pursuit is maintained even when occasional failures occur, and both self-efficacy and 
later persistence can be strengthened if determined and sustained effort results in eventual 
success.  Although self-efficacy tends to be context-specific, enhanced self-efficacy can 
generalise to other situations in which self-doubts resulted in preoccupation with personal 
inadequacies (Bandura, 1977), which suggests the potential for a flow-on effect of self-
efficacy enhancements in one area of diabetes self-care to other self-care areas.    
The second source of self-efficacy is vicarious experience, which involves making 
inferences from observations of other individuals’ behaviour to form self-referent symbolic 
representations (Bandura, 1977).  These representations involve extracting information about 
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ways to obtain desired outcomes (and thereby, gain confidence that they can be achieved) by 
observing others.  In this way, humans are able to learn from the experiences of others in 
deciding which course of action to take.  This is one way in which SCT accounts for the 
effects of individuals’ social milieu on their behaviour (Bandura, 1977).   
Verbal persuasion represents the third principal source of self-efficacy proposed in 
SCT, and refers to process by which people are persuaded to believe in their capabilities to 
have control over and/ or to cope with difficult situations (Bandura, 1977).  A number of 
factors, including personal beliefs and perceived trustworthiness of the source, can impinge 
on the success of this method in increasing self-efficacy, and it is not as powerful a 
contributor to self-efficacy as are experienced performance accomplishments.  Negative 
experiences such as failures easily overturn mastery expectations that are based on verbal 
persuasion.  However, when situations are arranged to facilitate success, persuasion that one 
has the capability to overcome performance challenges can be effective (Bandura, 1986).  
Many behavioural self-management interventions, including psychotherapy, incorporate 
verbal persuasion:  SCT predicts that attention to the potential vulnerability of this approach 
is needed, for it to have strong and lasting impact. .  
The fourth source of self-efficacy is the person’s physiological state, including their 
level of fatigue or other physiological need, and their emotional state.  Appraisals of 
physiological arousal are used to inform judgements about self-perceived control of 
potentially aversive outcomes (Bandura, 1977).  High arousal characteristically results in 
reduced performance attainments, evoking awareness of deficits and self-doubts about one’s 
coping abilities (Bandura, 1989; Kavanagh & Bower, 1985).  Interventions that promote 
relaxation and increasing self-perceived ability to exercise control over potential threats may 
increase reduce the risk of avoiding or withdrawing from challenging situations, and foster 
effective coping.           
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Self-efficacy is centrally influential to the cognitive formulation of anticipatory 
scenarios.  High self-efficacy is associated with the production of success scenarios that 
provide positive cognitive guidance for behavioural implementation and the cognitive 
envisagement of positive solutions to potential obstacles to success.  Low self-efficacy is 
linked to the anticipation and visualisation of failure scenarios and preoccupation with 
potential pessimistic outcomes, which tends to limit motivation and subsequently reduce 
performance attainments (Bandura, 1989).   
Perceived self-efficacy and cognitive simulations interact in a bidirectional fashion, 
such that high self-efficacy is likely to result in the investment of increased effort towards 
goal pursuits, which is more likely to lead to goal attainment, and the subsequent cognitive 
reinforcement of achievements further strengthens perceived self-efficacy (Bandura, 1989).  
In contrast, low self-efficacy is characterised by self-doubt, which results in the exertion of 
less effort and persistence.  Socio-cognitive functioning is optimised in individuals with a 
resilient sense of self-efficacy, who tend to attempt difficult tasks as challenges rather than 
exercising avoidance, and exercise enhanced endurance and quickly resume high self-
efficacy in the face of setbacks.  Furthermore, they tend to set higher goals to which they are 
likely to remain highly committed and their positive outlook results in enhanced cognitive 
functioning and performance attainments.   
In addition to self-efficacy, SCT proposes that determining key elements in human 
motivation, affect and behaviour, are the person’s outcome expectancies from a particular 
behaviour (Bandura, 1977).  While the person may believe they are capable of successful 
performance, the net value of the expected outcomes from that performance will determine 
whether the behaviour occurs.  Conversely, the expectation that desired outcomes will be 
obtained is insufficient to elicit an attempt to obtain the outcome if an individual does not 
believe in their ability to succeed in that attempt (Bandura, 1999).  Consolidation of positive 
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outcome expectations therefore joins self-efficacy as a critical element in an effective 
treatment. 
1.6.2 Self-Motivation via Self-Monitoring and Goal-Setting 
   SCT proposes that goal setting largely exerts its motivational effects on behaviour 
via self-referent processes, including self-evaluation of performance according to internal, 
personal standards (Bandura, 1989).  Goals essentially define the conditions that individuals 
must meet in order to experience positive self-evaluation, and thus are a potential source of 
intrinsic reward.  Similar to the negative feedback control loop proposed in control and dual-
processing theories, SCT purports that perceived discrepancies between personal standards 
and performance induce action to reduce these discrepancies (Bandura, 1989).  Feedback is 
thus instrumental to maintaining motivation, as is the constant re-evaluation and setting of 
new, challenging goals.  When internal personal standards are met, individuals tend not to 
take further action.  However, new challenges evoke motivation to fulfil the discrepancy.  
The practice of constant goal revision to set increasingly challenging goals is fundamental to 
maintaining motivation and to subsequent increases in performance attainments (Bandura, 
1989).  Self-efficacy has a major role in determining the types of goals that individuals set 
from the beginning, and in how much effort they will exert in striving to master performance 
accomplishments.  Therefore, self-efficacy is influential in individuals’ propensity to exercise 
control over their motivation. 
 Self-monitoring is an important sub-function in the self-regulatory process, which is 
affected by affective states and self-beliefs (Bandura, 1991).  Ideally, self-monitoring is 
undertaken in temporal proximity to execution of the intended behaviour, as this presents 
continuous information and thereby enables the individual to exercise self-influence in 
revising their behavioural strategies closest in timing to the event (Bandura, 1991).  
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Furthermore, self-monitoring should be performed continuously rather than intermittently, as 
this encourages individuals’ regular attention to their performance.   
Motivation for self-monitoring is best obtained on variables for which individuals 
wish to elicit change, as this ensures the effects of self-evaluation in terms of goal progress, 
as opposed to indifferent self-observation.  It is also important that individuals self-monitor 
their successes rather than their failures, which may diminish attempts at making 
performance accomplishments unless possible causes and suggestions for corrections are 
identified.   
Although the effects of self-observation are characteristically temporary, they can be 
highly resistant to change, and may last into the longer term in relation to relatively easily 
modifiable activities (Bandura, 1991).  SCT thus represents both goal-setting and self-
monitoring as fundamental aspects of successful behaviour change.  Whilst self-monitoring 
can produce little or no effects, in certain cases, as discussed, providing individuals with the 
tools to effectively undertake goal-setting and receive performance feedback may facilitate 
their motivation to implement desired behavioural changes.               
1.6.3 Mood, Emotions and Social Cognitive Theory 
 Highly related to the effects of self-efficacy on the mastery of performance 
accomplishments is the bidirectional relationship between self-efficacy and affective state.  
Low self-efficacy, characterised by one’s perception that they cannot control potential 
threats, increases the likelihood that they will develop depression and stress (Bandura, 1989).  
Perceived inefficacy to stop aversive cognitions is a key determinant of distress (Bandura, 
1999), with low self-efficacy beliefs exhibiting enduring influences on behaviour such as 
engagement in avoidance behaviours, regardless of whether cognitive arousal is present at the 
time (Bandura, 1989).  Conversely, a high sense of efficacy to cope with threats or challenges 
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results in reduced stress and anxiety due to its transformative effects on perceptions of the 
environment (Bandura, 1999).   
 SCT proposes that depressive affect is produced and/ or maintained by perceived 
inefficacy in a number of ways.  First, when individuals attempt to meet unrealistic personal 
standards that are attached to their self-worth and this results in failure, they devalue any 
progress they have made and experience depression (Bandura, 1999).  In turn, depression 
results in the weakening of self-efficacy beliefs which generates a downward cycle (Bandura, 
1999).   
A second suggested pathway is via the effects of a low sense of social efficacy, which 
leads to problematic interactions with current relationships and the failure to form new ones.  
Evidence that social support provides a buffer to the effects of chronic stressors and the 
contributions of social isolation and loneliness to the development and maintenance of 
depressive symptoms (Lin, Ye, & Ensel, 1999) supports this theory.  Thirdly, SCT proposes 
that depression manifests via cognitive generation as the result of low perceived efficacy to 
control ruminative thought processes (Bandura, 1999).  The complex interactions between 
environmental, psychosocial, and interpersonal factors that account for affective symptoms 
demonstrate the importance of addressing behavioural and socio-ecological constituents in 
interventions that target mood disorders.       
1.6.4 SCT Applied to Diabetes Self-Management 
Empirical evidence supports a positive association between diabetes self-management 
and self-efficacy (Aljasem, Peyrot, Wissow, & Rubin, 2001).  Self-efficacy has been shown 
to predict future adherence to diabetes care regimens (Kavanagh, Gooley, & Wilson, 1993), 
and also to mediate participation in self-care behaviours related to effective diabetes 
management (Hunt et al., 2012; Senécal, Nouwen, & White, 2000; Snoek, 2002; Strychar et 
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al., 2012), including physical activity (Blanchard et al., 2007; Dutton et al., 2009; Plotnikoff, 
Trinh, Courneya, Karunamuni, & Sigal, 2011; Smith, Avis, & Assmann, 1999; White, Terry, 
Troup, & Rempel, 2007).  However, a range of factors mediate the relationship between self-
efficacy and diabetes self-management, including social support (Kim & Kang, 2006; Xu et 
al., 2008), illness perceptions (Toobert et al., 2010), functionality (Bond et al., 2006), and 
health beliefs (Chao et al., 2005).  Depression is negatively related to self-efficacy, and this is 
particularly the case in those with chronic conditions (Noh et al., 2010; Quinn et al., 2011).  
Depression and anxiety mediate self-efficacy for participation in positive health behaviours 
including glycaemic control (Cherrington et al., 2010).  Further, self-efficacy has 
demonstrated mediating the relationship between engagement in self-care behaviours in those 
with diabetes and affective disorders (Wagner, Tennen, & Osborn, 2011). This evidence 
demonstrates the social cognitive complexity of factors involved in addressing diabetes self-
management and psychological/ emotional issues. 
Levels of stress and depression experienced in difficult situations are theorised to be 
dependent on one’s belief in their coping abilities in the context of that situation, including in 
chronic disease (de Ridder & Schreurs, 2001).  Factors including illness beliefs and symptom 
interpretation impact on self-efficacy to cope with the condition (Bandura, 1986).  Low self-
efficacy for diabetes management is a significant risk factor for inadequate diabetes control 
(Fursse, Clarke, Jones, Khemka, & Findlay, 2008), depression (Bandura, 1989) and stress 
(Bandura, 1990).  Outcome expectancies that specifically refer to diabetes include the belief 
that adequately self-managing the condition is likely to prevent or delay complications.  Low 
self-efficacy may be a risk factor for inadequate Type 2 diabetes self-management by 
magnifying the perceived threat of diabetes to psychosocial, physical, or role functioning, life 
satisfaction, self-esteem and/or morale (Castelnuovo et al., 2011).  These effects may be 
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implicated in the high comorbidity between diabetes and dysphoria, and suggest that 
targeting self-efficacy in diabetes self-management interventions may facilitate their efficacy. 
Gist and Mitchell (1992) emphasised the importance of perceived variability and control 
of self-efficacy determinants in behavioural change (Bond et al., 2007).  Perceived control is 
generally higher over internal than external factors, and when determinants are variable in the 
short-term, as opposed to remaining stable.  Resistance to changes in self-efficacy is highest 
when the causes of performance are perceived to be uncontrollable with low variability.  In 
Type 2 diabetes patients, perceived control over internal, physiological factors is likely to be 
compromised at times, for example when hypo- or hyperglycaemic symptoms occur.  
Further, perceived stability of the condition may result in a sense of loss of control, leading to 
resistance to changes in self-efficacy because the patient is likely to attribute his or her 
performance to uncontrollable factors that remain stable over time, or are likely to recur.  
Tasks perceived to be difficult, such as adherence to a complex treatment regime, may be 
avoided to reduce the risk of failure and diabetes-imposed threat to one’s lifestyle.  Findings 
that diabetes symptom severity mediates the relationship between self-care and self-efficacy 
(Chen, Wei, Huang, & Lin, 2011) support this view.  Furthermore, the Consequence Model 
proposes that perception of control is a fundamental constituent of the relationship between 
depression and diabetes (Sacco & Bykowski, 2010).  
Perceived availability of support may attenuate the effects of low self-efficacy on 
perceived diabetes-imposed threat by providing a foreground for more adaptive reactions to 
stressful situations (Toobert et al., 2010).  Considering the behavioural, medical and 
psychological issues implicated in living with Type 2 diabetes, it is essential to acknowledge 
and target the integral social and cognitive factors in Type 2 diabetes self-management 
interventions (Fisher et al., 1982).  
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1.6.5 Section Summary and Conclusions 
Evidence presented in this section indicates that SCT has indicated appropriateness as 
a theoretical basis for a Type 2 diabetes self-management and dysphoria intervention.  The 
theory is consistent with the underlying aims of this project, which include developing an 
intervention that fundamentally promotes patient empowerment and addresses the 
behavioural and psychological/ emotional needs of people with Type 2 diabetes, while 
accounting for the influence of intrapersonal and ecological factors.    
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Summary 
We reviewed the effect of behavioural telehealth interventions in Type 2 diabetes on 
glycaemic control and diabetes self-management.  The databases CINAHL, Medline and 
psychINFO were searched in August 2012.  Peer-reviewed journal articles that were 
published in English with a randomised controlled trial design using a usual care comparison 
group, and in which the primary intervention component was delivered by telehealth, were 
selected.  Relevant outcome measures were glycaemic control and one or more diabetes self-
care area of: diet, physical activity, blood glucose self-monitoring (BGSM) or medication 
adherence. Interventions were excluded if they were primarily based on a telemonitoring.  
The search retrieved 1027 articles, from which 49 were selected based on their title and 
abstract.  Fourteen articles (reporting 13 studies) met the eligibility criteria for inclusion.  
Four studies reported significant improvements in glycaemic control.  Five of eight studies on 
dietary adherence reported significant treatment effects, as did five of eight on physical 
activity, four of nine on blood glucose self-monitoring, and three of eight on medication 
adherence.  Overall, behavioural telehealth interventions show promise in improving the 
diabetes self-care and glycemic control of people with Type 2 diabetes. 
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2.2 Introduction 
Diabetes is responsible for the eighth-highest burden of disease in Australia.  Type 2 diabetes 
accounts for 92% of the burden due to diabetes (Begg et al., 2007), and affects 3.8% of 
Australians (Barr, Cameron, Shaw, & Zimmet, 2005). Glycaemic control is strongly 
associated with diabetes-related morbidity and mortality (Stratton et al., 2000), with higher 
glycaemia predicting increased physical, mental, psychological and psychosocial 
comorbidities.  Improvements in glycaemia to the recommended glycosylated haemoglobin 
(HbA1c) level of ≤7% (R. Colagiuri et al., 2009) are significantly related to a reduced risk of 
micro- and macro-vascular complications (Holman, Paul, Bethel, & al, 2008).  Maintaining 
essential diabetes self-care practises that include regular physical activity, healthy eating, 
blood glucose self-monitoring (BGSM) and medication adherence is integral to achieving 
this.4 However the majority of diabetes patients remain poorly controlled (HbA1c≥8%), 
which indicates that regular, accessible and effective Type 2 diabetes self-management 
support is required. 
 
Telehealth may assist Type 2 diabetes patients by improving accessibility to health care 
services.  This may be of particular importance in rural and regional areas.  Currently 26% 
(230,700) of Australians with diabetes live in inner regional, and 12% (110,400) in outer 
regional or remote areas (AIHW, 2011).  Whilst general practitioners (GPs) are the primary 
care providers for patients with Type 2 diabetes, only 20% of all GPs are based outside 
metropolitan city areas (AIHW, 2008).  Telehealth also presents a convenient, cost-effective 
way for patients with mobility or motivational problems to receive regular support, including 
the elderly and patients with complicated diabetes. 
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Telehealth applications including telephone counselling, videoconferencing and educational 
telephone-based interventions have been favourably received with good acceptability and 
uptake by Type 2 diabetes patients (Verhoeven et al., 2007).  Telehealth interventions have 
also shown efficacy in improving psychosocial, psychological and clinical outcomes in 
diabetes (Wu, Forbes, Griffiths, Milligan, & While, 2010).  Previous reviews of diabetes self-
management telehealth interventions have reported the effect of both isolated telephone 
support (Graziano & Gross, 2009) and multi-component interventions.  Whilst behavioural 
interventions and ongoing support are acknowledged as being cornerstones for effective Type 
2 diabetes self-management (Fisher et al., 2005) the efficacy of behavioural telehealth 
interventions specifically aimed at improving glycaemic control and diabetes self-care 
remains unexplored.    
 
We have therefore conducted a systematic literature review of the effects of behavioural Type 
2 diabetes telehealth interventions. 
2.3 Methods 
The EBSCOHOST research databases CINAHL (Cumulative Index to Nursing and Allied 
Health Literature), Medline and psychINFO were searched using the terms: (diabet* and 
random*) and (tele* or mobile or SMS or smart phone or video* or ehealth).  There was no 
limit on the date of publication. 
 
Eligible studies were peer-reviewed journal articles published in the English language that 
reported evaluating the effects of telehealth interventions on glycaemic control and at least 
one diabetes self-care outcome out of:  physical activity, diet, blood glucose self-monitoring, 
and medication adherence.  Studies had to be randomised controlled trials and included either 
a usual care comparison, or an active treatment control (where the telehealth condition 
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received the same treatment).  Included studies had a sample comprising adults (≥18 years) 
with the majority having Type 2, rather than type 1 diabetes.  The intervention could not 
primarily be telemonitoring, and must have been exclusively for diabetes management.  
Studies where medication titration was a major component were excluded, as intensive 
medication therapy would confound the effects of behavioural change on glycaemic control.  
Abstracts and titles were screened, and those that appeared to fulfil the eligibility criteria 
were retrieved (as were ones where eligibility was not able to be determined from the 
abstract).  Backward and forward searches of retrieved articles and relevant systematic 
reviews were performed to identify additional potentially eligible studies. 
 
The Cochrane Collaboration’s tool for assessing risk of bias (Higgins & Green, 2008) was 
used as a marker for each study’s internal validity.  Assessments were performed by 
indicating a yes/no judgement on each of the six domains of validity, and studies deemed to 
have a high risk of bias were excluded from the review.  Data from each study was abstracted 
and stored in a spreadsheet that included the study’s purpose, nature of the intervention, study 
conditions, outcomes and results. 
2.4 Results 
A total of 49 full papers were examined for eligibility, and 14 articles reporting on 13 studies 
were included in the review.  The study processes and outcomes of the included studies are 
summarised in Table 1. 
 
Interventions 
The majority of study interventions involved participants receiving regular telephone calls 
from trained staff who were mainly study nurses (Anderson, Christison-Lagay, Villagra, Liu, 
& Dziura, 2010; Frosch, Uy, Ochoa, & Mangione, 2011; Maljanian, Grey, Staff, & Conroy, 
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2005; Piette, Weinberger, Kraemer, & McPhee, 2001; Piette, Weinberger, & McPhee, 2000; 
Sigurdardottir, Benediktsson, & Jonsdottir, 2009) but also psychologists/social workers 
(Wolever et al., 2010), PhD (Kim & Oh, 2003) and Master’s (Nesari, Zakerimoghadam, 
Rajab, Bassampour, & Faghihzadeh, 2010) students.  An exception was the study by Bell et 
al. (Bell, Fonda, Walker, Schmidt, & Vigersky, 2012) in which each participant was sent 30- 
to 60-second video messages via their mobile phone every 24 hours on diabetes self-care 
topics.  Two studies (Piette, 2000; Piette et al., 2001) involved participants receiving 
automated telephone disease management (ATDM) calls to supplement nurses’ follow-up 
calls.  All interventions included diabetes education. 
 
The active intervention period ranged from 5 weeks (Frosch et al., 2011; Sigurdardottir et al., 
2009) to 12 months (Anderson et al., 2010; Piette et al., 2001; Piette et al., 2000; Walker et 
al., 2011) and periods for final outcome assessments ranged from 3 months (Kim & Oh, 
2003; Maljanian et al., 2005; Nesari et al., 2010) to 12 months post-baseline (Anderson et al., 
2010; Bell et al., 2012; Maljanian et al., 2005; Piette et al., 2001; Piette et al., 2000; Walker et 
al., 2011).  In most studies (69%), endpoint measures were taken directly post-intervention.  
Five studies assessed short-term maintenance (Bell et al., 2012; Frosch et al., 2011; 
Maljanian et al., 2005; Sigurdardottir et al., 2009; Trief et al., 2011), with the longest interval 
between post-intervention and final assessments being 6 months (Bell et al., 2012). 
 
Glycaemic control 
Four (Bell et al., 2012; Kim & Oh, 2003; Nesari et al., 2010; Walker et al., 2011) of thirteen 
studies reported significant treatment effects on glycaemic control.  Three also reported 
significant treatment effects on diabetes self-care (Kim & Oh, 2003; Nesari et al., 2010; 
Walker et al., 2011).  Two (Kim & Oh, 2003; Nesari et al., 2010) assessed all four self-care 
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outcomes in addition to glycaemic control, and reported significant improvements in them all.  
The majority of significant results for glycaemic control were measured directly following 
the active intervention period, at 3 months (Kim & Oh, 2003; Nesari et al., 2010) or 12 
months (Walker et al., 2011).  In Bell et al.’s study (Bell et al., 2012) significant 
improvements in HbA1c were seen 3 months into the 6-month intervention, but were not 
maintained at the 6-month post-baseline assessment. 
 
Whilst five studies reported on the dosage of intervention received by intervention group 
participants (Bell et al., 2012; Frosch et al., 2011; J. D. Piette et al., 2001; Piette et al., 2000; 
Walker et al., 2011) only two of them evaluated dosage relationships with glycaemic 
outcomes (Bell et al., 2012; Walker et al., 2011).  Both reported significant intervention 
dosage effects on glycaemic improvements.  Walker et al.’s study (Walker et al., 2011) -- a 
telephone intervention offering ≥10 calls over a year -- indicated that intervention group 
participants completing more than five telephone calls had a significantly greater reduction in 
HbA1c. Bell et al. (Bell et al., 2012) found significant between-group interactions for HbA1c 
at the 3-month post-baseline follow-up, but no differences at 12 months post-baseline, which 
was 6 months post-intervention.  However, further analyses revealed that “persistent viewers” 
(who viewed >10 video messages a month) experienced a significant reduction in HbA1c of 
0.6% over 12 months, compared with “early cessation” participants who did not view the 
videos or stopped viewing videos within 2 months post-enrolment. 
 
Dietary adherence 
Five of eight studies (63%) that assessed the effects of interventions on dietary adherence 
reported significant improvements (Anderson et al., 2010; Kim & Oh, 2003; Nesari et al., 
2010; Sacco et al., 2009; Walker et al., 2011).  In four of these, dietary improvements were 
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found directly following the active intervention (Kim & Oh, 2003; Nesari et al., 2010; Sacco 
et al., 2009; Walker et al., 2011).  There was no notable distinction between the type of 
dietary and lifestyle intervention offered by studies reporting significant improvements in diet 
and ones where no significant effect was found (Frosch et al., 2011; Sigurdardottir et al., 
2009).  While Kim & Oh’s positive study (Kim & Oh, 2003) included dietitian reviews of 
patient meal plans, Trief et al.(Trief et al., 2011) used dietary goal setting as the primary 
focus of their telephone counselling intervention, but found no significant dietary 
improvements.  Differences in the study populations may have accounted for the difference in 
results: in Trief et al.’s study (Trief et al., 2011), most participants were obese, and dietary 
changes may have presented a significant motivational hurdle. 
 
Physical activity  
Statistically significant treatment effects were reported in five of eight studies (63%) that 
assessed physical activity participation (Frosch et al., 2011; Nesari et al., 2010; Sacco et al., 
2009; Walker et al., 2011; Wolever et al., 2010).  Three of these (Frosch et al., 2011; Sacco et 
al., 2009; Wolever et al., 2010) did not find improvements in glycaemic control.  Sustained 
exercise can reduce insulin resistance and improve glycaemic control (Thomas et al., 2006) 
and most studies only tested for effects on glycaemic control immediately post-intervention.  
A delayed effect of increased physical activity on glycaemic control may have occurred, 
provided that behavioural changes were maintained.  Furthermore, different types of physical 
activity (e.g. resistance vs. aerobic) has differential impacts on glycaemia (Tompkins, Soros, 
Sothern, & Vargas, 2009).  Measures that are sensitive to specific activity changes would 
help to determine the clinical value of reported improvements. 
 
Blood glucose self-monitoring 
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Four of nine studies (44%) that measured BGSM found significant improvements in 
frequency (Kim & Oh, 2003; Nesari et al., 2010; Piette et al., 2001; Piette et al., 2000).  
Studies reporting significant effects required participants to regularly self-report their blood 
glucose levels to the researcher or nurse, indicating possible effects of accountability on 
monitoring.  However, the findings should be interpreted with caution, as self-report surveys 
rather than objective assessments were used both for regular BGSM reports during the study 
and study outcome measures.  Only one study (Bell et al., 2012) provided diabetes supplies at 
no cost to participants.  The cost of increased BGSM may have been a deterrent to increasing 
self-monitoring in some participants. 
 
Medication adherence 
Eight studies assessed medication adherence, with only three (Nesari et al., 2010; Piette et al., 
2000; Wolever et al., 2010) (38%) reporting significant improvements.  In Walker et al.'s 
study (Walker et al., 2011), significant improvements in medication adherence were reported 
on ASK-20 items, but not on items from the Morisky Adherence Scale.  Only one study 
reported the intervention group experiencing significant improvements in glycaemia as well 
as medication adherence (Nesari et al., 2010).  However, significant improvements in three 
other diabetes self-care outcome measures relevant to the present review also occurred, and 
those changes may have collectively influenced glycaemic improvements.  The study of 
Walker et al. (Walker et al., 2011) was the only one to compare medication adherence in 
insulin-dependent compared with non-dependent Type 2 diabetes:  It found no significant 
difference between these sub-groups. Future studies should include analyses of changes in 
medication adherence within diabetes treatment sub-groups to detect any mediating effects of 
treatment burden. 
 
95 
 
 
Study quality and validity 
Overall, improvements in study quality and validity of reporting are required, with internal 
validity being moderate at best amongst the studies.  In five studies, it was unclear whether 
allocation was concealed (Kim & Oh, 2003; Maljanian et al., 2005; Piette, 2000; Trief et al., 
2011; Wolever et al., 2010), presenting a risk of exaggerated treatment effects (Higgins & 
Green, 2008).  Most studies used relatively small sample sizes (Bell et al., 2012; Kim & Oh, 
2003; Nesari et al., 2010; Sacco et al., 2009; Sigurdardottir et al., 2009; Trief et al., 2011; 
Wolever et al., 2010), which may have resulted in difficulties detecting significant treatment 
effects.  Trief et al. (Trief et al., 2011) cited individual differences between study conditions 
as a potential source of bias in their results.  Most studies used samples comprised mainly of 
ethnic and socioeconomic minorities (Anderson et al., 2010; Bell et al., 2012; Frosch et al., 
2011; Kim & Oh, 2003; Nesari et al., 2010; Piette et al., 2001; Piette et al., 2000; Walker et 
al., 2011; Wolever et al., 2010), presenting problems for external validity. 
2.5 Discussion 
Considerable heterogeneity between study processes and outcomes meant that it was difficult 
to draw firm conclusions.  However, the present review demonstrated that behavioural 
telehealth interventions can significantly improve both glycaemic and diabetes self-care 
outcomes in Type 2 diabetes patients.  Of the diabetes self-care outcomes that were 
examined, physical activity and dietary adherence most commonly demonstrated 
improvements in response to telehealth. 
 
The longest study post-intervention follow-up period was only 6 months (Bell et al., 2012).  
Longer intervals between post-intervention and final endpoint follow-up measures would 
provide a better indication of the longevity of treatment effects and enable detection of 
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“sleeper” (delayed) effects.  This may also assist with determining optimum times for booster 
appointments in real-world implementations of telehealth interventions. 
 
In order to optimise the effect of telehealth for Type 2 diabetes, systematic evaluations of 
different dosages and durations of interventions are also needed, as are studies of specific 
subgroups of patients (e.g. insulin dependent/non-dependent).  Only two studies in the 
present review reported relationships between intervention exposure and clinical 
improvements, with both revealing stronger effects from more substantial interventions (Bell 
et al., 2012; Walker et al., 2011). 
 
The studies reviewed typically had samples of poorly controlled Type 2 diabetes patients.  
Whilst that allows significant treatment effects to be detected, it excludes participants who 
may benefit from a behaviourally focused telehealth intervention.  As shown in Piette et al. 
(Piette et al., 2001) and Wolever et al. (Wolever et al., 2010), sub-group analyses according 
to HbA1c allow the detection of treatment effects in cohorts of participants within higher 
baseline HbA1c ranges.  Undertaking sub-group analyses may be a solution for including 
individuals with reasonable glycaemic control in behavioural telehealth trials for diabetes.  
Furthermore, a focus on community sampling, rather than recruiting primarily from diabetes 
outpatient clinics and/or from minority groups, would enable greater generalisability of 
results.  
 
Finally, research in this field requires substantial improvements in study methodology, 
including blind assessment and allocation concealment.  Clearer reporting of study processes 
and outcomes would enable methodological quality and more confident conclusions to be 
drawn from reviews. 
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Table 1.  Study characteristics 
Study Sample characteristics (No; mean age; % 
female; mean baseline HbA1c; mean y since 
diagnosis; population type) 
Study conditions 
(1) Control 
condition 
(2) Intervention 
condition 1 
(3) Intervention 
condition 2 
 
Duration, 
intensity 
and follow-
up times 
Reported outcomes (relevant to review) and associated 
measures 
Effects of interventions 
Anderson, 
D.R. (2010) 
295 (149 Usual care; 146 Intervention); NR; 58%; 
8.0%; NR; mostly Hispanic or African American; 
Type 2 diabetes 
(1) TAU 
 
(2) Unscript
ed calls from nurse - 
brief clinical 
measures, self-care 
education, BGSM 
review, mailed 
educational 
materials. 
 
 
(2) 12 
months  
Call 
intensities: 
(i) HbA1c ≥ 
9%: weekly, 
(ii)<9%: 
biweekly, 
(iii)≤ 7%: 
monthly. 
 
Follow-up: 6 
& 12 months 
HbA1c: NR 
Diet: Brief Dietary Assessment survey (fruit and vegetable 
intake) 
Physical activity: Rapid Assessment of Physical Activity 
(RAPA) 
 
HbA1c 
NS. 6 & 12 months post-baseline 
- Group x Time. 
NS. Within-group. 
Diet  
N.S. 6 & 12 months post-
baseline – Group x Time. 
NS. Within-group. 
Bell, A.M. 
(2012) 
64 (33 Usual care; 31 Intervention); 58y; 45%; 
9.3%; NR; mostly African American, obese; Type 
1 or 2 diabetes 
(1) TAU: 
Received glucose 
meter and strips, 
broad-band enabled 
cell phone and 
services for 6 
months. 
 
(2) TAU + 
30 – 60-sec video 
SMS’s on diabetes 
self-care topics. 
 
 
 
 
(2) 6 months 
SMS’s: 24-
hourly. 
 
Follow-up: 3, 
6, 9 & 12 
months 
HbA1c: High performance liquid chromatography (HPLC; 
COBAS C 111 Analyzer) 
 
BGSM: Data upload frequency. 
HbA1c 
*3-months post-baseline – 
Group x time (P=.02).  
NS. 6-, 9- & 12-months post-
baseline. 
NS. Within-group. 
BGSM 
NS. Group x Time. 
NS. Within-group. 
Frosch, D.L. 
(2011) 
201 (100 Usual care; 101 Intervention); 55.5y; 
48.5%; 9.6%; 10y; mostly African American or 
Latino & obese; Type 2 diabetes 
(1) TAU: 
Received 20-page 
diabetes education 
brochure. 
 
(2) TAU + 
24-minute DVD 
program; booklet 
“Living with 
Diabetes” + phone 
coaching sessions 
with diabetes nurse. 
 
 
 
(2) 5 weeks 
≤ five phone 
sessions. 
Session 1: 
≤60 min; 2 & 
3:≤30 min; 4 
& 5:≤15 min. 
 
Follow-up: 1  
HbA1c: HPLC 
 
Diet, exercise, BGSM, medication: Summary of Diabetes Self-
Care Activities (SDSCA) Survey 
HbA1c 
NS. Group x Time.  
*Time effects across groups 
(P<.001). 
Diet 
NS. Group x time.  
*Time effects across groups 
(P<.001).  
Exercise 
* 6 months post-baseline – 
Group x Time (P=.04). 
NS. Time effects across groups. 
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Study Sample characteristics (No; mean age; % 
female; mean baseline HbA1c; mean y since 
diagnosis; population type) 
Study conditions 
(1) Control 
condition 
(2) Intervention 
condition 1 
(3) Intervention 
condition 2 
Duration, 
intensity 
and follow-
up times 
Reported outcomes (relevant to review) and associated 
measures 
Effects of interventions 
Frosch, D.L. 
(2011) 
  & 6 months  BGSM 
NS. Group x Time. 
*Time effects across groups 
(P=.03). 
Medication 
NS. Group x Time: (i) taking 
most medications, (ii) all 
medications.  
* 1 & 6 months post-baseline - 
Time effects across groups, (i) 
(P=.01), (ii) (P<.001). 
Kim, H. (2003) 50 (25 control; 25 intervention); 60.3y; 70%; 
8.5%; 13.7y; South Koreans, half < middle 
school; Type 2 diabetes 
(1) TAU 
 
(2) Diabetes care 
booklet & daily diet 
log; phone calls 
from PhD student - 
continuing 
education, 
reinforcement of 
diet & exercise; 
medication 
recommendations & 
frequent BGSM. 
Diet 
recommendations 
mailed from 
Dietitian after daily 
diet log review.  
 
 
(2) 3 months  
Calls ≥ 
twice/wk for 
1 mth; 
weekly for 
months 2 & 
3. 
Calls, M=25 
min. 
Follow-up: 3 
months 
HbA1c: HPLC (Variant II, Bio-Rad Hercules) 
 
Diet, exercise, blood glucose testing, medication-taking: Self-
Reported Adherence Questionnaire (Kim, 1999) 
HbA1c 
*Group x Time (P=.0001). 
* Within-group: intervention 
decline (P<.05); control increase 
(P<.05). 
Diet 
*Group x time (P=.006).  
*Within-group improvement - 
intervention (P<.05). 
Exercise 
NS. Group x time. 
NS. Within-group. 
BGSM 
*Group x time (P=.024). 
*Within-group improvement - 
intervention (P<.05). 
Medication 
NS. Group x time. 
NS. Within-group. 
Maljanian, R. 
(2005) 
336 (160 control, 176 intervention); 58y; 53.3%; 
7.9%; NR; mostly Caucasian, overweight; Type 1 
or 2 diabetes 
(1) TAU: 3 diabetes 
education classes; 
individual visits 
with Registered 
Nurse & 
Nutritionist; 
collaborative care 
management with 
written evaluations 
andrecommendation 
(1) Classes= 
4 hours each 
 
 
 
 
 
(2) 3 months 
 Calls: 
weekly. Call 
1, M=15-20  
HbA1c: HPLC (Bayer DCA 2000 Analyzer) or collected from 
participant’s Physician 
 
BGSM: Diabetes Quality Improvement Project (DQIP) items 
HbA1c 
NS. Group x time. 
NS. Within-group. 
BGSM 
NS. Group x time. 
NS. Within-group. 
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Study Sample characteristics (No; mean age; % 
female; mean baseline HbA1c; mean y since 
diagnosis; population type) 
Study conditions 
(1) Control 
condition 
(2) Intervention 
condition 1 
(3) Intervention 
condition 2 
Duration, 
intensity 
and follow-
up times 
Reported outcomes (relevant to review) and associated 
measures 
Effects of interventions 
Maljanian, R. 
(2005) 
 for Primary Care 
Provider. 
 
(2) TAU + phone 
calls from Research 
Nurse - education & 
self-management 
skills reinforcement. 
min; other 
calls, M=5-7 
min. 
Follow-up: 3 
& 12 months 
  
Nesari, M. 
(2010) 
61 (31 control; 30 intervention); 51.6y; 71.7%; 
9.0%; NR; mostly Iranian, overweight; Type 2 
diabetes 
(1) TAU: 3-day 
diabetes self-care 
education program. 
 
(2) TAU + phone 
calls from Master’s 
nursing student on 
health behaviours, 
education, & 
medication 
adjustment 
according to 
glucose levels. 
(1)Each 
session =60 
min (3/day) 
 
(2) 3 months 
Calls: 
twice/wk for 
1 mth; 
weekly for 
months 2 & 
3. 
Calls, M=20 
min. 
Follow-up:  3 
months 
HbA1c: HPLC (Pars Azemoo) 
 
Diet, exercise, BGSM, medication-taking: Level of adherence; 
Self-reported questionnaire (developed by research staff)  
HbA1c 
*3 months post-baseline – 
intervention better. (P<.001). 
* Within-group decline - 
intervention (P<.001). 
Diet 
*3 months- intervention better 
(P<.001).  
*Within-group improvement – 
both groups (P<.001). 
Exercise 
*3 months post-baseline – 
intervention better (P<.001). 
*Within-group increase - 
intervention (P<.001). 
BGSM 
*3 months post-baseline – 
intervention better (P<.001). 
NS. Within-group. 
Medication 
*3 months post-baseline – 
intervention better. (P=.001). 
*Within-group increase – 
intervention (P<.001) 
Piette, J.D. 
(2001) 
272 (140 control; 132 intervention); 60.5y; 
28.65%; 8.1%; NR; department of veterans affairs 
patients, overweight; Type 1 or 2 diabetes 
(1) TAU 
 
(2) Outbound 
automated 
telephone disease 
management 
(ATDM) calls with 
self-assessments 
(BGSM readings,  
 
 
(2) 12 
months 
ATDM calls: 
biweekly, 
M= 5- 8 min 
(+ promotion 
messages);  
HbA1c: NR 
 
BGSM, medication-taking (problems): NR (phone interview) 
HbA1c 
NS. Between-groups. 
*12 months post-baseline – 
Baseline HbA1c ≥8.0% - 
intervention better (P=.04); 
Baseline HbA1c ≥9.0% - 
intervention better (P=.04). 
BGSM 
*12 months post-baseline –  
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Study Sample characteristics (No; mean age; % 
female; mean baseline HbA1c; mean y since 
diagnosis; population type) 
Study conditions 
(1) Control 
condition 
(2) Intervention 
condition 1 
(3) Intervention 
condition 2 
Duration, 
intensity 
and follow-
up times 
Reported outcomes (relevant to review) and associated 
measures 
Effects of interventions 
Piette, J.D. 
(2001) 
 self-care activities, 
symptoms, medical 
care use); health 
promotion messages 
(optional) + nurse 
follow-up 
nurse calls: 
weekly, 
M=29 min. 
Follow-up:12 
months 
 intervention better (P=.05). 
N.S. Within-group. 
Medication 
NS. Between-groups. 
NS. Within-group. 
Piette, J.D. 
(2000) 
280 (124 control; 124 intervention); 54.5y; 73%; 
8.7%; NR; mostly Hispanic or Caucasian, 
overweight; Type 1 or 2 diabetes 
(1) TAU 
 
(2) Outbound 
ATDM calls with 
self-assessments 
(BGSM readings, 
self-care, 
symptoms, medical 
care use); “health 
tips”, diet & 
exercise self-care 
module (optional) + 
nurse follow-up 
 
 
(2) 12 
months 
ATDM calls: 
biweekly, 
M=5-14 min; 
nurse calls: 
weekly, 
M=20 min.  
Follow-up:12 
months 
HbA1c: NR 
 
BGSM, medication: Self-report survey questions 
HbA1c 
NS. Group x time. 
BGSM 
*12 months post-baseline - 
intervention better (P=.03). 
NS. Within-group. 
Medication  
*12 months post-baseline – 
intervention better (P=.003). 
 
Sacco, W.P. 
(2011), Sacco, 
W.P. (2009) 
62 (31 control; 31 intervention); 52y; 58%; 8.5%; 
9.5y; mostly Caucasian, obese; Type 2 diabetes 
(1) TAU 
 
(2) Phone coaching 
- BGSM review to 
identify causes of 
“out of range” 
readings; help 
translating broad 
goals into weekly 
implementation 
intentions; problem-
solving; 
reinforcement of 
positive changes. 
 
 
(2) 6 months 
Weekly calls 
– 3 months; 
biweekly – 3 
months. 
Initial intake 
call, M= 
53.63 min; 
other calls, 
M= 17.38 
min. 
Follow-up: 6 
months 
HbA1c: Baseline - medical records (majority HPLC; Bayer 
DCA 2000 Analyzer); follow-up – lab values 
 
Diet, exercise, BGSM, medication: SDSCA Survey 
HbA1c 
NS. Group x time. 
Diet 
*Group x time (P<.05). 
Exercise 
*Group x time (P<.001). 
BGSM 
NS. Group x time. 
Medication 
NS. Group x time. 
Sigurdardottir, 
A.K. (2009) 
53 (25 control; 28 intervention); 60.7y; 32%; 
8.0%; 8.7y; mostly overweight; Type 2 diabetes 
(1) TAU 
 
(2) One face-to-face 
session with Nurse 
Educator - diabetes 
knowledge, dietary 
& exercise  
 
 
(2) 5 weeks 
Face-to-face 
session = 1-2 
h; five calls, 
M= 15-20  
HbA1c: NR 
 
Diet, exercise, BGSM: 12 Items from SDSCA Survey 
HbA1c 
NS. Group x time. 
*3 months baseline – within-
group decline – both (P<.05). 
NS. 6 months post-baseline – 
within-group. 
Diet 
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Study Sample characteristics (No; mean age; % 
female; mean baseline HbA1c; mean y since 
diagnosis; population type) 
Study conditions 
(1) Control 
condition 
(2) Intervention 
condition 1 
(3) Intervention 
condition 2 
Duration, 
intensity 
and follow-
up times 
Reported outcomes (relevant to review) and associated 
measures 
Effects of interventions 
  behaviour survey 
items; guided goal-
setting; discussed 
obstacles to change; 
then five phone 
coaching sessions. 
min. 
Follow-up: 3 
& 6 months 
 NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
(P=.027). 
Exercise 
NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
(P=.045). 
BGSM 
NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
(P=.013). 
Trief, P. (2011) 44 (13 control; 12 individual intervention; 12 
couples intervention); 59.9y; 63.6%; 8.3%; 13.4y; 
mostly obese, all couples – 1 partner with T2D 
(1) TAU: Two 
diabetes education 
sessions & meal 
plan review by 
phone. 
 
(2) Individual: TAU 
+ phone sessions on 
dietary goal-setting, 
two on emotions re. 
Diabetes 
 
(3) Couples: TAU + 
phone sessions 
including partner on 
collaborative 
problem-solving. 
 
 
 
(2 & 3) 3 
months 
Nine phone 
sessions. 
Follow-up: 3 
& 6 months 
HbA1C: HPLC (DCA 2000 A1C Analyzer) 
 
Diet, BGSM: SDSCA Survey 
HbA1c 
NS. Group x time. 
NS. Within-group. 
Diet 
NS. Group x time. 
NS. Within-group. 
BGSM 
NS. Group x time. 
NS. Within-group. 
Walker, E.A. 
(2011) 
526 (264 control; 262 intervention); 55.5y; 
67.1%; 8.6%; 9.2y; mostly Black and Hispanic, 
overweight; Type 2 diabetes 
(1) TAU: Diabetes 
education materials 
mailed after 
randomisation. 
 
(2) TAU + phone 
calls from Health 
Educator -
medication 
adherence, problem- 
 
 
 
 
(2) 12 
months 
≥10 calls, 4- 
to 6-week 
intervals, 
M=14.1 min. 
HbA1c: “Dry-dot” Method (mail-out kits) 
 
Diet (number days/week following healthy eating plan); 
exercise (number days ≥30 min exercise); self-care: SDSCA 
survey; medication: Morisky Adherence Scale 
HbA1c 
*Group x time (P=.009). 
Diet 
*Group x time (P<.05). 
Exercise 
*Group x time (P<.05). 
Medication  
NS. Group x time. 
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Study Sample characteristics (No; mean age; % 
female; mean baseline HbA1c; mean y since 
diagnosis; population type) 
Study conditions 
(1) Control 
condition 
(2) Intervention 
condition 1 
(3) Intervention 
condition 2 
Duration, 
intensity and 
follow-up 
times 
Reported outcomes (relevant to review) and associated 
measures 
Effects of interventions 
  solving, goal-
setting, 
communication, 
planning medical 
visits, diet, physical 
activity. 
Follow-up: 
12 months 
  
Wolever, R.Q. 
(2010) 
56 (26 control; 30 intervention); 53y; 77%; 8.0%; 
11y; mostly African American; Type 2 diabetes 
(1) TAU 
 
(2) Integrative 
Health coaching by 
phone with trained 
social worker/ 
psychology 
graduate coaches. 
Guided in creating 
vision of health and 
long-term goals. 
Wheel of Health 
used to guide 
conversations; 
received educational 
materials. 
 
 
(2) 6 months  
8 weekly 
calls; 4 
biweekly. 
Final call 1 
mth later. 
Calls, M=30 
min. 
Follow-up: 6 
months 
HbA1c: lab values 
 
Exercise - (How many times/week exercised ≥ 15-20 minutes in 
past mth)” 
Medication: Morisky Adherence Scale, ASK-20 items. 
HbA1c 
NS. Group x time. 
*6 months post-baseline – 
within-group – intervention 
HbA1c≥7% (P=.03). 
Exercise 
*Group x time (P=.026). 
Medication 
*Group x time, ASK-20 survey 
(P=.036). 
NS. Group x time – Morisky 
Adherence Scale 
*6 months post-baseline – 
within-group – intervention 
(ASK-20, P=.001; Morisky, 
P=.004) 
NR, not reported 
NS, not significant (P>0.05) 
*P<0.05 
TAU, treatment as usual 
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2.6 Chapter Summary and Conclusions 
This review provided information about whether it would be wise use telehealth as the 
mode of intervention delivery for this research project.  On the basis of the evidence, it was 
decided that telehealth has been explored in Type 2 diabetes intervention to a large degree, 
and that we might offer no superior efficacy to that demonstrated.  Furthermore, as part of the 
initial exploratory stage of the project, the review contributed to forming the foundation of 
the qualitative study in the next chapter, as it provided the impetus for exploring a 
technological means of intervention delivery that did not involve telehealth with participants, 
namely being the web-based modality. 
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CHAPTER 3 
PERCEIVED NEEDS FOR SUPPORTED SELF-MANAGEMENT OF DIABETES: 
A QUALITATIVE INVESTIGATION OF THE POTENTIAL FOR A 
WEB-BASED INTERVENTION 
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3.1 Notes 
This paper has been published in the Australian, peer-reviewed journal, ‘The Australian 
Psychologist’. 
Citation for this manuscript: 
Cassimatis, M., Kavanagh, D.J., & Smith, A.C. (2013). Perceived Needs for Supported Self- 
Management of Diabetes: A Qualitative Investigation of Potential for A Web-based 
Intervention, Australian Psychologist, 49, 75-85.  
Journal Impact Factor: 0.607. 
Authors’ contributions to this paper: 
 The candidate, who is the first author, conducted the qualitative interviews upon 
which this paper is based and was responsible for transcribing the interviews, thematic 
analysis of participants’ responses, and drafting the manuscript.  The co-authors are both 
members of the candidate’s supervisory team.  The second author collaborated with the 
candidate on the derivation of categories from the data.  Both co-authors provided editorial 
suggestions on the manuscript. 
Overview of this paper:  
This paper contributes to the scientific literature as one of the few studies in Australia 
that provides insight into the experiences of living with Type 2 diabetes from patients’ and 
practitioners’ perspectives using a qualitative approach.  The paper forms the second part of 
the project’s exploratory stage and forms a foundation for optimising the incorporation of 
patient empowerment into the intervention. 
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Perceived Needs for Supported Self-Management of Type 2 Diabetes: A Qualitative 
Investigation of the Potential for a Web-Based Intervention 
 
 
 
 
 
 
 
 
 
 
    
 
Abstract 
The estimated one million Australians with type 2 diabetes face significant risks of morbidity 
and premature mortality.  Inadequate diabetes self-management is associated with poor 
glycaemic control, which is further impaired by comorbid dysphoria.  Regular access to 
ongoing self-management and psychological support is limited, especially in rural and 
regional locations.  Web-based interventions can provide complementary support to patients’ 
usual care.  Semi-structured interviews were undertaken with two samples that comprised (i) 
13 people with type 2 diabetes, and (ii) 12 general practitioners (GPs).  Interviews explored 
enablers and barriers to self-care, emotional challenges, needs for support, and potential web-
based program components.  Patients were asked about the potential utility of a web-based 
support program, and GPs were asked about likely circumstances of patient referral to it.  
Thematic analysis was used to summarise responses.  Most perceived facilitators and barriers 
to self-management were similar across the groups.  Both groups highlighted the centrality of 
dietary self-management, valued shared decision-making with health professionals, and 
endorsed the idea of web-based support.  Some emotional issues commonly identified by 
patients varied to those perceived by GPs, resulting in different attributions for impaired self-
care.  A web-based program that supported self-management and psychological/emotional 
needs appears likely to hold promise in yielding high acceptability and perceived utility. 
 
200 words 
Keywords: behavioural self-management, chronic disease, diabetes, emotional disorders, 
health psychology, online intervention, e-health, qualitative research. 
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3.2 Introduction 
 Type 2 diabetes is one of the most significant health issues to date, affecting an 
estimated 1.9 million Australians, with numbers rising (IDF, 2012b).  Modifiable lifestyle 
risk factors including lack of physical activity, poor nutrition, and obesity are major 
contributors to type 2 diabetes etiology and glycaemic control (AIHW, 2012a).  Treatment 
non-adherence is exceedingly common in type 2 diabetes patients, with the uptake and 
maintenance of key lifestyle factors being a major challenge (Peyrot et al., 2005).  The link 
between diabetes self-management and glycaemic control is strong (DCCT Research Group, 
1993), placing these patients at increased risk of diabetes complications, which include 
blindness, amputation, and chronic kidney disease (IDF, 2009a).  Patients with diabetes are 
also at significantly greater risk of cardiovascular disease after adjustment for other risk 
factors (Stratton et al., 2000).  Therefore, behavioural self-management intervention is 
essential to improve the health outcomes of people with type 2 diabetes, with physical 
activity and nutrition being fundamental components (Colagiuri et al., 2009). 
 Dysphoria is significantly associated with inadequate diabetes self-management, and 
is at least twice more common in people with diabetes than in the general population (Ali et 
al., 2006).  Dysphoria impairs functioning and quality of life and increases the risk of 
diabetes complications and premature mortality, both by its direct effects on metabolic status 
and by affecting the maintenance of health behaviours (Fisher et al., 2007).  Further, it tends 
to recur and persist for longer periods in diabetes patients (Fisher et al., 2008).  However, 
dysphoric mood remains largely unrecognised and subsequently is under-treated in diabetes 
patients (Li et al., 2010; Pouwer, 2009).  This is particularly the case with subclinical 
symptoms, which exert significant impacts on diabetes self-management (Gonzalez et al., 
2007). 
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 In Australia, diabetes is one of the commonest chronic conditions managed by general 
practitioners [GPs; (Britt et al., 2012)].  GPs have indicated that psychological counselling 
about modifying lifestyle factors including weight, nutrition and physical activity, is one of 
their most common roles in type 2 diabetes patient consultations (AIHW, 2010b).  However, 
both intrapersonal [e.g. low self-efficacy; (Bambling et al., 2007)] and system-level barriers 
(Zhang, Van Leuven, & Neidlinger, 2012) prevent GPs from addressing these issues in 
sufficient depth.  It is also difficult for primary care practitioners to provide the frequency or 
intensity of support for self-management that may be required (Fisher et al., 2007), and this is 
particularly the case when patients present with comorbid psychological and/ or emotional 
issues (Hajos et al., 2011). 
A variety of factors further complicate patients’ access to regular diabetes self-
management support (Delamater, 2006).  For example, embarrassment about sub-optimum 
self-management or stigma about dysphoria may inhibit people from seeking assistance.  The 
greater geographical spread and lower ratio of practitioners in non-metropolitan regions 
means that residents in remote locations face particular challenges in obtaining sufficient help 
from practitioners.  In Australia, almost one third of people with diabetes face these ‘inequity 
of access’ issues (AIHW, 2011).  A different support model is warranted—one that is less 
reliant on the physical location of the health workforce and more easily accessible where and 
when support is needed. 
Rapid advances in technology are fast making web-based provision of type 2 diabetes 
self-management interventions a feasible alternative to traditional face-to-face treatment 
(Griffiths & Christensen, 2007).  However, there have been no Australian trials of web-based 
type 2 diabetes self-management support interventions.  Implications for providing combined 
diabetes self-management and emotional support to type 2 diabetes patients include reduced 
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strains on the health care system, and increased outreach of motivational and emotional 
support to rural and remote areas that is more convenient and accessible.  
 We intended to develop a web-based program that would provide reliable and 
ongoing informed, motivational, and emotional support to improve type 2 diabetes self-
management and dysphoria symptoms.  Patient empowerment refers to “...helping patients 
discover and develop the inherent capacity to be responsible for one’s own life” (Funnell et 
al., 1991).  Empowerment has been shown to enhance motivation for diabetes self-care, with 
its emphasis on respecting patients’ decision-making being fundamental to the psychological 
and emotional processes associated with implementing effective self-care.  Based on past 
chronic disease research (Anderson et al., 1995; Deakin et al., 2003; Mark, 2010) and the 
Diabetes Australia guidelines (Colagiuri et al., 2009), we wanted to ensure that patient 
empowerment was a key factor in the intervention.  In order to have a firm basis for design of 
such a program a critical initial step was to explore the perspectives of patients and GPs on 
type 2 diabetes self-management and emotions, and examine the role that such a program 
could potentially have.  We considered that the reliance of type 2 diabetes patients on GPs as 
primary carers for their disease management necessitated also obtaining the views of GPs on 
barriers and enablers with which patients commonly present during treatment.  Further, 
information about GPs’ insights into patients’ experiences may assist with efforts to enhance 
patient outcomes by promoting additional effective strategies and aiming to fulfil patients’ 
unmet needs.  These responses would help articulate issues that challenge and influence 
success with diabetes self-management. 
 Self-management of diabetes is influenced by an array of complex, inter-related 
factors associated with individual, social, and ecological domains (Fisher et al., 2005). 
Situations specific to each individual create unique challenges and enhancers of self-care 
(2002).  Personalised self-management interventions may be needed to best cater for the 
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extensive variety of diabetes self-management challenges that patients face according to their 
socioeconomic, interpersonal, and intrapersonal circumstances (Bandura, 1986; Fisher, 
Brownson, O'Toole, Anwuri, & Shetty, 2007).  Accordingly, the present study uses a 
qualitative, individualised approach that enables unique facilitators and barriers to self-care, 
as well as personally relevant emotional experiences, to emerge.  Further, consideration of 
these issues in the context of those identified in the recent literature and implementing strong 
theoretical (namely, Social Cognitive Theory and the Theory of Planned Behaviour) 
foundations is aimed to provide a conventional, evidence-based framework for the 
intervention.  Results from this trial inform the development of a menu of components within 
the web-based support program, from which users can select ones that best address their 
individual needs and most closely match their preferences.  This qualitative research forms 
the first, fundamental step in empowering patients to achieve better type 2 diabetes self-
management and wellbeing via a novel web-based self-management program. 
3.3 Method 
Participants 
 Participants in the patient sample (Study 1a) were: aged 18-75 years, diagnosed with 
type 2 diabetes ≥ 3 months ago, and living in Brisbane, Australia.  Recruitment took place at 
a Diabetes Australia – Queensland Expo.  Eligible individuals provided their telephone and e-
mail contact details, and preferred times for further contact and interview.  GPs (Study 1b) 
were in current practice and had experience treating type 2 diabetes patients.  Recruitment 
involved calling and sending letters to the general practice managers of 16 medical practices 
in Brisbane, and by direct personal approaches of individuals with type 2 diabetes who 
attended Diabetes Australia – Queensland expos.   
Measures 
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Participant characteristics/demographics 
Assessed patient characteristics included age, gender, occupation, relationship status, 
duration of type 2 diabetes, diabetes treatment regimen, types of practitioners involved in 
their diabetes care, accessed support for diabetes self-management and self-perceived 
diabetes status.  GPs completed a survey that assessed their age, gender, and duration of 
treating type 2 diabetes. 
Kessler-10 (K10) 
The patient sample completed the K10, which comprises 10 items assessing the 
frequency of symptoms of distress over the previous 30 days.  The scale has sound internal 
consistency and external validity for use in a type 2 diabetic population (Kessler & Mroczek, 
1994). 
Research Questions Explored Using Semi-Structured Interviews 
A qualitative, semi-structured interview was used to explore: (a) facilitators  and 
challenges in relation to effective type 2 diabetes self-care in general, and physical activity 
and healthy eating in particular; (d) emotional challenges associated with having type 2 
diabetes; and (e) suggestions for web-based support program content.  Patients were asked 
about circumstances in which they would use web-based type 2 diabetes self-management 
support, and GPs were asked about circumstances where they would refer patients to such a 
program. 
Procedure 
Interviews with the patient sample took place at the Wesley Research Institute and the 
Queensland University of Technology, both in Brisbane, Australia. Interviews with GPs took 
place at their practices or by phone.  All participants completed the preliminary survey (Study 
1a: demographic survey and K-10 scale; Study 1b: GP characteristics), followed by the semi-
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structured interview. All interviews were audio recorded, with participants’ consent.  
Approval for this study was granted by the relevant ethics and management committees - 
Uniting Care Human Research Ethics Committee (#Cassimatis9111) and the Queensland 
University of Technology University Human Research Ethics Committee (#1100000783).  
Analytic Strategy 
Interview data were transcribed verbatim, categories (major themes) and sub-
categories (minor themes) were derived based on common responses amongst the patient and 
GP samples.   Thematic analysis was used to analyse and present categories and sub-
categories (Charmaz, 2006).  Categories were derived separately for patients and GPs, and 
commonalities and variations in responses were then identified. 
3.4 Results 
Sample characteristics 
Patients (N= 13; 46% male) had a mean age of 57.1 (SD= 7.8) years and a mean type 
2 diabetes duration of 7.2 (SD= 3.8) years.  The majority (85%) were on anti-diabetes 
medication, with over 50% on diet, physical activity, tablets and insulin.  Most (>65%) saw a 
GP for their primary diabetes management.  Almost half the sample reported seeing an 
endocrinologist, though visits were typically less frequent than to their GP and often were 
restricted to occasions when they had management difficulties.  Patients’ average K-10 was 
16.3 (SD= 5.4, Range= 8 – 24), which indicates moderate symptoms of depression, anxiety, 
and/or psychological distress.  Most classified their diabetes control as mostly or fairly 
unstable, and 28% claimed that it was good or excellent. 
The GP sample comprised 12 practitioners (8 males) who were located in practices 
within the region of Brisbane, Australia, and had been treating type 2 diabetes for an average 
of 26 years (SD= 9.3).   
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Attitudes and perceptions regarding diabetes management 
 Table 1 displays themes around the attitudes and perceptions of the patient and GP 
samples regarding type 2 diabetes management.  Variations in responses between GPs and 
patients primarily occurred within sub-categories, rather than between major categories.  
Responses to questions about facilitators and barriers to general type 2 diabetes self-
management, participation in physical activity, and healthy eating also had very similar 
categories.  Where there was significant overlap, categories from these three domains were 
collapsed into common major categories. Categories that related specifically to only one 
domain of self-care are presented separately. 
    
 
Table 1. Common Categories and Sub-Categories on Facilitators of Type 2 Diabetes Self-Management 
Common categories Common sub-categories Patient Sample  GP Sample  
Informational support General diabetes self-
management 
Physical activity – 
enjoyable & appropriate 
options 
Nutrition – recipes, food 
groups, effects of foods 
on blood glucose 
Wider range of 
information sources  
Variety of activities 
 
 
 
Mainly doctors, allied 
health, leaflets 
Light, incidental 
exercise, stretching 
Social support Partner 
Family 
Friends 
Others with diabetes 
Counsellor 
Weight loss group 
 
Doctor-patient relationship Patient treatment choice 
Good communication 
Doctors help to 
understand diabetes 
Directive approach by 
doctor 
Explanation about 
treatment 
Proactive doctor 
Reasons and barriers to 
change 
Motivational support Reminders 
Goal-setting blood 
glucose, clinical targets 
(weight, blood 
pressure…) 
Monitoring – blood 
glucose, HbA1c 
Feedback – HbA1c, 
blood pressure, 
cholesterol 
Accountability to health 
professional 
 
 
Diet and Exercise 
Short-term incentives for 
self-care (energy, well-
being…) 
 
 
Clinical parameters 
(blood pressure, 
cholesterol, urinary 
albumin) 
 
Psychological support Acceptance of type 2 
diabetes 
 
Self-discipline/ 
“willpower” 
Own reasons to improve 
health 
 
Plan/ preparedness Routine – testing blood 
glucose at same time 
each day; fitting self-care 
including activity into 
daily routine 
Having a plan – physical 
activity plan 
Eat according to a 
routineDiet preparation – 
pack own food, choose 
from online menu before 
dining out 
 
Morbidity salience Timing in disease – early, 
before anti-diabetic 
medications 
Threat of diabetes 
complications 
When a complication is 
diagnosed 
 
    
 
Themes and Sub-themes across Facilitators and Barriers to Self-Care 
Tables 2 and 3 present the common major categories and sub-categories that were derived 
from interview responses regarding facilitators of and barriers to effective type 2 diabetes 
self-management, as perceived by both the patient and GP groups.  Patients specified more 
sub-categories for facilitators and barriers to self-management than did GPs.  Patients 
indicated that accessing a broad range of informational supports facilitated their diabetes self-
management; whereas being inadequately informed about diabetes self-management and 
processes of the disease was cited as a substantial barrier to adequate self-care.  However, 
GPs often cited patients’ lack of health literacy as a barrier to their understanding of diabetes, 
rather than primarily attributing it to a paucity of specific information, as the patient sample 
had.  GPs generally assumed that patients were well informed about reasons for insulin 
therapy and attributed patients’ reluctance to commence insulin to practical concerns and 
psychological barriers, rather than to confusion, which was reported by most of the patient 
group.   
Both samples indicated that having options for appropriate and enjoyable physical 
activities were helpful in encouraging greater involvement in physical activity.  Alternatively, 
being unsure about suitable and convenient activities was indicated by both groups as 
significantly limiting patients’ likelihood of physical activity participation.  GPs suggested 
that patients commonly held misconceptions about what constitutes physical activity.  
Nutritional information was regarded by both groups as fundamental to dietary adherence.  
Confusion about the effects of various foods on blood glucose levels, healthy alternatives to 
unhealthy food choices, and diabetes-friendly diet was regarded by both samples to be 
detrimental to patients’ efforts to maintain a healthy diet as well as being a source of 
hopelessness and frustration.  Psychosocial pressures presented major challenges to dietary 
adherence and physical activity.  In particular, eating out was commonly reported as a barrier, 
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and some patients reported only dining out rarely due to difficulty finding healthy options on 
the menu.   
 Patients mentioned more forms of social support than did GPs, indicating that 
members of their wider networks, including neighbours, facilitated their diabetes self-
management.  In contrast, GPs mainly focused on the role of family members.  Both patients 
and GPs said that a communicative patient-practitioner relationship supported diabetes self-
management.  While many patients advocated that their doctors use a directive approach, 
none of the GP sample mentioned this technique as a facilitator of self-care. 
 Patients said that accountability to health professionals motivated their self-
management, and reported that they put more effort into improving their glycaemic control 
and self-care shortly before an appointment.  Follow-up calls from health professionals, 
setting goals for blood glucose, assessing clinical parameters including weight, and providing 
progress feedback were considered to promote improved self-care.  Patients who kept an 
exercise and/ or diet log reported that this helped them maintain their motivation.  Both 
patients and GPs said that acceptance of type 2 diabetes and the receipt of psychological 
support were also important factors.  Patients emphasised a perceived importance of 
“willpower” for effective self-management but GPs did not specify this factor. 
 Both samples regarded having a plan and following a routine, including having set 
times for monitoring blood glucose and medication adherence, undertaking physical 
activities, and having meals, to be facilitative.  Dietary preparedness, including packing 
healthy foods and viewing restaurant menus online before dining out was also reported by 
patients to assist their nutritional adherence.  While patients said that awareness of the 
potential for diabetes complications motivated them to practise better self-care, GPs focused 
on the motivational power of having an actual diagnosis of a diabetes-related complication.  
Accordingly GPs suggested that a key factor in patients’ lack of awareness of the 
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consequences of type 2 diabetes was its asymptomatic nature, particularly in the disease’s 
early stages.  In contrast, patients said they were aware of the consequences of poor self-
management from the time of type 2 diabetes diagnosis. 
Emotional challenges associated with type 2 diabetes 
Table 3 summarises the common categories from patients and GPs concerning the emotional 
challenges presented by type 2 diabetes. 
    
 
Table 2. Categories and Sub-Categories on Barriers to Effective Type 2 Diabetes Self-Management 
Common Categories Common Sub-
categories 
Patient Sample  GP Sample  
Lack of information/ understanding Appropriate physical 
activities 
Conflicting nutrition 
information 
Type 2 diabetes 
causes, progression 
Reasons blood glucose 
fluctuates 
Ideal BGSM & med 
timing, purposes 
Not enough time to 
ask GP questions 
Nutritional values 
Do not understand 
consequences 
Asymptomatic = no 
need to manage 
Poor health literacy 
Physical activity 
misconceptions 
Do not understand diet 
Psychosocial pressures Social diet/ alcohol-
related pressures 
Family responsibilities 
Relationship conflict 
Special/ family 
occasions 
Friends/ family give 
unhealthy foods  
Eating out/ travelling 
“Psychological 
factors” 
Medication-taking barriers Forget medications/ 
BGSM 
Medication side 
effects 
“No point” to BGSM 
Get “sick of” BGSM 
Avoid testing high 
blood glucose 
Work– no time, 
deprioritise self-care 
Resist treatment 
regime complexity 
Difficulties accepting 
changes 
Resistance to insulin initiation Fear needles 
Self-perceived failure 
Feel responsible for 
going on insulin 
Belief exercise & diet 
control OK 
Fear insulin 
permanence 
Confused re effects of 
insulin 
Fear weight gain 
“Mental hurdle” for 
patients 
Practical limitations Financial costs – 
medications, health 
appointments, healthy 
food 
Physical activity-
weather, no time, 
tiredness 
Eating on the run 
Costs of diabetes 
supplies–lancets, test 
strips 
Eat high energy food 
“to stay awake” 
Limited restaurant 
menu options 
Costs of individual 
exercise 
Motivational issues Diabetes chronicity- 
adherence over time 
Comorbidities take 
priority 
Sense of defeat  
Want a break from 
treatment 
Tiredness/ exhaustion 
Weight gain, high 
HbA1c, poor BGLs 
Oppose living within 
boundaries 
Asymptomatic – no 
immediate 
biofeedback 
Psychological issues Stress – work, family, 
diabetes  
Emotional toll- 
treatment complexity 
Stress- fear 
complications 
Emotional eating, 
disinhibition, alcohol 
Depression 
    
 
Table 3. Categories and Sub-Categories on Emotional Challenges Associated with Having Type 2 Diabetes. 
Common Categories Common sub-
categories 
Patient Sample  GP Sample  
Reaction to initial diagnosis  “shock” and “fear” 
Feel responsible for 
onset 
 
 
Uncertainty about 
lifestyle 
implications  
‘Forced acceptance’ 
of diabetes 
Sense of 
powerlessness 
Regret– past 
lifestyle (self-blame) 
Anxiety about 
complications 
Difficulties 
accepting chronicity 
“Denial” reaction/ 
difficulty taking 
ownership 
Boosts in self-care 
motivation 
“Psychological 
factors” to deal with 
Fear of treatment 
regime commitment 
Resistance to anti-diabetes medications Fear of lifestyle 
restrictions 
Frustration – side 
effects 
Frustration, 
depression-treatment 
complexity, 
adherence issues 
Self-blame for not 
preventing 
medications  
Perceived failure for 
taking insulin 
Fear– medication 
taking control of 
body; weight gain 
Embarrassment 
about injecting 
insulin 
Discomfort- 
Perceived stigma re 
injecting 
“Mental hurdle” for 
patients 
Difficulties accepting diabetes chronicity Depression- non-
adherence; need to 
maintain lifestyle 
changes 
Distress– boundaries 
“Battle metaphor” 
Worry- 
consequences of 
going off track 
“Emotional battle”– 
lifestyle changes 
required to keep 
good diabetes 
control 
Difficulties managing type 2 diabetes Frustration, worry- 
high blood glucose/ 
fluctuations; not 
meeting treatment 
targets 
Avoidance/ non-
adherence 
Depression 
Hopelessness/ 
powerlessness 
Guilt- not achieving 
treatment targets 
Anger, distress- 
treatment 
complexity 
Distress related to future health prognosis Current 
complications 
Depression- 
comorbidities 
Worry- impending 
physical impairment 
Fears of developing 
complications 
Uncertainty- effects 
on body 
Anxiety- poor 
glucose control 
Frustration - 
physical limitations 
Distress Self-care 
motivation increase 
Dysphoria pattern 
related to diabetes 
progression 
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Reaction to initial diagnosis 
 Most patients and GPs initially discussed patients’ reactions to the diabetes diagnosis.  
Patients said that uncertainty about the implications of diabetes for their lifestyle and long-
term wellbeing resulted in distress and feeling ‘down’.  One woman recollected:  
So I just say to myself the only thing...how come I got to this stage to have this?  And 
that’s the thing, is that it worries me, and that’s it. There’s nothing I can do to change it.  
 Many patients reported feeling guilty upon receiving the diagnosis and were upset 
about being responsible for its development.  A middle-aged woman who had been 
overweight before her diagnosis said: 
It comes back to that emotional thing about, have I really, seriously...has my pancreas 
really done the dinner, and that’s it for me, and I can’t ever return back to normal... 
 GPs acknowledged the emotional impact of a type 2 diabetes diagnosis, and 
commonly attributed this reaction to difficulties patients had with accepting diabetes’ 
chronicity.  They unanimously reported that the shock experienced by patients at diagnosis 
resulted in an initial boost of motivation to make positive lifestyle changes, largely to avoid 
going on diabetes medications.  Many patients also reported this reaction and its motivation. 
 While some patients reacted to distress over the diagnosis by making lifestyle 
changes, for some, a sense of powerlessness undermined any attempt to manage their 
diabetes.  A middle-aged man said he never attempted to follow his doctor’s treatment 
recommendations:  
...you sort of realise the uselessness of doing anything.  I mean, I take my medication, 
and that’s about all.  If my sugar is high, what can I do about it? 
 In general, patients said that feelings of initial shock at diagnosis eventually gave way 
to acceptance of their diabetes and awareness of its implications for their lifestyle. However, 
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anxiety about its effects on the body remained, and was present in most of patients, from the 
newly diagnosed to those who had the disorder for ten years or more.  In contrast, GPs 
suggested that patients were initially unaware of the consequences of type 2 diabetes. 
Resistance to anti-diabetes medications 
 All patients and many GPs reported a reluctance to take anti-diabetes medications, 
especially insulin.  Patients commonly reported frustration due to medication side effects.  A 
male in his 60’s who suffered erectile dysfunction, claimed it was exacerbated by his oral 
medication. 
I still take the tablets...and I grit, and I yell, and I scream a bit, and my wife says, “Just 
calm down,” but I think you do sort of then think, “Well hell, I don’t want it to get any 
worse, you know.” 
Patients voiced their concerns about medications taking control of their body and 
further restricting their lifestyle, particularly as the complexity of the treatment regime 
increased.  Even patients already taking insulin who claimed it improved their blood glucose 
levels and gave them more energy, discussed wanting to “get off the insulin, or at least reduce 
the dose I’m on.” Some patients said they were embarrassed to inject themselves, and 
believed that there was a public stigma about using needles.  A female in her early 60’s 
reported feeling uncomfortable about discussing her fears about injecting insulin with her 
doctor, who had told her that it was “silly” to feel that way. 
 Patients commonly perceived that insulin therapy was preventable or reversible if 
they could exercise enough “willpower” in adhering to lifestyle recommendations.  Patients 
idealised a life without diabetes medication.  A male who had been on insulin for the past 8 
years said: 
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...as they say, it’s not a lifetime thing with type 2 (diabetes). You can manage it, and if 
you get on top of it, manage it with your diet, which is great. And that’s your challenge, 
your goal; to be insulin free and tablet free, and I think if you can strive for it, it’s a 
good challenge; strive for it. 
 Surprisingly, most patients who expressed similar beliefs indicated that their view was 
endorsed by their GP or endocrinologist. 
Patients commonly described having received warnings from their doctors that they 
would need to take tablets or insulin if they did not improve their exercise and diet.  The 
negative connotation commonly associated with requiring medication, appeared to exacerbate 
their anxiety and reluctance about commencing it.  Perhaps as a result of the idealisation of 
non-pharmacological diabetes management, patients on insulin reported guilt and a sense of 
being at fault or having failed. 
 GPs commonly expressed concerns that resistance to commencing insulin was 
impairing their patients’ glycaemic control.  They acknowledged that most patients were 
afraid to start insulin, but regarded its resolution as an issue that needed to take its own 
course. 
Difficulties accepting the chronicity of type 2 diabetes  
 Patients and GPs indicated that one of the most common emotionally challenging 
aspects of having type 2 diabetes was its chronic nature.  Many patients used the “battle 
metaphor” in describing their attempts to achieve good diabetes control, and three women 
cried as they discussed their experiences. One commented: 
...it’s just that constant bringing yourself back on track and just remembering that it is 
one day at a time, basically. 
Another described the constant discipline required to effectively manage type 2 diabetes as: 
124 
 
 
...a constant battle to do what’s right and to try and keep away from what’s wrong. 
A third described it as: 
...the constant battle, I think...the battle to get it into a manageable state and keeping it 
there is...I think for me, the biggest emotional thing, as you can tell.” 
 Patients commonly regarded Type 2 diabetes as inflicting an eternal boundary on their 
lifestyle flexibility, with no leniency for lapses in their health behaviours. One woman 
reflected: 
...I always want to keep it (diet and exercise) under control anyway, but I guess this is 
going to keep me....going:  I can’t stop doing what I’m doing. I guess it’s about no 
choice. When you feel that you have no choice, it’s no longer an option for you. 
GPs acknowledged patients’ distress and frustrations about the need for long-term 
commitment to lifestyle and treatment regimens and commonly said that this issue severely 
affected patients’ self-management.  Substantial congruence was seen in patients’ and GPs’ 
views about the emotional impact of diabetes, although patients went into more depth in 
describing their experiences. 
Difficulties managing type 2 diabetes 
 Patients commonly reported distress about problems with control of their diabetes, 
particularly when they had expended great effort in their attempt.  GPs also noted that this 
caused patients frustration and distress.  One patient summed up the views of many:  
...you just get to a stage where it’s unmanageable, and then it [HbA1c level] goes out, 
and I think, ‘What have I changed?’ and I’ve changed nothing.  Even when you’re 
thoroughly on track, and you’re doing everything you’re supposed to, it’s still all over 
the shop, so that’s hard. 
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 Some patients reported avoiding blood glucose self-monitoring because they did not 
see the point, but this was rare.  More commonly, they reported avoiding self-monitoring 
when they thought their blood glucose level was high.  Some reduced the frequency of testing 
to avoid negative emotional impacts from detection of fluctuations: 
I’ve tried not to do too many blood glucose tests during the day because I do fluctuate a 
fair bit in the day time. It’s very, very worrying. 
GPs reported similar observations:  
A lot find it hard to continue to monitor and evaluate their diabetes when their control 
is not very good.  
They empathised with patients’ anger and distress concerning their treatment regimen.  Some 
reported that patients sometimes directed anger toward their practitioners:  
...if they don’t see a quick response in their blood sugars, they’ll come back and say to 
me, “I stuck to that diet you gave me that time, and look at this!  My blood sugars have 
been awful and I’ve actually put on a kilo.”  They don’t see the point, and that’s a 
difficult challenge. 
Distress related to future health prognosis 
Patients reported distress and worry about their future health, and particularly about 
developing diabetes complications, and GPs also reported this issue.  This emotional response 
was exacerbated by difficulties controlling blood glucose levels, and many patients reported 
that it increased with the duration of inadequate blood glucose control.  A woman who had 
been diagnosed 6 months prior to the interview and who had difficulties balancing her weight 
and medications, said: 
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...the longer it’s unmanageable, I think the greater the possibility that complications 
will occur, and I know that I’ve got to get it to a manageable state to forestall the 
complications. 
In contrast, no GP described patient distress over potential complications, instead 
suggesting that patients only realised the consequences of inadequate diabetes control when 
actually diagnosed with a complication. Some GPs described the patients’ dysphoria as 
typical of chronic diseases in general: 
I find that with any chronic disease, any change in their condition is a whole, new 
grieving step.  Each time something changes they have to reacquaint themselves with 
the idea of having diabetes all over again. 
There was consensus amongst GPs that a diabetes complication reminded patients of 
their mortality and the importance of self-care to prevent further physical and emotional 
debilitation. GPs reported that patients’ motivation for self-care increased at the onset of a 
complication.  They reported noticing a pattern of dysphoria that was related to the stages of 
type 2 diabetes progression, from diagnosis to the disease endpoint. 
Many patients reported worry about limitations to their physical abilities, and 
frustration that these limitations would restrict their activity and impair their ability to 
improve glycaemic control. Feelings of loss were common, as reported by a middle-aged 
patient: 
I had this awful thought once when I was out walking, that I may never be able to run 
again, and as I was a very, very active teenager and 20 year old...that was a real shock 
to me. 
Declines in physical ability were commonly attributed by patients, including those in their 
40’s and 50’s, as normal ageing.  Having diabetes seemed to bring reflections on a range of 
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reduced physical capabilities to attention, which accentuated frustration and distress.  Lack of 
perceived physical capability was commonly cited as a barrier to being active.  As stated by a 
woman in her 40’s: 
It’s just the fact that I’m getting older, it’s getting harder, and I can tell you everything 
that’s the right thing to do, but actually doing it is the...hardest thing. 
    
 
Table 4. Patients’ and GPs’ Suggestions for Online Program Content Inclusions. 
Common Categories Common sub-categories Patient Sample  GP Sample  
Self-monitoring tools Blood glucose levels 
HbA1c level 
Diet 
Exercise 
Emotions Blood pressure, 
cholesterol, urinary 
albumin 
Weight  
Feedback Goal progress – clinical 
parameters 
 
 
Daily blood glucose 
levels 
Reinforcement - self-care 
targets 
Information Nutrition 
Physical activity 
General type 2 diabetes  
Medications – purposes, 
effects 
Referrals to health 
professionals 
Frequently asked 
questions section 
Contact with health 
professional/s 
Diabetes complications 
Worksheets – how 
insulin changes blood 
glucose levels, dosage 
guide 
Foot care – how to check 
feet, signs of 
complications… 
Instructions on finding 
own pulse 
 
Motivational support Appointment reminders 
Self-care reminders - 
emails 
Help with the 
“psychology of it” (self-
management) 
Motivational tools 
Physical activity/ 
stretching videos 
  Social support – chat 
room/ forum 
 
  Emotional support – help 
with feeling down 
 
 
Suggestions for online program inclusions 
Patients’ and GPs’ suggestions for online program inclusions are presented in Table 4.  
Overall, patients were in favour of using an online diabetes support program.  Just one patient 
indicated that she would not use such a program, as she opposed the use of technology in 
general, including mobile phones.  Common suggestions for components to incorporate in an 
online diabetes support program overlapped with patients’ and GPs’ perceived barriers and 
facilitators to adequate diabetes self-management.  Additionally, many patients suggested 
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including a chat program or blog site, and access to e-mail contact with a health care 
professional in the program. 
Patients considered the benefits of an online support program to include anonymity to 
discuss private health issues and for, “Somewhere you could go when you’re having a really 
bad day”.  Patients said online information would be easier to refer to than paper-based 
information, and it would be useful to have more regular support between seeing health care 
professionals.  Two patients did not own a computer but claimed they would use an online 
program from a friend’s house or library.  Patients indicated that they would find an online 
diabetes support program, “really helpful”. 
 In contrast to the patient sample, GPs suggested presenting information about the 
consequences of poor glycaemic control, including photographs of retinas inflicted by 
diabetic retinopathy, and foot complications that were not too graphic.  They indicated that 
patients should be able to relate to the included content, and indicated that they would most 
likely refer their younger type 2 diabetes patients (< 60 years) to an online support program.  
The cross-cultural relevance of the program was mentioned as a dictating factor in one 
doctor’s decision about whether to refer ethnic patients to the program.  GPs emphasised the 
importance of knowing that the program was established by reputable professionals.  Their 
own familiarity with the nature of the program’s content in the first instance was also cited as 
an important determinant of their referral likelihood.  In general, GPs supported referring 
their patients to an online diabetes self-management support program, with the major 
contention being that older patients may have difficulty using it.  However, some suggested 
taking older patients through instructions on how to use the program as a solution. 
Overarching themes that summarised responses to each of the questions were 
identified that describe the major areas facing patients in managing type 2 diabetes.  
Specifically, these themes were centred on the areas of: practical, psychosocial, and 
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psychological/ motivational factors.  A primary practical constituent that was considered 
fundamental to effective diabetes self-management by patients and GPs was informational 
support.  Both samples indicated that lack of adequate information undermined effective 
diabetes self-management and resulted in confusion when patients attempted to make day-to-
day decisions about diet and medications.  Accordingly, patients reported that lack of 
understanding accentuated emotional difficulties in coping with diabetes.  In addition, having 
the practical means to enable effective self-care, including adequate financial resources, 
environmental conditions for physical activity, and access to healthy food choices, were also 
important to stable self-management.  Under the broad theme of psychosocial support, social 
support from partners, family members, and friends was considered to be essential to 
effective self-care.  In addition, the doctor-patient relationship was considered a key influence 
of patients’ self-management behaviours.  Psychological and motivational support was seen 
as vital by both samples to enable optimum emotional well-being and the maintenance of 
recommended self-care.  In particular, issues including daily work-related and interpersonal 
as well as diabetes-related stress and feeling depressed were emphasised by patients as 
problematic to their well-being and self-care.  Patients reported that these issues tended to 
increase their resistance to consistent medication-taking and in particular their dietary 
adherence.  GPs indicated that emotional disturbance in patients was particularly common, 
and that this tended to influence their efforts to effectively supporting patients with their self-
management. 
Links to online support program components 
Overall, interview results provided useful feedback from patients and GPs regarding 
their experiences managing type 2 diabetes.  Specifically, the importance of using a holistic 
approach in supporting the effective day-to-day management of the condition was 
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emphasised.  The relevance of emotional support as a key influential factor to self-care was 
made clear by both samples, as well as practical and psychosocial support.  
3.5 Discussion 
 Overall, the perceptions of patients and GPs showed close correspondence, although 
patients’ reports were more detailed and more thoroughly emphasised ongoing, daily 
challenges than GPs’ reports.  It appeared that patients may not fully share their emotions and 
related concerns with their GPs, which may be due to a number of factors, including the time-
limited nature of medical consultations, inadequate screening for emotional issues in diabetes 
patients, and difficulties in communication [2002; (Maddigan, Majumdar, & Johnson, 2005)].  
While GPs acknowledged that patients sometimes struggled with emotional issues, especially 
in relation to initial diagnosis and to insulin therapy, they most commonly explained patients’ 
barriers to self-care in terms of practical factors. 
Findings of the current study are consistent with an ecological perspective on diabetes 
management, which emphasises the contributions of individual, psychosocial and ecological 
factors in optimal diabetes management (E. B. Fisher et al., 2005).  Our results are also 
consistent with those of the Diabetes Attitudes, Wishes and Needs (DAWN) Study, which 
indicated that social relationships are crucial to assisting patients to implement effective 
coping strategies in managing their diabetes Alberti, 2002).  The present study confirmed that 
a social support network can be conducive to encouraging physical activity and dietary 
adherence, and may also buffer against some barriers to self-care, such as eating to alleviate 
loneliness or depression.  However, similar to the DAWN Study results (Alberti, 2002), the 
current study found that some family influences detrimentally affected patients’ diabetes self-
management.  For example, many patients and GPs recognised that family pressures 
including relationship conflict and demands by children led patients to fail to prioritise 
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diabetes management.  Further, these situations induced stress, which affected patients’ 
capacity for self-care. 
 Although K-10 scores suggested that there were no extremely distressed patients in 
our sample, most participants in the patient group exhibited emotional vulnerability as they 
discussed their experiences.  This was particularly evident as they described the challenges 
involved in daily diabetes self-management, in particular when it was difficult to maintain 
adequate blood glucose control, with many unable to understand why this was occurring.  
Self-blame was common amongst patients, particularly when they did not fully adhere to 
their treatment regimen.  Beverly and colleagues (Beverly et al., 2012) recently reported that 
physicians also feel responsible for their patients’ difficulties in meeting treatment targets, 
although that was not seen in the current study.  In future, GPs’ own emotional responses to 
management of type 2 diabetes would be a useful vantage point from which to further unpack 
patient-provider issues in diabetes self-management intervention. 
The need for additional behavioural self-management, emotional, and motivational 
support was unanimously expressed by patients.  This result was consistent with baseline 
findings of the landmark Australian study, Diabetes MILES (management and impact for 
long-term empowerment and success), which emphasised the importance of behavioural, 
psychological and psychosocial support if diabetes patients are to optimise their wellbeing 
and health outcomes (Speight, Browne, Holmes-Truscott, Hendrieckx, & Pouwer, 2012). 
Most patients were enthusiastic about the idea of a web-based diabetes self-
management support program.  Two participants who did not own a computer said they 
would happily use the program at a friend’s house or library, and only one was adamant that 
they would not use any technological support, including a mobile phone.  Most GPs indicated 
that they would refer any type 2 diabetes patients who were interested in a web-based support 
program.  They argued that technology might be difficult for older patients to use.  One GP 
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suggested making the program available in an outpatient clinic or medical surgery so that 
patients could be shown how to use it, or alternatively offering a set of “stepped tutorials” to 
learn how to use the program.  In fact, previous web-based type 2 diabetes self-management 
interventions specifically trialled in older type 2 diabetes populations have demonstrated 
reasonable acceptability, utility and usability (Bond et al., 2007; Cho & et al., 2010). 
Overall, interview findings demonstrate external validity when compared with other 
research studies on facilitators and barriers to diabetes self-care (Beverly et al., 2012; Hayes 
et al., 2006; Nam et al., 2011) and on emotional experiences in managing the condition 
(Beeney, Bakry, & Dunn, 1996).  Being a qualitative study, this research has the limitation of 
potential sample bias.  It was acknowledged that the sample was chosen primarily from the 
Brisbane area, in which case they may have differential views to those of patients and GPs 
residing in more remote areas.  However, this limitation is tempered by the fact that the 
purpose of the research was used to provide information about type 2 diabetes patients’ 
personal experiences with the condition, and GPs views that would serve to complement, 
rather than replace, current empirical research in informing the development of an online 
support program.  Further limitations include the relatively small sample size, which limits 
the generalisability of findings to the current study cohorts.  Time limitations also prevented a 
rural or remote sample from inclusion in the study.  However, the authors were able to garner 
challenges faced by rurally residing type 2 diabetes patients from the literature, whilst the 
program aims to meet personalised emotional and self-management challenges that may 
affect both rural/ remote and metropolitan-residing patients.  In light of these limitations, 
web-based program content was aimed to be developed using a strong evidence basis from 
the current literature and the professional expertise of research team members and additional 
allied health professionals.  Findings from the present study indicate the potential for 
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assisting patients with managing a variety of challenges that are associated with type 2 
diabetes self-management and dysphoria using a web-based program. 
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What is already known about this topic 
• Adherence to optimal diabetes self-management is a significant community health 
issue 
• Depression and anxiety symptoms are 2-3 times more common in people with 
diabetes. 
• For optimum efficacy, diabetes self-management interventions should address 
emotional as well as behavioural self-management issues. 
• People with diabetes in rural and regional areas face additional barriers to receiving 
self-management support. 
What this paper adds 
• Both patients and practitioners identify dietary self-management is their key 
challenge.  
• Emotional issues that are experienced by people with type 2 diabetes only partially 
correspond with those reported by practitioners. 
• A need for additional motivational and practical support for emotional challenges and 
self-care, including a web-based program, is identified by both patients and 
practitioners. 
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3.6 Chapter Summary and Conclusions 
This paper emphasised patients’ needs for additional psychological, emotional and 
Type 2 diabetes self-management support from both patient and practitioner perspectives.  
Further, results indicated that the web was considered acceptable to this population as a 
means of intervention delivery.  These outcomes were fundamental to Stage 2 of the research 
program, in which responses informed the content that was included in the OnTrack Diabetes 
program. 
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CHAPTER 4 
STUDY PROTOCOL FOR A TRIAL OF THE ON-TRACK WEB-BASED PROGRAM 
FOR SELF-MANAGEMENT OF TYPE 2 DIABETES AND DYSPHORIA 
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Abstract 
Background:  Type 2 diabetes prevalence is rising, with the majority of affected people 
having inadequate disease self-management.  Depression, anxiety and diabetes-specific 
distress present additional challenges to motivational issues experienced by patients in 
relation to self-care.  Internationally, health systems struggle to deliver routine specialist 
services which are equally accessible across the population.  The popularity of web-based 
intervention delivery among people with diabetes is increasing, as it has the potential to 
provide frequent, accessible support, regardless of time and location.  This paper describes 
the study protocol of an Australian national randomised controlled trial of the OnTrack 
Diabetes program. OnTrack Diabetes is an automated, interactive, self-guided, web-based 
program aimed at improving and maintaining glycaemic control, diabetes self-care and 
dysphoria symptoms in patients with Type 2 diabetes. 
Objective:  The objective of this paper was to report on the stages involved in the 
development and evaluation of the OnTrack Diabetes program in order to elucidate the 
processes involved in this trial.  The aim of this was to inform researchers about the sequence 
of stages adopted in creating a web-based intervention of this nature and to enable 
associations to be established between trial processes and outcomes.  
Methods/Design:  Three stages are involved in the processes of program development, pilot 
testing, and the main trial of the OnTrack Diabetes program.  Initially, qualitative interviews 
of General Practitioners and people with Type 2 Diabetes were undertaken to inform program 
content.  Study 1 is a three-arm, randomised-controlled pilot trial that tests program 
functionality, effectiveness, and user acceptability and satisfaction.  Pilot trial arms include: 
(i) wait-list control – undertakes usual diabetes care for three months post-baseline followed 
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by full-program access; (ii) brief, modified (physical activity) arm – receives access to a 
brief, modified version of the program, which includes access to diabetes information 
resources and the physical activity module from baseline to trial endpoint; and (iii) full 
intervention – receives full program access from baseline to trial endpoint.  The main RCT 
(Study 2) implements two study conditions which include: (i) wait-list control – undertakes 
usual diabetes care for three months post-baseline, followed by access to the full OnTrack 
Diabetes program, and (ii) full intervention – receives full program access from baseline to 
trial endpoint.  Measures are at baseline, 3-, 6-, and 12-month follow-up for the pilot and 
main trial.  Primary outcomes are glycosylated haemoglobin A1c (HbA1c) level and 
depression, anxiety, and diabetes-specific distress.  Secondary outcomes are diabetes self-
care adherence, self-efficacy, and quality of life.  Cost-effectiveness, access to community 
resources and program uptake, acceptance, perceived usability, utility, and user satisfaction, 
and implementation feasibility will also be evaluated. 
Results:  This trial is currently ongoing with funding support from the Wesley Research 
Institute in Brisbane, Australia, and with clinical trial registration from the Australian and 
New Zealand Clinical Trials Registry (Registration number: ACTRN12612000620820). 
Discussion:  This is the first known trial of an automated, self-guided, web-based support 
program that uses a holistic approach in targeting both Type 2 diabetes self-management and 
dysphoria.  Findings will inform the effectiveness and practicality of implementing such a 
program in the real-world context, including in rural and regional locations. 
KEYWORDS  
Type 2 diabetes; depression; anxiety; self-management; internet; web; online; intervention; 
randomised; protocol 
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4.2 Introduction 
Diabetes affects an estimated 346 million people globally and Type 2 diabetes accounts for 
85 - 90% of all cases (WHO, 2011a).  In Australia, Type 2 diabetes affects 3.8% of the 
population and the direct healthcare were estimated to cost Australians AUD$828 (1AUD = 
1.04USD) million per annum 2004-05 (AIHW, 2008).  Diabetes is the eighth-highest burden 
of disease, and Type 2 diabetes accounts for 92% of this burden (AIHW, 2012a).  With the 
rapidly rising prevalence of diabetes the impact of inadequate diabetes self-management 
continues to increase, and resulting diabetes complications and premature mortality become 
more urgent to address.  Diabetes is the leading cause of blindness, end-stage renal disease 
and lower limb amputation in the world (WHO, 2011a).  Moreover, the effects of diabetes on 
quality of life, mental health, work productivity and other intangible losses are substantial 
and add further to diabetes-related burden. 
Depression (Ali et al., 2006; Anderson et al., 2001) and anxiety (Grigsby et al., 2002) are 
significantly more prevalent in people with diabetes than in the general population.  Co-
morbid mental health conditions are barriers to effective diabetes self-care (Gonzalez, Safren, 
et al., 2008) and further increase diabetes-related governmental costs (Egede et al., 2002).  
Dysphoria complicates the achievement of adequate glycaemic control through several 
mechanisms.  Comorbid depression and/or anxiety with diabetes predispose individuals to 
diabetes-specific distress (Fisher et al., 2009; Kokoszka, Pouwer, Jodko, Radzio, MuÄ‡ko, et 
al., 2009), affecting glycaemic control (Fisher, Mullan, et al., 2010), both directly (via 
physiological mechanisms), and by increased vulnerability to self-care non-adherence 
(Gonzalez et al., 2008; Katon et al., 2010; Scollan-Koliopoulos et al., 2010).  Even 
subclinical manifestations such as dysphoria are associated with clinically deleterious 
outcomes, including reduced self-care (Gonzalez, Safren, et al., 2008), poorer glycaemic 
control (Anderson et al., 2002; Pouwer et al., 2010), increased incidence and progression of 
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diabetes complications (de Groot et al., 2001; Williams et al., 2010) and greater disability 
(Von Korff et al., 2005).  Stress additionally contributes to other common physical co-
morbidities in diabetes patients, including the metabolic syndrome and cardiovascular disease 
(Kyrou & Tsigos, 2009).  The combined effects of inadequate glycaemic control and 
dysphoria on morbidity and mortality in people with diabetes (Egede et al., 2005; Zhang et 
al., 2005) calls for urgent intervention.  
Prior research indicates the need for behavioural diabetes self-management interventions to 
incorporate psychological and emotional support components for optimum efficacy (Fisher et 
al., 2007).  Improvements in diabetes self-care are strongly associated with improved 
glycaemic control (Asche, LaFleur, & Conner, 2011; Holman et al., 2008), which indicates 
that providing behavioural intervention to support diabetes self-care can be successful in 
improving diabetes-related clinical and self-care outcomes (Heinrich, Schaper, & de Vries, 
2010).  However, improvements in glycaemic control are not generally associated with 
significant improvements in mood (Fisher et al., 2007).  Conversely, psychological 
treatments for depression and anxiety in people with diabetes do not reliably produce 
improvements in glycaemic control (Ismail et al., 2004).  However, diabetes self-
management interventions do not typically address both issues, and perhaps partly as a result, 
single-focused interventions report limited success in improving both glycaemic and 
psychological outcomes (Wang et al., 2008).  In addition, trials on self-management 
interventions are often followed up over relatively short periods (e.g. 6 months or less 
(Ramadas et al., 2011)), preventing assessment of their long-term effects.  
Internationally, health systems have limited capacity to provide adequate Type 2 diabetes 
self-management support and intervention (AIHW, 2008).  System-level barriers include a 
shortage of health professionals and inadequate availability of services and resources in 
geographically rural and remote regions.  Health practitioners are challenged by 
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practitioner/patient communication barriers, time-limited medical consultations, an inability 
to provide required psychological interventions (Peyrot et al., 2005), and a lack of standard 
guidelines for dysphoria screening in diabetes.  Patient-level barriers to appropriate care 
include complexity of the Type 2 diabetes treatment regime (Odegard & Capoccia, 2007), 
poor recognition of dysphoria symptoms (National Institute for Health and Clinical 
Excellence., 2010; Pouwer, 2009), patients’ failure to acknowledge a need for support, and 
lack of motivation to significantly improve lifestyle behaviours (Hayes, McCahon, Reeve 
Panahi, Hamre, & Pholman, 2007).  While deficiencies in the availability of highly cost-
effective diabetes self-management interventions continue, health systems will remain 
challenged to meet the demands for additional support to enable optimum diabetes self-
management.  This shortcoming will particularly affect patients at risk of psychological 
comorbidities (Anderson et al., 2001). 
Recent evidence demonstrates that web-based diabetes self-management interventions have 
good potential efficacy, feasibility, user acceptance, and uptake (Ramadas et al., 2011).  
Web-based programs offer potentially cost-effective, easily accessible, and ongoing support 
with wide-spread dissemination and outreach (Griffiths, Lindenmeyer, Powell, Lowe, & 
Thorogood, 2006).  They can encourage early recognition of dysphoria symptoms, suggest 
strategies for addressing these symptoms and assist patients to overcome reluctance to seek 
psychological treatment, within an anonymous or safe and confidential context.  Web-based 
diabetes support programs have demonstrated producing statistically significant 
improvements in clinical, behavioural (Glasgow et al., 2003; Glasgow et al., 2006; Liebreich, 
Plotnikoff, Courneya, & Boulé, 2009), psychological, emotional, and psychosocial outcomes 
(Bond et al., 2010).  Additionally promising is the high uptake and acceptability of online 
Type 2 diabetes self-management support programs by users, including mature (Bond et al., 
2007) and novice diabetic users (McKay, King, Eakin, Seeley, & Glasgow, 2001).  
  145 
 
 
Recently trialled web-based diabetes self-management programs based on Social Cognitive 
Theory [SCT (Bandura, 1986)] have demonstrated effectiveness (Anderson-Bill, Winett, & 
Wojcik, 2011; Liebreich et al., 2009; Lorig, 2010).  Central tenets of SCT include self-
efficacy, or one’s belief in their capabilities to execute desired courses of action, and outcome 
expectancies, or personal predictions of likely outcomes resulting from certain courses of 
action (Bandura, 1986).  SCT encompasses the key recommendations in national practice 
guidelines for diabetes management (Australian Centre for Diabetes Strategies, 2010).  These 
include encouraging patient empowerment (promoting self-efficacy), ongoing monitoring of 
target outcomes (self-evaluation), and providing diabetes education (instructions).  SCT 
thereby provides a theoretical avenue by which to address both behavioural self-management 
and emotional issues (Bandura, 2004b).  Self-efficacy has significant positive associations 
with behavioural outcomes including physical activity participation (Plotnikoff et al., 2008; 
Plotnikoff et al., 2011), nutrition intake (Nouwen et al., 2011; Savoca & Miller, 2001), 
weight loss (Winett, Tate, Anderson, Wojcik, & Winett, 2005) and diabetes self-care 
(Weinger, Butler, Welch, & La Greca, 2005), as well as with emotional outcomes, including 
depression (Sacco et al., 2007) symptoms, in people with diabetes.  
Web-based diabetes self-management programs have demonstrated producing positive effects 
on psychological and emotional outcomes, but there are some inconsistencies in their results 
and further data are needed on their potential to improve glycaemic control (Markowitz et al., 
2011).  For example, Lorig et al. trialled a diabetes self-management intervention that 
included modules to assist users in coping with emotional challenges both related and 
unrelated to diabetes as well as relaxation audios (Lorig et al., 2010).  While improvements 
were found in self-efficacy, patient activation and glycosylated haemoglobin (HbA1c) level 
at 6 months post-enrolment, there was no significant improvement in health behaviours 
including exercise participation.  Emotional outcomes and effects on long-term glycaemia 
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were not determined.  Conversely, Glasgow and colleagues similarly reported that their 
internet-based diabetes education program (D-Net) did not significantly improve mood or 
glycaemic control, but the program was found to produce significant improvements in 
behavioural and psychosocial outcomes (Glasgow et al., 2003).  Hence, current trials indicate 
promise for web-based programs to provide diabetes self-care intervention, whilst indicating 
a need to report on and further enrich their effects on both mood and glycaemia. 
A mood-specific intervention is currently being trialled in the Netherlands and examines a 
cognitive-behaviour therapy (CBT), web-based program that targets depression symptoms 
and psychological distress in people with diabetes (van Bastelaar et al., 2011).  A structured 
sequence of lessons is provided, following which participants are required to submit weekly 
homework tasks to a “coach” who provides feedback by e-mail.  Participants can self-monitor 
mood within the program and are encouraged to relate this to their own offline blood glucose 
self-monitoring record.  Guided programs of this nature may be tailored to meet the general 
needs of the diabetic population and have shown efficacy in improving the health outcomes 
that they specifically target. However, Type 2 diabetics must maintain consistent self-care in 
the context of unique daily challenges, which include psychosocial (Fisher, 2006) and 
emotional stressors (Alberti, 2002), which suggests that personalised, self-guided behavioural 
and emotional support may be optimally efficacious in improving overall wellbeing.  Thus, 
there remains a need for research on the effects of web-based interventions with components 
that target improving both dysphoria and diabetes self-care (Markowitz et al., 2011).  
Personalised web interventions that utilise a holistically inclusive approach to diabetes self-
management intervention can inform the refinement of current programs and enhance the 
development of future ones.  Further, holistic web programs that combine diabetes self-care 
and mood intervention may be more appropriate in supporting users’ individual daily 
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challenges, and have potential implications for addressing both short- and long-term disease 
management, psychological, and emotional issues. 
This paper describes the study protocol for two randomised controlled trials of the OnTrack 
Diabetes program, an automated, web-based intervention aimed to achieve and maintain 
improvements in Type 2 diabetes self-management and dysphoria symptoms.  Specifically, 
the program targets physical activity participation, nutrition, adherence to health routines, and 
mood disturbance (depression, anxiety and everyday stressors).  Information resources and 
program content were in part guided by an initial study conducted by the first author, which 
involved qualitative interviews of people with Type 2 diabetes and General Practitioners 
(GPs; Figure 1).  Participants were questioned about self-perceived barriers and enablers to 
effective Type 2 diabetes self-care, emotional challenges associated with managing diabetes, 
and requirements for additional support.  Type 2 diabetic participants were asked if they 
would use an online diabetes self-management support program, and GPs were asked the 
circumstances in which they would refer their patients to such a program.  Both groups were 
asked to provide suggestions for program content and diabetes self-care areas that should be 
addressed. 
OnTrack Diabetes is based on SCT and incorporates CBT and motivational interviewing 
techniques.  Specifically, the program includes informational resources; goal-setting, 
planning, creating routines for self-care behaviours, feeling confident and problem solving 
via interactive tools; goal attainment scaling via self-monitoring tools, quizzes, and 
automated feedback graphs; relaxation and mindfulness audios; and an electronic diary.  
Users are encouraged to increase their access to social support due to the fundamental role of 
psychosocial factors in facilitating behaviour change (Anderson-Bill et al., 2011).  Increased 
access to health providers in their diabetes care team is also promoted.  Whilst program 
sections appear in an ordered structure, users can choose to undertake segments in any 
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order—a feature that is intended to foster user empowerment (Anderson et al., 1995).  Both 
provided text and entered text is minimised, with extensive use of icons and pictures, simple 
sentences and vocabulary, so that reading requirements do not exceed Year 7 educational 
levels.  OnTrack Diabetes builds upon previous work by Kavanagh and colleagues, with their 
OnTrack Alcohol and Depression program providing a basis for the OnTrack Diabetes layout 
and a majority of the information technology programming logic.  
A pilot randomised controlled trial compares three conditions:  an Immediate condition that 
accesses the full program straight after Baseline, a Delayed condition that accesses the full 
program after 3 months, and a Brief condition that accesses a modified program that only 
addresses physical activity.  The main trial omits this last condition.  Both trials evaluate the 
efficacy of the OnTrack Diabetes program in improving glycaemic control and mood, 
physical activity participation, diet, blood glucose self-monitoring, medication taking and 
dysphoria (depression, anxiety, and diabetes-specific distress) symptoms.  User acceptability, 
ease of use, utility, program satisfaction, feasibility of implementation and cost-effectiveness 
are also assessed.  It is hypothesised that at 3 months post-enrolment the Immediate  
condition will show the greatest improvements in glycaemic control (glycosylated 
haemoglobin A1C; HbA1c), symptoms of depression, anxiety and diabetes-specific distress, 
behavioural outcomes, diabetes self-efficacy and quality of life, compared with the Delayed 
condition (and in the case of the pilot, the Brief, modified intervention).  In both the pilot and 
main trial, results of the Immediate and Delayed conditions are expected to be similar at 6 
months, when both conditions will have received the full intervention.  In the pilot, superior 
6-month outcomes from both the Immediate and Delayed conditions are expected than from 
Brief intervention. 
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4.3 Methods 
Design and Setting 
The pilot and main trials both implement a randomised-controlled design with the participant 
as the unit of randomisation.  The trial is conducted Australia-wide.  Program implementation 
takes place wherever participants can obtain regular internet access.  The researcher is based 
at the Wesley Research Institute in Brisbane.  Flow diagrams for the pilot (Figure 1) and 
main (Figure 2) trials are shown below. 
  150 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Consort diagram of OnTrack Diabetes pilot trial protocol. 
Qualitative interviews and 
program development 
Pilot RCT 
Recruitment and eligibility screening 
Do not meet study criteria 
Ineligible (Receive full 
program access outside 
trial) 
 Meet study criteria except 
selection criterion a or g Pending participant 
Recontact Eligible (meet all study selection 
criteria) 
Participant informed consent obtained 
Baseline data collection 
Randomisation 
N=51 
Brief (physical 
activity) condition 
(n=17) 
Baseline to 3 months 
Post-Baseline 
(Physical activity 
module only) 
Wait-List Control 
condition (n=17) 
Baseline to 3 months 
Post-Baseline 
(Information sheets & 
quizzes only) 
Full Intervention         
condition (n=17) 
Baseline to 3 months 
Post-Baseline 
(Full program access) 
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Figure 2. Consort diagram of OnTrack Diabetes main randomised controlled trial protocol. 
Main RCT 
Recruitment and eligibility screening 
 
Do not meet study criteria 
Ineligible (Receive full 
program access outside 
trial) 
 Meet study criteria except 
selection criterion a or g 
Pending participant 
Recontact Eligible (meet all study selection criteria) 
Participant informed consent obtained 
Baseline data collection 
Randomisation 
N=300 
 
Wait-List Control 
condition (n=100) 
Baseline to 3 months 
Post-Baseline 
(Information fact sheets 
& quizzes only) 
Full Intervention              
condition (n=100) 
Baseline to 3 months 
Post-Baseline 
(Full program access) 
Intervention 2              
condition (n=100) 
Baseline to 3 months 
Post-Baseline 
(Full program access) 
3 – 12 months Post-
Baseline 
(Full program access) 
3 – 12 months Post-
Baseline 
(Full program access) 
3 – 12 months Post-
Baseline 
(Full program access) 
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Recruitment and sample 
Recruitment strategies for the pilot and main trial are primarily community-based: newspaper 
advertisements, health organisation newsletters, radio broadcasts, notice board postings, 
bulletins, e-mails and online advertisements.  Targeted methods include distributions of study 
flyers and posters to medical centres, letters to health institutions, pharmacies, and Health 
Professionals, and featuring the OnTrack Diabetes website URL on state-wide Diabetes 
Australia research web pages.  Attendance at Diabetes expos and events allows in-person 
recruitment and further promotion of the project to Health Professionals. 
A sample of 51 is aimed to be enrolled in the pilot trial.  The main trial aims to enrol 300 
participants.  Selection criteria for both studies include: (a) Type 2 diabetes diagnosis (by 
medical physician/ according to WHO criteria) ≥ 3 months; (b) aged 18 – 75 years; (c) living 
in Australia without plans to leave within 12 months; (d) regular computer and internet 
access; (e) contactable by phone; (f) clear command of written English (at least year 5 
education); and (g) stable diabetes pharmacotherapy (medication dose stable ≥ 4 weeks; 
medication type stable ≥ 3 months).  Study exclusion criteria include: (a) current diagnosis of 
mental disorder other than depression or anxiety; (b) current suicidal risk; (c) significant 
cognitive disorder (e.g. from head trauma or dementia); (d) currently on steroid medication , 
or likely to commence these in the next 12 months; (e) pregnant or likely to become pregnant 
in the next 12 months.  The pilot trial has an additional criterion of HbA1c ≥ 6.5% in order to 
provide a better chance of detecting between-group differences in HbA1c in the smaller 
sample. 
All participants are asked to undertake a medical assessment by their General Practitioner 
prior to enrolment in the pilot or main trial.  Individuals with physical limitations or 
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concurrent physical disorders are advised of the need to exercise caution in setting physical 
activity goals according with their doctor’s advice. 
Study measures 
Assessments for both the pilot and main trials are administered at baseline, 3-, 6-, and 12-
month follow-up points.  
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Table 1. Measures used for OnTrack Diabetes program evaluation in pilot trial and main RCT. 
Variable  Measure Administration time 
point(s)  
Administration method 
Time-line follow-back All 
 
Phone interview 
 
 
 
 
- Time-line 
follow-back 
Clinical 
HbA1c (%) Pathology sample at 
same laboratory 
Behavioural 
Physical activity Active Australia 
Survey 
Nutrition intake  
OnTrack Diabetes Questionnaire All Online 
 Demographics  
Clinical 
Weight (kg) Same set of scales 
Waist circumference 
(cm) 
Same measuring tape 
Psychological/emotional 
Depression, anxiety 
and distress 
DASS-21 
Diabetes-specific 
distress 
Diabetes Distress Scale 
(2 sub-scales) 
Self-efficacy for 
diabetes self-care 
Diabetes Self-efficacy 
Scale  
Diabetes self-care 
behaviours 
AusDiab study survey 
Alcohol consumption  
Smoking TSQ 
Psychosocial 
Quality of Life EQ-5D and SF-36 
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Cost-effectiveness 
Health Service 
Utilisation 
Health Service 
Utilisation Survey 
(includes cost data) 
OnTrack Diabetes Evaluation Questionnaire 
User satisfaction 10-point likert scale 
rating, from 0, “not at 
all” to 10, “totally” 
3 months Online & phone 
interview 
Perceived ease of use 10-point likert scale 
rating from 0, “not at 
all” to 10, “extremely 
easy” 
Perceived program 
usefulness 
10-point likert scale 
rating from 0, “not at 
all” to 10, “extremely” 
Implementation 
feasibility 
10-point likert scale 
rating from 0, “not at 
all” to 10, “extremely” 
  
 
Study conditions 
Procedures for participant recruitment, eligibility screening and enrolment are identical for 
the pilot and main trials.  Participants register interest on the study website and select a time 
to undertake an eligibility screening appointment by phone.  Eligible individuals undertake 
baseline measures by e-mail and phone interview at their selected appointment time.  
Individuals who satisfy all criteria except inclusion criterion (a)—time since diagnosis— or 
(g)—stable medication—are asked if they wish to be recontacted for future screening and if 
so, are categorised as “pending”.  Individuals who are ineligible are allowed to use the 
program without being enrolled in the trial.  
Following baseline measures, all eligible participants receive a secure username and 
password with which they log on to the program.  Computer-generated randomisation occurs 
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automatically.  One week prior to the due date for follow-up study measures, participants 
receive an email notification with a link to the online survey and a pre-set time for the 
timeline follow-back phone interview.  The email requests that participants email the 
researcher if the phone interview time does not suit them. 
Study 1 (Pilot Trial) Conditions 
Wait-list Control 
Participants receive access to a blank screen and undertake their usual diabetes care.  
Following 3-month follow-up study measures, they receive access to the full OnTrack 
Diabetes program. 
Brief, Modified Intervention – Physical Activity 
Participants receive access to information resources about general diabetes self-care which 
include guidelines for physical activity, nutrition, blood glucose self-monitoring, and areas 
including foot and eye care.  In addition, they can access the physical activity module, 
Keeping Active and Feeling Great.  An example of a page from the Ideas about Fun Physical 
Activities tool is shown in Figure 3, below. 
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Figure 3. A summary page example from the Ideas about Fun Activity tool. 
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Full Intervention  
Participants receive access to the full OnTrack Diabetes program.  In addition to content 
received by the Brief, Modified Intervention condition, this includes access to a nutrition 
module (Eating Well and Feeling Healthy), a module focused on adherence to health regimes 
(Health Routines), an emotional well-being module (Thinking Well and Feeling Fine), and a 
maintenance module (Keeping On Track).  The first section of each module includes a series 
of interactive tools that incorporate guided imagery, planning goal implementation, goal-
setting, and confidence building.  The planning tools guide participants in proceeding towards 
their own, personalised goals in incremental steps.  A second section of each module is 
entitled “More On...” (e.g. More On Health Routines), and involves setting a weekly schedule 
to increase participation in desired health behaviours and pleasurable activities, and tools for 
problem-solving challenges.  A printable summary is provided on completion of each 
interactive tool:  These summaries can be accessed on future occasions, and participants can 
also complete tools or modules repeatedly if they wish.  Self-monitoring tools allow daily 
monitoring of highest and lowest blood glucose levels, best and worst mood, and the degree 
that physical activity and nutrition goals were met.  Automated feedback graphs on progress 
are provided for the past week, month, or 3 months.  Mindfulness audios are playable on the 
computer, or can be downloaded to an MP3 player. 
Study 2 (Main Trial) Conditions 
Wait-list Control 
Participants receive an email advising them to undertake their usual diabetes care.  Following 
3-month follow-up outcome measures, they receive access to the full OnTrack Diabetes 
program.  
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Full Intervention 
Participants receive access to the full OnTrack Diabetes program from baseline onwards.  
The full program is identical to that received by the Pilot trial Intervention group.  In 
addition, participants receive an automated reminder e-mail if they fail to log on to the 
program for 2 weeks or more. 
Statistical Analyses 
Preliminary analyses assess for baseline differences, and subsequent analyses control for any 
observed differences.  The primary analyses will comprise multiple regressions, predicting 
post-treatment and follow-up results from Baseline measures and treatment contrasts, and 
multiple imputation will be used to predict missing data.  Mixed models ANOVAs with 
repeated measures will also be applied, to confirm whether effects are still obtained without 
imputations.  Both methods allow an intention-to-treat approach to the data.  
 Program Evaluation 
User satisfaction, perceived ease of use, and usefulness and examined with ANOVAs.  
Program reach, acceptability, implementation feasibility and outreach are assessed using the 
RE-AIM framework. 
 Cost-effectiveness evaluation 
Costs and outcomes for Delayed Intervention and Intervention conditions will be compared 
and the incremental cost-effectiveness ratio (ICER) calculated.  Cost-effectiveness analysis 
(CEA) from a primary perspective of direct medical costs to the government is used.  
Standard costs are applied to Health Care Utilisation in both arms.  Intervention costs are 
calculated including set-up costs that will be annualized and operating costs for the 
intervention.  Out-of-pocket and time costs are also examined.  Health outcome data recorded 
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during the trial is used as the health outcome measures in the CEA.  Utility weights are 
derived from EQ-5D using the Australian scoring algorithm (Viney et al., 2011) and SF-36 
data transformed using the SF-6D derived from an Australian population.  Detailed one-way 
sensitivity analyses will be undertaken on key parameters as well as a probabilistic sensitivity 
analysis.  
Sample size and retention 
Using multiple regression from Baseline, a sample of 50 in the pilot trial will have the power 
to detect a moderate effect size in outcomes at Post (f = .17) with power = .80, α = .05, if 
planned contrasts are used to test the hypotheses that the full intervention is superior to the 
wait list, and that the physical activity module gives intermediate effects.  The sample of 300 
in the main trial has the power to detect a clinically and statistically significant effect in the 
primary clinical outcome of HbA1c level between the two conditions of wait-list and full 
intervention (f  = .027) with power = .80, α = .05, using a regression approach.  This result is 
based on power calculations that were performed using the statistical software package g-
power.  
While studies use all allocated participants in the outcome analyses, efforts are made to 
maximise retention in the study, by developing rapport at the baseline assessment and 
collecting multiple means to contact participants, which include e-mail and landline and 
mobile phone contact details.  With these strategies, the studies aim to have at least 70% 
retention at 12 months. 
Ethics 
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Ethics approval to conduct this project was granted by the Uniting Care Health Human 
Research Ethics Committee (#Cassimatis 9111) and the Queensland University of 
Technology Human Research Ethics Committee (#1100000783). 
4.4 Discussion 
Results from this trial will provide insight into the efficacy, practicality and user perspectives 
on the effects of such a program and the success of its dissemination within the Australian 
context.  A 12-month follow-up period will provide data on the maintenance of effects from 
the programs, as well as patterns of usage over time and the relationship of these variables to 
study outcomes.  
Previous trials of diabetes self-management web-based programs indicate that a common 
limitation of such programs is a reduction in user engagement over time (Glasgow et al., 
2003; Glasgow et al., 2011; Lorig et al., 2010).  It is expected that ongoing access to 
interactive tools and self-monitoring that users can apply to issues with self-management and 
dysphoria as they arise will help to maximise engagement and retention.  Fortnightly e-mail 
reminders may also assist users to keep on track of their program usage and prompt continued 
user engagement with the program (Wangberg, Bergmo, & Johnsen, 2008).  Follow-up 
assessments in the trial will ask about usage of other treatments and website resources, but 
the validity of those reports cannot be guaranteed.  
Findings will provide information about the effectiveness of using a self-guided approach to 
web-based Type 2 diabetes self-management intervention.  Limitations to generalisability 
that affect studies conducted within specific clinical or experimental settings are avoided 
(Glasgow, McKay, Piette, & Reynolds, 2001) by provision of nation-wide access.  As well as 
assessing whether the OnTrack Diabetes program will improve Type 2 diabetes self-
management and dysphoria, this trial is intended to serve as a source of information about the 
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successes and shortcomings entailed in implementing such a program.  Results will provide 
information upon which future trials of web-based CBT interventions can build in terms of 
processes that enhance and those that impede the practicality and rigour of research in this 
domain.
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4.5 Chapter Summary and Conclusions 
This paper demonstrated the sequence of studies that comprise the OnTrack Diabetes 
project, which enables links to be made between study outcomes and the project 
methodology.  The next chapter presents the second part of the research program’s 
developmental stage. 
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CHAPTER 5 
DEVELOPMENT OF THE ONTRACK DIABETES PROGRAM: 
DESIGN OF A RANDOMISED CONTROLLED EVALUATION TRIAL 
 
165 
 
5.1 Notes 
This manuscript was accepted with minor revisions by the international, peer-reviewed 
journal, ‘Journal of Medical Internet Research’. 
Citation for this paper: 
Cassimatis, M., Kavanagh, D.J., Hills, A.P., Smith, A.C., Scuffham, P.A., Edge, S., & 
Gibson, J. (2014). Development of the OnTrack Diabetes Program and Design of a 
Randomized Controlled Evaluation Trial. Journal of Medical Internet Research. Accepted 
with revisions January 2014.  
Journal Impact Factor: 4.07. 
Authors’ contributions to this paper: 
 The candidate is the first author, whose contributions included taking part in 
developing the written content and information technology program coding for the OnTrack 
Diabetes program, and drafting of this manuscript.  The second author is the Principal 
Supervisor of the candidate, who co-developed written content for OnTrack Diabetes and 
guided program development.  The second, third and fourth co-authors are also members of 
the candidate’s supervisory team and provided edits to this manuscript.  Further, each author 
had input into informing the design of the trial and making suggestions for program content.  
The final two co-authors were the information technology programmers who developed the 
programming logic and program database.   
Overview of this paper: 
Contributions of this paper to the scientific literature include its demonstration of the 
steps required in web-based intervention development.  Furthermore, the paper emphasises 
differences in its developmental approach from other study interventions, due to the pre-
established programming logic, amongst other variations. 
 
JMIR RESEARCH PROTOCOLS   166 
 
 
“Program Development Paper” 
Development of the OnTrack Diabetes Program: Design of a Randomized Controlled 
Evaluation Trial. 
Mandy Cassimatis1,2, David J. Kavanagh2, Andrew P. Hills3, Anthony C. Smith4,5, Paul A. 
Scuffham6, Steven Edge2, and Jeremy Gibson2 
1Institute of Health & Biomedical Innovation and School of Psychology & Counselling, 
Queensland University of Technology, Brisbane, Queensland, Australia. E-mail: 
m1.cassimatis@qut.edu.au (Corresponding author) 
2Institute of Health & Biomedical Innovation and School of Psychology & Counselling, 
Queensland University of Technology, Brisbane, Queensland, Australia. E-mail: 
david.kavanagh@qut.edu.au 
steven.edge@qut.edu.au 
jeremy.gibson@qut.edu.au 
3Mater Mothers’ Hospital, Mater Medical Research Institute and Griffith Health Institute, 
Griffith University, Brisbane, Queensland, Australia. E-mail: ahills@mmri.mater.org.au 
4 Centre for Online Health, The University of Queensland, Brisbane, Queensland, Australia. 
E-mail: asmith@uq.edu.au 
5 Queensland Children’s Medical Research Institute, Brisbane, Queensland, Australia. 
6 School of Medicine & Griffith Health Institute, Griffith University, Brisbane, Queensland, 
Australia. E-mail: p.scuffham@griffith.edu.au 
JMIR RESEARCH PROTOCOLS   167 
 
 
Sources of support: Funding for this project was awarded in a grant from Mitsubishi 
Development Proprietary Limited via the Wesley Research Institute in Brisbane, Australia. 
Word count: 3179 
Number of figures: 2. Number of tables: 0. 
JMIR RESEARCH PROTOCOLS   168 
 
 
Abstract 
Background. Type 2 diabetes affects an estimated 347 million people worldwide and often 
leads to serious complications including blindness, kidney disease, and limb amputation.  
Comorbid dysphoria is common and is an independent risk factor for poor glycaemic control.  
Professional support for diabetes self-management and dysphoria has limited availability and 
involves high costs, especially after hours and in rural and remote areas.  Web-based 
cognitive behaviour therapy (CBT) interventions offer potentially acceptable and cost-
effective support for people with diabetes and can be accessed from almost anywhere.  This 
paper describes the development of the OnTrack Diabetes program, which is a self-guided, 
web-based program aimed to promote euthymia and improved disease self-management in 
people with Type 2 diabetes. 
Method. Semi-structured interviews with 12 General Practitioners and 13 patients with Type 
2 diabetes identified enablers of and barriers to effective diabetes self-management, 
requirements for additional support, and potential elements of a web-based support program.  
Existing information resources and research data informed the development of content, and 
consultants from relevant disciplines provided feedback on draft segments and reviewed the 
program before release.  Costs were contained by using a self-guided delivery format and 
adapting program features and modules from an existing OnTrack program.   
Conclusions. Development of the OnTrack Diabetes program demonstrates strategies to be 
employed to ensure that a program is acceptable to users and incorporates both authoritative 
information and evidence-based strategies.  The next stages involve testing users’ experiences 
and examining the program’s effectiveness and cost-effectiveness in randomized controlled 
evaluations. 
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5.2 Introduction 
Type 2 diabetes is a burgeoning epidemic that affects an estimated 347 million people 
worldwide (WHO, 2011a), and is becoming one of the leading causes of global disease 
burden (WHO, 2011a).  Inadequate diabetes self-care is strongly associated with poor 
glycaemic control, which increases the risk of diabetes complications including peripheral 
limb amputation, blindness and end-stage renal disease (WHO, 2011a), as well as 
cardiovascular disease and stroke (Holman et al., 2008).  A 21% decrease in the incidence of 
diabetes complications occurs with each 1% improvement (reduction) in glycosylated 
haemoglobin A1c (HbA1c) level (UK Prospective Diabetes Study (UKPDS) Group, 1998), 
which indicates the utility of improving diabetes self-management.  However, patients often 
struggle to meet recommended treatment targets and find it difficult to implement the 
behaviour changes required to achieve such improvements. 
Diabetes patients are two to three times more likely than people without diabetes to 
experience depression, anxiety, stress and reduced wellbeing (Ali et al., 2006; Fisher et al., 
2008; Funnell, 2006).  Dysphoria appears to be both a consequence of Type 2 diabetes and to 
have a role in the condition’s pathogenesis (Carnethon et al., 2007), impairing glycaemic 
control both directly via physiological mechanisms, and indirectly via reduced diabetes self-
care (Gonzalez, Delahanty, et al., 2008; Gonzalez et al., 2007).  As a result, dysphoric 
patients have an increased risk of diabetes complications (de Groot et al., 2001; Williams et 
al., 2010) and premature mortality (Lin et al., 2009).  Optimal diabetes management therefore 
requires support for both mood and behavioural disease self-management.  
Controlled trials of diabetes self-management interventions have shown that effective 
components include diabetes education (Duke et al., 2009; Norris, Engelgau, & Narayan, 
2001), promotion of adherence to blood glucose self-monitoring (Durán et al., 2010; Kempf, 
Kruse, & Martin, 2012), physical activity (Richert et al., 2007; Sigal et al., 2004), dietary 
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(Dämon et al., 2011), and medication regimes (Haynes et al., 2008), and emotional support 
(Fisher et al., 2007).  Interventions that incorporate only behavioural components have 
generally failed to produce robust and sustained improvements in psychological and 
emotional outcomes (Fisher et al., 2007).  Similarly, interventions that specifically target 
depression or anxiety have typically failed to produce substantial improvements in diabetes 
self-management and physical outcomes (Wang et al., 2008).  Even for high-functioning 
individuals the complexity of the Type 2 diabetes treatment regime exposes patients to a 
range of daily physical and emotional challenges (Funnell, 2006).  A holistic intervention that 
incorporates both behavioural and psychological support may therefore offer optimum 
efficacy.  
While some key components of effective support for Type 2 diabetes self-management have 
been identified, health system limitations prevent its reliable provision (Fisher et al., 2007), 
especially after hours or in more remote locations, where greater population spread and 
reduced practitioner to population ratios conspire to reduce access.  Diabetes self-
management support services that offer wide outreach and cost-effectiveness are needed.  
Over recent years web-based interventions, and in particular those based on cognitive-
behaviour therapy (CBT), have produced substantial improvements in emotional and 
behavioural outcomes in a range of problem areas (Hedman et al., 2012), with their effects 
similar in size to those of face-to-face treatments (Eland-de Kok, van Os-Medendorp, 
Vergouwe-Meijer, Bruijnzeel-Koomen, & Ros, 2011).  CBT-based Type 2 diabetes 
interventions similarly have produced significant improvements in diabetes self-care 
(Ramadas et al., 2011), mood (Griffiths, Farrer, & Christensen, 2010), and psychosocial 
outcomes.  These programs have also shown high user uptake, acceptability and usability, 
even in older users (Bond et al., 2007).  Globally, web access is increasing rapidly, with the 
proliferation of cable and mobile networks increasingly bridging geographical and even 
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socioeconomic divides (ABS, 2009).  Web-based delivery of intervention programs may 
assist with meeting the need for improved access to additional disease self-management 
support by people with Type 2 diabetes (Fisher et al., 2007), conveying the advantages of 24-
hour availability, broad access, privacy, lack of stigma and (particularly in the case of self-
guided programs) steeply falling unit costs as user numbers increase.  
Web programs based on empirically well-established theories have shown superior efficacy 
in improving diabetes self-management outcomes compared with programs that do not have a 
strong theoretical and empirical basis (Ramadas et al., 2011).  In particular, chronic disease 
self-management programs that use Social Cognitive Theory (SCT; Bandura, 1986) as their 
theoretical underpinning have demonstrated efficacy (Bandura, 2004b).  SCT is an 
appropriate theoretical basis for chronic disease self-management interventions, as it specifies 
predictors of human motivation and behaviour that can be targeted in self-management 
(Bandura, 2004b), including specific skills, self-efficacy, goals, and self-administered 
incentives (Bandura, 1986).  SCT encourages patient empowerment, positing that humans 
actively make sense of the world and shape their own experiences, giving them the capacity 
to exercise choice and change their behaviour.  The theory holds that environmental, 
interpersonal and intrapersonal variables are interlocked in processes of reciprocal 
determinism.  Research that demonstrates that behavioural self-management (Hunt et al., 
2012; Marks, Allegrante, & Lorig, 2005; Steinsbekk, Ø Rygg, Lisulo, Rise, & Fretheim, 
2012; Strychar et al., 2012) and mood (Sacco & Bykowski, 2010; Sacco et al., 2007) have 
strong associations with cognitive and psychosocial factors is consistent with this view and 
lends support to diabetes self-management interventions being based on SCT principles. 
SCT emphasises the importance of a person’s self-efficacy, or their current confidence in 
being able to successfully reach a performance target (e.g. to attain a specific adherence goal) 
(Bandura, 1977).  When self-efficacy is strong, the individual is more likely to invest effort 
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and to persist in the face of challenges considered to be the driving force behind initiating 
behaviour change.  This is particularly important for people with Type 2 diabetes, who must 
learn to master a range of new skills for successful diabetes self-management as well as have 
the motivation to carry them out routinely.  The primary driver of self-efficacy is the person’s 
previous accomplishments, placing a strong emphasis on skill acquisition, successful 
performance, and the availability of recalled successes when making a self-efficacy 
judgment.  In turn, skill acquisition is obtained by instruction, vicarious learning, and 
practice, which is refined by performance feedback. 
Increased self-efficacy in chronic disease patients has demonstrated associations with 
improved health behaviours, including physical activity (Blanchard et al., 2007; Dutton et al., 
2009), dietary adherence (Nouwen et al., 2011), and general diabetes self-care (Aljasem et 
al., 2001).  Self-efficacy can significantly predict future adherence to the diabetes treatment 
regime, even after controlling for past levels of adherence (Kavanagh et al., 1993).  The focus 
of SCT on autonomous cognitive and behavioural processes that encourage patient 
empowerment and target motivation supports its appropriateness as a theoretical basis for 
chronic disease self-care and psychological intervention (Fisher et al., 1982; Marks et al., 
2005). 
Outcome expectancies or incentives form a further key element of SCT (Fisher et al., 1982) 
and together with self-efficacy are critical to establishing motivation and investment of effort.  
In self-management, self-administered incentives, including self-evaluations against personal 
standards, are particularly important in the sustained self-regulation of behaviour (Bandura, 
2004b).  If self-efficacy is robust, falling short of a goal motivates increased effort.  However, 
if self-efficacy is fragile or the experience triggers very negative emotion, falling short of 
personal standards undermines confidence and motivation, and the person may even 
relinquish the goal (Gist & Mitchell, 1992; Snoek, 2002).  Accordingly, an intervention based 
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on SCT encourages ambitious goal setting but tempers emotional responses to lesser 
attainments, focusing on success-related aspects and strategies to further improve 
performance, encouraging attributions of performance deficits to the difficulty of the task and 
goal rather than to immutable personal characteristics.  Moderation of the goal to achieve 
stepwise increments in successful performance is sometimes required. 
Web-based CBT has shown efficacy in reducing depression and anxiety symptoms in people 
who have diabetes (van Bastelaar et al., 2011).  However, interventions primarily focused on 
targeting mood have yielded mixed results in terms of their effects on glycaemic control 
(Markowitz et al., 2011).  Conversely, while behavioural-focused Type 2 diabetes 
interventions have demonstrated improved glycaemic control and behavioural outcomes, the 
majority have not evidenced improvements in psychological and emotional outcomes 
(Ramadas et al., 2011).  Recently, a web-based CBT-style intervention that addressed 
diabetes-specific issues in the context of depression treatment was shown to be successful in 
producing significant mood improvements (van Bastelaar et al., 2011).  However, similar to 
other mood-specific programs this intervention did not specifically incorporate behavioural 
diabetes self-management support.  Evidence of the poor effects of such programs on 
glycaemia indicates that programs that simultaneously address behavioural aspects of Type 2 
diabetes self-care are needed (Markowitz et al., 2011).  Such interventions would be 
appropriate for implementation in the mainstream Type 2 diabetic population and may 
support those experiencing primarily psychosocial barriers to self-care, as well as those with 
co-occurring distress.  Long-term relevance to each patient is also attainable using this 
approach, as individuals may move between phases of treatment adherence and less stable 
performance. 
Most current web-based CBT interventions are guided programs that incorporate support 
from a health professional (Lorig et al., 2010; van Bastelaar, Pouwer, Cuijpers, Twisk, & 
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Snoek, 2008).  However, studies that compare guided CBT-based programs with minimal 
support have similar impacts on clinical (Lorig et al., 2010; Lorig, Ritter, Villa, & Piette, 
2008) and behavioural (Glasgow et al., 2010) outcomes as well as user engagement (Glasgow 
et al., 2011).  Self-guided web-based interventions have shown equal effectiveness to guided 
interventions (Berger, Hämmerli, Gubser, Andersson, & Caspar, 2011) and offer the 
advantages of self-paced learning and skill acquisition, and higher perceived autonomy and 
privacy.  Further, web-based programs encourage users to adopt an independent role in their 
disease management, which may enhance patient empowerment.  There remains a need for 
further research on self-guided, web-based Type 2 diabetes self-management programs that 
incorporate mood support. 
This paper describes the development of the OnTrack Diabetes program, which is a self-
guided, web-based Type 2 diabetes self-management and dysphoria intervention.  With a 
SCT (Bandura, 1986) foundation, OnTrack Diabetes is based on CBT and motivational 
interviewing techniques.  The program is designed to improve Type 2 diabetes self-
management, glycaemic control and dysphoria, including depression, anxiety and diabetes-
specific distress symptoms.  OnTrack Diabetes targets physical activity, diet, and adherence 
to health routines by providing informational and interactive behavioural, psychological and 
emotional support.  The program promotes access to social and disease management support 
from family and friends as well as allied health professionals.  It provides interactive tools 
designed to engage users in adopting personalised goals for each diabetes self-care area.  
Self-monitoring tools encourage users to record their daily progress with mood (best to 
worst), blood glucose levels (highest and lowest), physical activity and nutrition goal 
adherence (0 – 100%).  Automated graphs give users feedback on progress in each area over 
the past week, month, and 3 months.  The program is designed to provide a holistic approach 
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to improving Type 2 diabetes self-management and mood and to endorse user empowerment 
by encouraging users to take an autonomous role in managing their condition. 
5.3 Methods 
Development of the OnTrack Diabetes program 
Step 1. Qualitative research.  Semi-structured interviews were conducted to explore 
enablers and barriers associated with effective Type 2 diabetes self-care, together with 
diabetes-related emotional challenges, requirements for additional disease management 
support and suggestions for online support program inclusions.  The sample comprised 13 
people with Type 2 diabetes and 12 General Practitioners (GPs).  GPs were asked the 
circumstances in which they would refer patients to an online Type 2 diabetes self-
management support program and the factors that may inhibit patient referral.  Results 
revealed that patients and GPs shared most perspectives on diabetes self-management.  Both 
the patients with diabetes and GPs identified a need for additional informational, 
motivational, emotional and social support.  Suggestions for program content included self-
monitoring tools, informational support, motivational assistance with improving and 
maintaining physical activity and diet, goal setting assistance, progress feedback, social 
support via a chat room and accessibility to health professionals.  Detailed results are 
available in a separate paper. 
Step 2. Basic structure and functionality.  OnTrack Alcohol and Depression was 
previously developed by the second author and his colleagues as part of a suite of CBT-based 
web programs.  OnTrack Alcohol and Depression was proposed as a basis for the layout of 
OnTrack Diabetes and the appropriateness of this was confirmed by a review of the Alcohol 
and Depression program structure.  Motivational videos, mindfulness and relaxation audios 
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and Information Technology coding from some of the self-monitoring and program tools 
were adapted for use in OnTrack Diabetes.  
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Figure 1. Steps involved in OnTrack Diabetes program development. 
Step 2: September – December 2010 
Review OnTrack Alcohol & Depression 
program structure 
Step 3: January – June 2011 
Obtain data for program content 
Step 4: January – August 2011 
Develop written program content 
Step 5: August – March 2012 
Information technology programming 
Step 6: February – March 2012 
Preliminary program testing 
Step 7 – March 2012 
OnTrack Diabetes launched live to air 
Step 8: April 2012 
Review of program by experts and two 
people with Type 2 diabetes 
Step 9: April 2012 
Implement suggested revisions from Step 8 
Step 10: April 2012 
Public launch of OnTrack Diabetes 
Step 1: September – December 2010 
Qualitative interviews; N=13 people with 
Type 2 diabetes; N=12 General 
Practitioners 
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Step 3. Assembly of information resources.  Sources that informed the development of 
OnTrack Diabetes information resources and tools included the Diabetes Australia Guidelines 
for Type 2 diabetes management (Australian Centre for Diabetes Strategies, 2010); National 
Health and Medical Research Council physical activity and nutrition guidelines for 
Australian adults (Department of Health and Aged Care, 2005); Optometrists Association 
Australia (Optometrists Association of Australia, 2011); Australasian Podiatry Council 
(Australasian Podiatry Council, 2009); Medicare Australia (Australian Government 
Department of Human Services, 2012), and relevant peer-reviewed empirical literature.  A 
nutritionist, ophthalmologist and podiatrist were consulted to discuss proposed content. 
Step 4. Content development.  The first author compiled the obtained information and 
discussed proposed content inclusions with the second author.  The program content 
addressed the barriers to Type 2 diabetes self-care identified in Study 1, and attempted to 
maximise enhancers.  Information resources complement the program’s interactive tools and 
provide the impetus for goal-setting and planning while providing resources that can be 
integrated into primary care.  For example, the “My Feet Check Resource” contains a 
diagram of feet on which the date and any changes can be marked and a checklist to tick off 
symptoms that can be taken to Podiatry appointments. 
Step 5. Programming.  OnTrack Diabetes Information Technology programming 
logic is based on eXtensive Mark-up coding developed for OnTrack Alcohol and Depression 
by IT programmers (the last two authors).  In collaboration with them, the first author coded 
tools and guidebook pages for the site.  Programming modifications and the development of 
new features exclusive to OnTrack Diabetes was then undertaken.  The administration site 
was built to include functions specific to this trial, including data recording and storage, 
access to study measures, and a schedule of follow-up study measure reminders.  A graphic 
designer designed the website interface, inserted relevant images and formatted the program. 
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Step 6. Preliminary testing.  OnTrack Diabetes was tested several times for bugs, 
errors in functionality and design issues by both the IT programmers and external observers. 
Step 7. Test of the live program. OnTrack Diabetes was privately launched live to the 
web to enable further screening for bugs and tests for functionality. 
Step 8. Expert review.  An Endocrinologist, Diabetes Educator, AH, AS, PS, and two 
people with Type 2 diabetes reviewed OnTrack Diabetes and provided feedback. 
Step 9. Program revision.  The program content was revised in response to the 
reviews that were undertaken in Stage 8. 
Step 10. Launch and efficacy trial.  A randomized controlled trial was commenced 
with potential participants registering interest on the site’s home page.  
OnTrack Diabetes program content 
The layout of OnTrack Diabetes is in the form of a “journey map” (Figure 2).  My Journey 
contains five signposts, or modules, each of which comprises a series of interactive tools.  
Each tool is preceded by guidebook pages that inform users what the tool is about and a 
printable summary page is provided at the conclusion.  Tool completion can be tracked in the 
section entitled What I’ve Done.  
Social Support 
Psychosocial factors including social support are highly influential to behavioural change and 
its maintenance (Bandura, 2004b).  The Building My Support Team tool encourages users to 
form a social support network from the outset of the program that includes trustworthy family 
members, a partner, friends, and/or colleagues.  Users are also encouraged to list the contact 
details of doctor/s and other health professionals, and can print a summary of these details.  
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OnTrack Diabetes Signposts  
Users are encouraged to undertake the signpost modules and access the resources as they 
choose, although the program is structured in a logical sequence.  The signposts are: Keeping 
Active and Feeling Great, Eating Well and Feeling Healthy, Health Routines, Thinking Well 
and Feeling Fine, and Keeping OnTrack.  All but the last signpost are comprised of two 
sections, with the first comprised of tools that facilitate identifying the potential benefits of 
functional changes, goal formation, the recollection of relevant past successes, and creation 
of a detailed, stepwise plan.  
The second section of each signpost (named More on...) contains tools that assist with 
planning a routine for the coming week.  For example, users can plan to add incidental and 
short bursts of activity to their week as well as longer physical activity sessions, and specify 
the times and days that they will do them.  Since the program is aimed to address dysphoria 
as well as health behaviours, the focus is on deriving pleasure from physical activity, healthy 
eating and health routines.  The interactive tools encourage users to form a habit in 
implementing positive changes.  Problem solving is an important skill for effective diabetes 
self-management (Steed, Cooke, & Newman, 2003).  The second section of each signpost 
thus contains a problem solving tool to assist with overcoming challenges to reaching users’ 
personalised goals.  This tool can also be used to solve other problems, including threats to 
emotional wellbeing.  
Users are asked to focus on practising the skills learned in each section for 1-2 weeks before 
moving forward in the program.  In the meantime they are encouraged to log on to the site 
regularly to self-monitor, use resources, undertake and revisit tools as needed.  The signpost 
Keeping OnTrack provides support whilst aiming to support the maintenance of progress.  It 
focuses on moving on from past maladaptive behaviours and maintaining positive, new 
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beginnings in the broader context of the individual’s life.  Users are asked to evaluate positive 
changes since starting the program without losing sight of other life goals (e.g. education, 
travel).  
Self-Monitoring and Goal Attainment Scaling 
‘My Diary’ provides an electronic self-monitoring record of: (a) daily goal attainments in 
relation to physical activity, eating and health routines (on a sliding scale from 0 to 100%); 
(b) highest and lowest blood glucose levels; and (c) mood (on a scale from best to worst).  
Entries are represented in feedback graphs that are shown in the “How I’m Doing” section of 
the program.  The graphs display feedback for the previous month (average per day) and 3 
months (average per week) for each self-monitoring area.  Users are encouraged to compare 
results on different outcomes and are encouraged to recognise patterns between them.  This 
function accords with the principles of self-evaluation and reinforcement. 
 
Figure 2. Screenshot of the OnTrack Diabetes program layout. 
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Self-Screening by Quizzes 
Four self-administered quizzes enable users to evaluate their participation in diabetes self-
care activities, mood, physical activity participation, and fat and fibre intake.  Self-screening 
enhances early recognition of distress, which may lead to significant risk factors for major 
depressive disorder (Cuijpers et al., 2005; Karsten et al., 2011) and although requiring long-
term assessment in diabetes patients (Fisher et al., 2008) commonly remains undiagnosed in 
primary care (Li et al., 2010). 
OnTrack Diabetes Program Information Resources 
Information resources on a number of Type 2 diabetes-related areas are included as printable 
fact sheets within the program.  Specifically, information and resources are provided in the 
areas of: general Type 2 diabetes information; hyper- and hypo-glycaemia; weight 
management; physical activity guidelines and steps to increasing physical activity; nutritional 
guidance including reading nutrition labels, counting carbohydrates, sugars, the glycaemic 
index and glycaemic load, protein, fats, fibre, dairy, salt intake, and alcohol; eye care; foot 
care, and erectile dysfunction.  Information sheets detail the roles of each primary care 
professional to diabetes management and include web URLs to relevant organisations that 
allow a search for primary care professionals within any area of Australia to be performed.  
Additional Resources – Mindfulness Resources and Videos 
The Resources section also contains mindfulness audios that provide spoken instructions on 
performing various forms of mindfulness (e.g. mindfulness meditation and mindfulness of 
pleasure).  Users are encouraged to listen to the audios on their computer or download them 
to an MP3 player for use offline.  Guidebook pages throughout the program refer users to the 
most relevant mindfulness resources to each area.  Inclusion of these resources is based on 
JMIR RESEARCH PROTOCOLS   184 
 
 
evidence regarding the deleterious effects of stress on glycaemic control and its tendency to 
increase susceptibility to dysphoria and diabetes-specific distress.  Users are trained to 
mitigate worrying thoughts by meditative practice. 
Further, brief videos that feature role models on key health-related and behaviour change 
areas (e.g. alcohol modification, physical activity) are included, which provide vicarious 
experience. 
5.4 Conclusions 
This paper provides information on the processes involved in developing a self-guided, web, 
CBT-based intervention for Type 2 diabetes self-management and dypshoria.  Providing 
details about web program development has implications for researchers with an interest in 
developing or refining current web interventions.  Further, the effectiveness of the approach 
used to develop OnTrack Diabetes and its content can be evaluated by assessing links 
between the design methods, program components, and study outcomes.
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5.5 Chapter Summary and Conclusions 
This paper concludes the description of the developmental stage of the research 
program, and described the groundwork that was built upon in Stage 3 – the pilot randomised 
controlled trial of OnTrack Diabetes. 
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CHAPTER 6 
EVALUATION OF THE ONTRACK DIABETES PROGRAM: 
3-MONTH OUTCOMES OF A RANDOMISED CONTROLLED PILOT TRIAL 
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6.1 Notes 
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Citation for this paper: 
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Abstract 
Background.  Type 2 diabetes is an urgent global health concern, with most patients not maintaining 
adequate self-management, which leads to increased risk of complications and premature mortality.  
Comorbid dysphoria is highly prevalent, and further impairs glycaemic control.  Health systems are 
challenged to provide the extra support required to improve patient outcomes.  Web-based support 
may offer a feasible solution.  The OnTrack Diabetes program is a fully automated, web-based 
intervention designed to provide support for motivational self-management and psychological/ 
emotional issues.  This paper describes 3-month outcomes of the OnTrack Diabetes pilot trial. 
Method.  This was a randomised controlled pilot trial.  Participants: were aged 18-75, had type 2 
diabetes ≥ 3 months, a glycosylated haemoglobin (HbA1c) level ≥ 6.5%, lived in Australia, and had 
computer and internet access.  Study arms included: (i) Wait-List Control: usual care from Baseline, 
then full program access from 3 months Post-Baseline; (ii) Brief/ Modified Intervention: access to 
information and physical activity module from Baseline; (iii) Full Intervention: access to full program 
from Baseline.  Measures were at Baseline and 3 months Post-Baseline.  Primary outcomes: HbA1c 
level and mood.  Secondary outcomes: diabetes self-care, diabetes self-efficacy, and quality of life.  
Qualitative evaluations of perceived program acceptability, utility, and usability and implementation 
feasibility were undertaken.   
Results. The sample comprised 38 participants with a mean age of 60.42(SD=10.03), and a mean 
diabetes duration of 8.91(SD=7.77) years.  Mixed Model Analysis revealed that there were no 
statistically significant changes in primary outcomes within or between groups, including HbA1c level 
(F(1,32)= 3.85, p=.06), depression (F(1,32)= .005, p=.95), or anxiety symptoms, (F(1,32)= 2.28, p=.08).  
Analyses of secondary outcomes revealed that there was a significant reduction in the intake of sweet 
foods across groups over time (F(1,32)= 6.50, p=.02), but no significant differences between groups 
were found.  There were no significant differences across time for other secondary outcomes.  
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Qualitative outcomes revealed that users perceived the program to be highly acceptable, easy to use, 
and personally relevant.  Both the brief/ modified and full intervention groups demonstrated poor 
engagement in the program according to number of log-ins (M=4.40, SD=4.36).  Users commented 
that reminders to log on and/ or regular follow-up contact may improve their program engagement. 
Discussion. Overall, results indicate that OnTrack Diabetes was positively perceived by users. The 
small sample size and poor user engagement were major limitations.  Results suggest that reminders 
or reinforcement to log on to a web-based program regularly may improve user engagement.  A larger 
sample size is aimed to be recruited to the main trial of OnTrack Diabetes, which will better indicate 
the program’s potential to significantly improve primary and secondary outcomes.  This pilot has 
informed the feasibility of implementing web-based support in Australians with type 2 diabetes. 
ANZCTR #: 362543 
Keywords: diabetes self-management, depression, anxiety, diabetes-specific distress, web-based, 
online, intervention, comorbidity 
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6.2 Introduction 
An estimated 371 million people are living with type 2 diabetes world-wide, and projections 
indicate that the condition is a dire challenge to health care systems, including those in developed 
countries (IDF, 2012b).  Maintaining consistent type 2 diabetes self-management is essential to the 
effective control of clinical parameters including glycaemic control (I. M. Stratton et al., 2006), which 
is strongly associated with diabetes complications (The Diabetes Control and Complications Trial 
(DCCT) Research Group, 1995) and premature mortality (Barr et al., 2007).  Comorbid dysphoria, 
referring to depression, anxiety, and diabetes-specific distress, is highly prevalent in diabetes patients 
(Anderson et al., 2001; Collins, Corcoran, & Perry, 2009) and is evidenced to be both an antecedent 
and a consequence of physical health conditions (Penninx & van Dyck, 2010).  Dysphoria has been 
shown to reduce engagement in diabetes self-care (Gonzalez et al., 2008), worsen long-term health 
prognosis (Bruce, Davis, Starkstein, & Davis, 2005; Lin et al., 2009), and to contribute to severe 
emotional problems in diabetes patients, even at subclinical levels (Kokoszka, Pouwer, Jodko, Radzio, 
MuÄ‡ko et al., 2009).  Diabetes-related morbidity and mortality cost an estimated $US 471 billion 
globally in 2012 (IDF, 2012b), with the effects of comorbid dysphoria likely to have contributed 
substantially to this burden.  With health systems even in developed countries being at full capacity, 
the personal and economic burden is set to increase. 
Regular, ongoing support for type 2 diabetes patients has been widely recognised as essential 
to maintaining psychological and emotional health and quality of life in the face of the demands 
imposed by diabetes (Fisher et al., 2007).  A unique range of emotional, interpersonal and 
intrapersonal situations are experienced by patients (Alberti, 2002) that are strongly influenced by 
their ecological surroundings (Fisher et al., 2005).  The role of psychosocial and environmental 
influences on diabetes self-care has been well-established in empirical research (Chida & Hamer, 
2008; Glasgow & Toobert, 1988), which has demonstrated that using a holistic approach to provide 
intervention for diabetes self-management is important.  The inter-related impacts of each aspect of 
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the individual’s experience necessitates that associated key barriers and facilitators to self-
management be addressed.  When it is not possible to target all key factors of self-management, 
encouraging chronic disease sufferers to feel empowered to manage their condition(s) (Capaldi, 2008) 
is of ultimate importance.  Adequate coping and problem solving skills and self-efficacy are vital 
constituents to the maintenance of self-care behaviours, including exercise participation (Bandura, 
1990) and chronic disease management (Bandura, 2004a).  Chronic disease patients must persist with 
following their prescribed treatment regime in the context of a number of personal, psychosocial, and 
systemic barriers.  Furthermore, emotional and psychological issues, which include anxiety (Adili et 
al., 2006) and depression (Snoek & Hogenelst, 2008), are common in those with diabetes (Collins et 
al., 2009; Snoek & Hogenelst, 2008) and present significant challenges to patients’ motivation for 
self-care (Al-Hayek et al., 2012; Gonzalez et al., 2008), and impairments to their quality of life (Ali et 
al., 2010; Chyun et al., 2006). 
Type 2 diabetes places substantial strains on health system resources and hence despite the 
strongly recognised need for extra diabetes self-management and emotional support, traditional 
approaches to address this issue remain limited.  For example, in Australia, efforts have been at large 
to provide a framework for improving the outcomes of diabetes patients by encouraging access to an 
annual cycle of care comprised of consultations with allied health professionals, including 
psychologists.  However, recent data indicates that just 18% of diabetes patients nationally utilised 
this service in 2012 (AIHW, 2012a).   
Despite emphasis on the need for early recognition and screening of emotional issues and 
mood disorders in diabetes patients, under-diagnosis and under-treatment remain common.  GPs are 
the primary care providers for the majority of type 2 diabetes patients, and are frequently required to 
fulfil a lifestyle and psychological counselling role (Britt et al., 2011).  However, time limitations and 
role constraints prohibit thoroughness in this aspect of their care (Presseau et al., 2009).  Furthermore, 
intermittent consultations do not provide sufficient regularity to support patients in maintaining 
193 
 
 
motivation for implementing consistent self-care (Fisher et al., 2007).  Interventions that can deliver 
consistent and regular patient support are needed to complement the care received by health 
professionals so that adequate diabetes self-management and psychological support are received by 
this population as required. 
Web-based support has accrued substantial popularity in the chronic disease self-management 
field, with trials to date of web-based diabetes self-management interventions demonstrating that the 
web is an effective, reliable, and accessible mode of intervention delivery (Ramadas et al., 2011).  
Findings from trials of web-based interventions in samples of diabetes patients over 50 years of age 
have indicated their potential to produce lifestyle improvements, and that patients perceive these 
interventions to be highly acceptable and usable with satisfactory utility (Aalbers, Baars, & Rikkert, 
2011).  Furthermore, the web provides a promising modality via which to address geographical 
limitations to regular chronic disease self-management support, including access and health service 
availability issues.  With use of the internet becoming increasingly wide-spread and cost-effective, the 
web offers a potentially feasible and acceptable means by which to supplement traditional forms of 
type 2 diabetes self-management support. 
This paper presents 3-month pilot randomised controlled trial results of a web-based type 2 
diabetes self-management and dysphoria intervention dubbed OnTrack Diabetes, which represents an 
Australian first.  Details of the project protocol and program development are presented elsewhere.  
The OnTrack Diabetes program is based on social cognitive theory (Bandura, 1986), with interactive 
tools based on techniques from cognitive behaviour therapy and motivational interviewing.  Extensive 
information resources on type 2 diabetes, diabetes self-care behaviours, and details about health 
professionals on the diabetes care team, amongst other topics, are provided.  Self-monitoring tools to 
record daily blood glucose levels (highest and lowest), mood (best to worst), and physical activity and 
dietary goal adherence (from 0% not at all to 100% totally) enable participants to take part in goal-
attainment scaling.  Automated feedback graphs display progress with goal attainment in the past 
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month and 3 months.  The program was built on the results of qualitative interviews with type 2 
diabetes patients and general practitioners (GPs) of self-perceived facilitators and barriers to effective 
type 2 diabetes self-management; emotional challenges associated with living with type 2 diabetes and 
suggestions for program inclusions.  This has enabled the program to be developed in accordance with 
the ethos of patient empowerment in aiming to improve diabetes self-management, psychological and 
emotional health, and quality of life.   
6.3 Methods 
Design and Setting: A randomised controlled trial design with the participant as the unit of 
randomisation was used.  The researcher was based at the Wesley Health and Medical Research 
Institute and the Queensland University of Technology in Brisbane, Australia.  Enrolled individuals 
participated wherever they could access the program. 
Recruitment and Enrolment: Expressions of interest were registered via the open access OnTrack 
Diabetes website page (www.ontrack.org.au/diabetes/).  The site enabled individuals to select a 
preferred time to receive an eligibility screening call from the researcher.  Recruitment methods 
included advertising in the Diabetes Australia – Queensland newsletter, and local regional newspapers 
in Australia.  A link to the OnTrack Diabetes homepage was provided on the Diabetes Australia – Vic 
and Diabetes – SA websites.  Study flyers and posters were provided to health professionals, including 
GPs and allied health professionals (Diabetes Educators, Podiatrists, Exercise Physiologists and 
Nutritionists) to display in their workplaces, or distribute to clients with type 2 diabetes.  
 Study selection criteria included:  (a) type 2 diabetes diagnosis (by medical physician/ 
according to WHO criteria) ≥ 3 months; (b) aged 18 – 75 years; (c) HbA1c level ≥ 6.5%; (d) living in 
Australia without plans to leave within 12 months; (e) regular computer and internet access; (f) 
contactable by phone; (g) clear command of written English (at least year 5 education); and (h) stable 
diabetes pharmacotherapy (medication dose stable ≥ 4 weeks; medication type stable ≥ 3 months). 
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Study exclusion criteria included: (a) current diagnosis of mental disorder other than depression or 
anxiety; (b) current suicidal risk; (c) significant cognitive disorder (e.g. from head trauma or 
dementia); (d) use of steroid medication, or likely to commence in the next 12 months; and (e) 
pregnancy.  
 All individuals were asked to undertake medical clearance to confirm their suitability to 
participate in the program’s physical activity module.  Once enrolled in the trial, participants were 
further advised to seek medical approval before increasing their physical activity levels, and to respect 
their physical limitations when setting activity goals. 
Study Measures 
 All enrolled participants undertook study measures at Baseline and at 3 months Post-Baseline.  
All measures were administered via online survey but for HbA1c level, physical activity participation 
and dietary intake, which were obtained by phone. Participants received an e-mail that contained the 
study survey link and which indicated an appointment time for the phone-based measures.  Study 
measures are shown in Table 1, below. 
Table 1. Psychometric instruments used to measure outcomes for OnTrack Diabetes pilot trial. 
Measurement area Outcomes assessed Measure/s 
Demographics Age, gender, type 2 diabetes duration, 
education level, nationality, country of 
birth, relationship status, employment 
status, occupation, income, private health 
insurance 
Short answer and multiple choice items 
Clinical  Glycosylated haemoglobin (HbA1c) level Venous blood sample 
Emotional Depression, anxiety, stress levels Depression, Anxiety, Stress (brief version; 
DASS-21) scale (Handley, Shumway, & 
Schillinger, 2008) 
  Diabetes-related emotional burden and 
interpersonal distress sub-scales 
Diabetes Distress Scale (Fisher et al., 
2008) 
Psychological  Self-efficacy for diabetes self-care: blood 
glucose monitoring, physical activity, 
nutrition, medication-taking 
Diabetes Self-Efficacy Scale (Kavanagh et 
al., 1993) 
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Measurement area Outcomes assessed Measure/s 
Psychosocial Health-related quality of life EQ-5D (Shea, 2007) 
Behavioural Physical activity Active Australia Survey (Armstrong, 
Bauman, & Davies, 2000) 
Time-Line Follow-Back method 
 Dietary intake – number of serves of fruit, 
vegetables, sweet and fatty foods in the 
past week 
Time-Line Follow-Back method 
 Diabetes self-care – blood glucose self-
monitoring, medication-taking, nutrition 
and physical activity 
Diabetes Self-Care Activities Survey 
(Toobert, Hampson, & Glasgow, 2000) 
User program evaluations  Users’ internet usage, program usage, 
perceived utility and acceptability, ease of 
use, user interface, and satisfaction with 
program 
OnTrack Diabetes Program Evaluation 
Survey 
   
Study Procedures 
Participants registered interest in the trial on the OnTrack Diabetes homepage following which they 
received an eligibility screening call.  Individuals who were eligible to enrol received baseline study 
measures.  Individuals who were ineligible for study enrolment were provided with ongoing program 
access. 
Following baseline measures, enrolled participants received an email that specified a secure 
username and password with which to log on to the program.  Randomisation to study conditions was 
performed via automated computer-generated random permutation.  One week before the due date for 
3-month Post-Baseline measures participants received an e-mail notification with a link to the online 
survey and an appointment time to undertake the timeline follow-back measure by phone and to 
provide their HbA1c result.   
Pilot Trial Experimental Conditions 
Wait-list Control 
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 From enrolment, participants received access to a blank screen and undertook their usual 
diabetes care.  Following 3-month Post-Baseline measures, they received access to the full OnTrack 
Diabetes program. 
Brief, Modified Intervention – Physical Activity 
 From enrolment, participants received access to the program’s information resources and the 
physical activity module, Keeping Active and Feeling Great.  The module included a series of 
interactive tools that encouraged physical activity participation via goal-setting, working on increasing 
self-efficacy, problem-solving for obstacles, and setting a routine to incorporate desired changes into 
the coming week.   
Full Intervention 
 From enrolment, participants received access to the full OnTrack Diabetes program.  In 
addition to content received by the Brief, Modified Intervention condition, the full program included 
modules targeting dietary adherence (Eating Well and Feeling Healthy), health regime adherence 
(Health Routines), emotional wellbeing (Thinking Well and Feeling Fine), and maintaining positive 
changes (Keeping On Track).  There were two sections to each module.  The first section included 
tools incorporating guided imagery techniques, planning, goal-setting, and confidence building.  The 
second section started with the words “More On...” (e.g. More On Health Routines).  Included tools 
focused on setting routines to implement changes in the coming week, and problem-solving for 
obstacles to starting/ maintaining change.  A printable summary page was shown on completion of 
each tool.  Self-monitoring tools enabled the daily recording of best and worst mood, highest and 
lowest blood glucose levels, and adherence to physical activity and nutrition goals from 0% = not at 
all, to 100% = totally).  Automated feedback graphs in the program displayed users’ progress on 
recorded measures for the past month and 3 months.  A range of mindfulness and meditation audio 
resources that could be downloaded to an MP3 player or computer were also available. 
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Statistical Analyses 
Univariate Analysis of Variance (ANOVA) was used to assess for potential differences 
between study conditions on baseline variables.  Main outcome analyses that predicted 3-month Post-
Baseline outcomes were conducted using Mixed Model Analysis with repeated measures.  An 
intention-to-treat approach was applied to the data.  Differences between study conditions on 
quantitative user evaluations were assessed using Univariate ANOVA. 
Ethics 
This project received ethics approval from the Uniting Care Health Human Research Ethics 
Committee (#Cassimatis9111) and the Queensland University of Technology University Human 
Research Ethics Committee (#1100000783). 
6.4 Results 
Recruitment and enrolment processes are displayed in Figure 1, which outlines the distribution of 
expressions of interest and details participant attrition.  Over one-third (37.68%) of expressions of 
interest were excluded from participation based on selection criteria, with the main criterion being 
failure to meet the HbA1c threshold of ≥ 6.5%.  The participant retention rate at the 3-month Post-
Baseline follow-up was 89.47%.    
 
 
 
199 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Consort diagram of OnTrack Diabetes pilot randomised controlled trial recruitment 
and enrolment processes. 
 
Assessed for eligibility (n = 69) 
Excluded (n = 31) 
Not meeting inclusion criteria (n = 26) 
Refused to participate (n = 3) 
Other reasons (n = 2) 
• Comorbid disease burden (n = 1) 
• Doctor declined testing HbA1c (n = 1) 
 Randomised (N = 38) 
Allocated to Wait-list Control  
(n = 12) 
 
Allocated to brief intervention  
(n = 13) 
Received allocated intervention 
(n = 13) 
 
Allocated to intervention (n = 13) 
Received allocated intervention 
(n = 13) 
 
Lost to follow-up (n = 1) 
• Began another 
intervention 
 
 
 
 
Lost to follow-up (n = 1) 
• Uncontactable (n = 1) 
Discontinued intervention (n = 0) 
 
 
Lost to follow-up (n = 0) 
Discontinued intervention (n = 2) 
• Comorbid lupus 
• Gastric lap-banding 
 
Analysed (n = 11) 
Excluded from analysis (n = 0) 
 
Analysed (n = 12) 
Excluded from analysis (n = 0) 
 
Analysed (n = 11) 
Excluded from analysis (n = 0) 
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A sample of 38 participants (13 males, 37.14%) was enrolled in the trial and included in data 
analyses, as shown in Figure 1.  The sample had a mean age of 60.42 (SD=10.03; range=23 – 75), a 
mean type 2 diabetes duration of 8.91 (SD=7.77; range=1 – 27) years, and an average HbA1c level of 
7.09% (SD=1.08, range=6.5 – 10.8%).  Most of the sample was overweight, with an average body 
mass of 96.71 (SD=22.41; range=56 – 173.5) kg and a mean waist circumference of 109.59 
(SD=13.76; range=85 – 137) cm.  Most had at least one comorbid condition with type 2 diabetes, 
which primarily included hypertension (n=14), followed by asthma (n=7) and arthritis (n=7).  The 
majority were employed in professional roles (40.7%, n=13), with 21.8% (n=7) working in senior/ 
managerial positions, and the same proportion being unemployed.  There were no statistically 
significant differences between experimental conditions on any participant baseline characteristics, 
which are displayed in Table 2, below.  
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Table 2. Participant baseline characteristics according to experimental condition. 
(N=38) 
Characteristic 
Wait-list control 
(n=11) 
Full intervention 
(n=13) 
Brief intervention 
(n=11) 
Age(yrs), M(SD) 62.27(5.98) 56.2(13.58) 62.6(9.06) 
Gender (%) 
Males 
Females  
 
7 
4 
 
2 
11 
 
4 
7 
Weight(kg), M(SD) 95.79 (0.79) 96.42 (26.79) 97.95 (20.55) 
Waist(cm), M(SD) 111.22 (13.22) 105.76 (10.62) 113.06 (17.83) 
T2D duration(yrs), M(SD) 9.0(7.37) 9.22(8.82) 8.43(7.98) 
HbA1c level(%), M(SD) 7.94 (1.15) 7.52 (0.79) 7.99 (1.34) 
Income level(per yr) *$50 – 75 000 $50 – 75 000 $50 – 75 000  
Employed (%)       81.82 76.92 62.5 
Note: *Income is in Australian dollars 
Quantitative Data Analyses 
There were no significant differences between experimental conditions on any baseline 
outcomes.  As shown in Table 3, there were no statistically significant differences between 
experimental conditions from Baseline to 3 months Post-Baseline on primary outcomes.  Analyses 
revealed a significant improvement from Baseline to 3-months Post-Baseline across experimental 
conditions on the secondary outcome number of serves of sweet foods consumed in the past week, as 
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shown.  However, there was no significant difference found in sweet food consumption according to 
experimental condition, over time (F(2, 30)=1.19, p=.32).  No further statistically significant differences 
were revealed in secondary outcomes between Baseline and 3 months Post-baseline. 
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Table 3. Results of Analyses Comparing Outcomes from Baseline and 3-months Post-Baseline. 
Outcome Baseline 
M (SE) 
3 months 
Post-
Baseline 
M (SE) 
df Overall sample 
      F              p 
Between-groups 
F        p 
HbA1c level       7.82(.19)     7.47(.17)    31.02      3.85       .06     .67          .52 
Anxiety 5.24(.96) 4.24(.95) 31.14 2.28 .14 2.6 .09 
Depression 7.03(1.23) 6.96(1.17) 31.14 .005 .95         .57 .57 
Stress 10.13(1.16) 9.81(1.28) 31.16 .07 .79         .32 .73 
DD emotional burden 2.26(.21) 1.98(.17) 31.54 3.85 .06 2.1 .14 
DD social support 1.97(.20) 1.93(.18) 31.05 .13 .73         .73 .50 
Incidental activity 34.19(8.85) 24.17(6.72) 32.26 1.44 .24         .87 .40 
Walking 100.26(18.87) 123.57(20.57) 30.73 1.02 .32 1.5 .24 
Moderate activity 72.97(15.64) 75.99(17.39) 30.45 .03 .86 1.0 .37 
Vigorous activity 27.49(12.12) 29.20(13.28) 31.61 .01 .91 .35 .71 
Fruit serves   14.58(1.38)    13.89(1.11)    32.36        .27        .61        .57       .57 
Vegetable serves 19.49(1.78) 18.42(1.68) 29.11 .35 .56 .03 .97 
Sweet food serves 7.17(1.45) 4.50(1.28) 29.98 6.5 .02        1.2 .32 
Fatty food serves 4.55(1.07) 2.95(.72) 31.98 1.76 .19 .75 .48 
HR-QOL .27 .30 32 .61    .20 .20 .82 
Note. df = degrees of freedom; DD = diabetes distress; HRQOL = health-related quality of life 
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Analyses of Exposure to Intervention & User Feedback 
Overall, participants in the full intervention condition reported that the OnTrack Diabetes program had 
high acceptability, useability, and utility, as shown in Table 3.     
Table 4. Quantitative User Evaluations of the OnTrack Diabetes Program at 3 months Post-Baseline According to 
Experimental Condition. 
Variable Full Intervention  
(n=12) 
M(SD) 
Brief/modified 
Intervention  
(n=11) 
M(SD) 
Between-groups differences 
F                           p 
Number of log-ins          4.62(6.56)          4.18(2.14)        3.9       .06 
Time online/week(h) 2.3(1.5) 2.5(1.6) .64 .44 
Problems with online access 2.3(.95) 2.33(1.03) .08 .79 
User-friendly 3.4(.52) 4.17(.98) 8.59 .01 
Easy to understand 3.8(.79) 4(.89) .01 .90 
Trustworthy 4(.94) 4.33(.82) .05 .80 
Confident in suggestions 3.78(.67) 3.17(.41) 1.8 .20 
Useful (program) 3.3(.95) 3.5(1.05) .08 .79 
Useful (information resources) 3.5(.85) 3.67(1.03) .10 .76 
Easily applicable to self 3.1(1.66) 3.33(1.03) 6.7 .02 
Addressed exercise well 3.33(.87) 3(1.26) 0 1.0 
Addressed diet well 3.1(1.1) 3(1.41) .02 .90 
Addressed health routines well 3.67(1.12) 3.2(1.48) .05 .84 
Addressed emotional challenges well 2.63(.92) 2.8(1.1) 0 .10 
Attractive pages 3.22(.97) 3.83(.98) 1.5 .70 
Text/graphics easy to read 3.78(.97) 3.83(.75) 2.46 .14 
Engaging to use 2.89(.93) 3.5(1.05)               .46 .51 
Boring       2.6(1        1.83(.98)   .59       .46 
Note. Values represent mean ratings on a scale from 1 (Not at all) to 5 (Extremely). 
 
Participants indicated that the program was easy to understand, engaging and easy to use.  
They also indicated that they trusted using the program’s suggestions and found it to be personally 
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relevant.  On average, participants reported that they found the program at least moderately useful for 
their purposes in addressing physical activity, healthy eating, and in particular health routines.  
However, they perceived that the program was slightly less useful in addressing their emotional 
challenges.  Most claimed that they would be likely to refer someone they knew with type 2 diabetes 
to the program. 
Qualitative Program Feedback at 3-Months Post-Baseline 
Some aspects of the program that participants reported liking most included, “...its one-on-one 
involvement”, the information fact sheets, its personalised nature, the self-monitoring tools, and its 
presentation.  Participants commented that the program “...provided me with the opportunity to 
discuss my particular problems with a professional, and made me aware that I could also do this with 
my GP and diabetes nurse.”  Additionally, OnTrack Diabetes was regarded to be “...well prepared and 
sectioned not to overwhelm.  It provided realistic goals”.  Another user indicated liking that 
“...everything (in the program) is interconnected and you can go from one to another part.  It is all 
there in front of you.”  Further comments by participants about the most useful aspects of the program 
included: 
The one (tool) that tracks your mood, blood glucose levels, nutrition and exercise goals.  I like 
seeing the trends especially if there is an improvement in my control.  I don't like when the 
dots don't connect. 
 (Female, 58 years, full intervention condition)    
 Provided a program that I could access for information and motivation.  It was available when 
I needed to clarify something and I did not have to leave home or spend time in waiting rooms  
(Female, 44 years, full intervention condition)             
(I most liked)...just having a single online place to store the daily records. 
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(Female, 62 years, full intervention condition)       
Participants commented that remembering to visit the program regularly was problematic at 
times.  Suggestions were made to implement reminders to log on.  Further suggestions for 
improvements included converting the web program into an application that could be accessed via a 
smart phone or tablet to increase its accessibility.  Furthermore, participants suggested including a 
blog or page from which health professionals or support persons could be contacted from within the 
program.  Some users who had access only to the brief, physical activity intervention commented that 
they were dissatisfied at having been randomised to this condition.  For example, two participants 
indicated that they already undertook regular physical activity, and were hence frustrated about only 
receiving access to this module. 
6.5 Discussion 
This pilot trial represents the first of an automated, interactive web-based support intervention 
for type 2 diabetes self-management and dysphoria.  Results reflect the feasibility, acceptability and 
perceived utility of the OnTrack Diabetes program in an Australian type 2 diabetic population.  
Failure to detect statistically significant differences between experimental conditions is largely 
reflective of the small sample size.  Indeed, utilising a small sample size for the pilot trial must be 
acknowledged as a limitation to achieving adequate statistical power to detect real differences in study 
outcomes.  This shortcoming was primarily due to the time constraints imposed on the pilot trial due 
to budgeting and resource limitations.  Nonetheless, this pilot trial has shown to be useful in informing 
the research team about the feasibility of the study protocol and testing the program’s functionality 
and user evaluations, as this specific form of intervention is novel in the Australian context.   
 Our finding that anxiety produced a downward trend across time concurs with that of a meta-
analysis of web-based, cognitive behavioural therapy interventions for mood, which indicated that 
effect sizes of interventions for anxiety symptoms were generally larger than those for depressive 
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symptoms (Spek et al., 2007).  However, the difference in the amount of therapist-based support 
included in these interventions was suggested to be a potentially contributing factor.  The reduction in 
the consumption of sweet foods may be indicative of participants’ desire to improve their diabetes 
control, and hence enrol in a research trial.  Related to this is the fact that the mean HbA1c level for 
participants in all conditions was just above 7%, which indicates that despite substantial power issues 
due to the small sample size, especially within a 3-month time period, the result is close to reaching 
clinical significance.  This suggests that the program has the potential to produce clinically and 
statistically significant improvements, and that this may be determined using a larger sample size.     
 Most importantly, it is necessary to reflect on the fact that the majority of participants in the 
brief and full intervention conditions demonstrated poor engagement in the program, with many 
acknowledging that they wished they had used the program more often.  Participants in the brief 
intervention condition were not satisfied with the perceived paucity of resources and tools that they 
received, indicating that they considered receiving only a brief module to be insufficient.  In particular 
this was an issue for those individuals who did not wish to work on improving their physical activity.  
Results from the full intervention condition indicated that even if users had a choice about which 
program module to access, they are unlikely to have experienced improvements in primary or 
secondary outcomes due to poor engagement.   
 Participants who received the full intervention reported being pleased about the personalised 
aspects of the program, which they could relate to their own issues and experiences with type 2 
diabetes self-management.  This feedback is parallel with previous research that indicates the 
importance of an individualised approach to diabetes treatment and self-management intervention 
(Kaufman, 2010).  The program was reported by this group to be highly acceptable and easy to use, 
with an acceptable graphical presentation and lay-out.  Users in this group also reported that the 
program helped them to feel more comfortable discussing issues with their health care providers.    
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Suggestions made by users will be used to inform refinements of the OnTrack Diabetes 
program for the main randomised controlled trial.  Reminder e-mails or SMS’s will be sent to 
participants at regular intervals to encourage them to log on more frequently.  User engagement has 
been reported as a common issue in previous web-based trials of intervention support programs 
(Glasgow et al., 2011; Lorig et al., 2010).  This issue suggests that the implementation of therapist 
support and/ or reminders may be instrumental to encourage user engagement in web-based 
interventions, at least until a routine is established and/ or users are at a maintenance stage of self-
care, which may require less regular access.  Overall, results from this initial pilot trial of OnTrack 
Diabetes have indicated that, whilst the program gains users’ trust and is perceived to be acceptable 
and easy to use with a range of features that they consider to have utility, techniques to improve user 
engagement are needed.  These issues will be worked upon prior to recruiting a large sample to the 
main randomised controlled trial of the program, which will provide greater power to reasonably 
assess clinical, mood, and behavioural outcomes.  
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6.6 Chapter Summary and Conclusions 
This paper reported a number of strengths, limitations, and areas for improvement in the 
OnTrack Diabetes program implementation that will be extended upon in the main randomised 
controlled trial of the program. 
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CHAPTER 7 
DISCUSSION, SUMMARY AND CONCLUSIONS 
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7.1 Abstract 
This PhD project was comprised of three stages that fulfilled its overarching objective, which 
was the development and evaluation of an automated, web-based type 2 diabetes self-management and 
dysphoria intervention.  Specific aims of the project were associated with each stage, with provided a 
foundation for the progression of consecutive stages and formed the basis for contributions to the 
scientific literature via journal publications.  Stages comprised: (1) Exploration – (i) investigation of 
telehealth as a means of intervention delivery by systematic review (Paper 1) and (ii) qualitative 
interviews on patients’ and physicians’ perceptions of living with type 2 diabetes (Paper 2); (2) 
OnTrack Development – (i) consolidation of project protocol (Paper 3); (ii) development of the 
OnTrack Diabetes program (Paper 4); and (3) Evaluation – pilot trial evaluation of the OnTrack 
Diabetes program (Paper 5).  Overall, this project can thus be seen to have resulted in valuable 
scholarly contributions that will assist with shaping the future of web-based diabetes self-management 
research.  This chapter discusses how the project findings and their resulting papers link with the 
project aims at each stage.  Project outcomes are then discussed in the context of Social Cognitive 
Theory.  Finally, strengths and limitations, practical implications and future directions are presented 
followed by concluding remarks.  
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7.2 Overall Discussion 
The overarching objective of this PhD project was to develop and evaluate a web-based 
intervention for type 2 diabetes self-management and dysphoria, which was fulfilled.  Each stage of 
this project formed a foundation for the later ones.  Information on the effects of behavioural 
telehealth interventions on glycaemic control and diabetes self-care (Paper 1) provided information on 
the potential efficacy of this form of intervention.  Due to the paucity of well-reported research, 
defined by the quality and validity of its reporting, and the heterogeneity of included studies, it was 
difficult to draw firm conclusions.  However, it appeared that behaviourally-based telehealth 
interventions are generally not effective at producing significant improvements on diabetes self-care 
outcomes.   
The qualitative responses of patients and physicians on experiences of living with type 2 
diabetes (Paper 2) provided evidence of the need for additional self-management support for people 
with type 2 diabetes, and emphasised the need for emotional and psychological support in particular.  
The subsequent development of the program was an iterative process that was described in two 
papers; the procedures used in the project (Paper 3), and the steps involved in developing the web-
based support program (Paper 4).   
The final stage comprised the randomised controlled pilot trial of the OnTrack Diabetes 
program (Paper 5).  There was no significantly differential effect for the web intervention on any 
outcome over the initial 3 months, which was largely due to the limited sample size which prevented 
adequate statistical power from being achieved to detect statistical differences amongst outcomes.  
This limitation was largely the result of restrictions in project resources which prevented the 
recruitment of research staff to undertake assessments and implement the program.  In this context, 
the time constraints of the PhD program made for a tight timeline in terms of program development, 
testing, and implementation, which substantially limited the pilot trial recruitment period.  
Nonetheless the result for anxiety approached significance, suggesting that an effect may be obtained 
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with a larger sample.  Program evaluations indicated that users had high levels of satisfaction with the 
program, and it had moderate to high acceptability, utility, and ease of use.  Users also reported that 
the program provided trustworthy information, and that they liked its graphical presentation and lay-
out. Overall, the project provided an important contribution to understanding the unmet needs of 
people with type 2 diabetes and the role that a web-based program may have in meeting these.  It 
created a self-management intervention for both type 2 diabetes and dysphoria that for the first time 
could be delivered with or without coaching support.  It also offered a preliminary trial of this 
program’s efficacy.  
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7.3 Discussion of Papers in Relation To Project Aims 
The initial aim of this research was to build a remotely accessible intervention via which type 
2 diabetes self-management and mood support could effectively be delivered.  Telehealth was at first 
explored as a possibility for this intervention.  Although there is a plethora of scientific literature 
reporting on telehealth studies, there is a paucity of evidence on the effects of telehealth interventions 
on both diabetes self-management and mood.  Further, it was difficult to distinguish the effectiveness 
of particular components of multi-faceted interventions, and this is particularly useful in the case of 
informing diabetes self-management interventions, which typically have a range of behavioural self-
management components to address.  Therefore, we wished to ascertain a general idea about what the 
current status of telehealth research could offer type 2 diabetes patients in terms of behavioural and 
clinical improvements, and thus conducted a systematic literature review (Paper 1).   
Specifically, behavioural components of diabetes self-management interventions were the 
focus of the review to evaluate their effectiveness.  Results indicated that much improvement is 
required in the efficacy of behavioural telehealth interventions that aim to address glycaemic control 
and at least one diabetes self-care area.  In addition, it was decided that we may not be able to offer 
much more than previous telehealth interventions already have in terms of producing an original 
intervention with superior efficacy.  Thus, it was decided to explore the more novel, web-based 
approach to diabetes self-management intervention.  Paper 1 adds to the health psychology and 
diabetes self-management arena by emphasising the need for improvements in telehealth 
interventions.  Results also make clear the inconsistencies and poor quality and validity of study 
reporting in this area, which made it difficult to draw conclusions based on the available research.  
The review was also useful for providing an overview of the theoretical approaches that are 
commonly used in primarily behavioural telehealth interventions for diabetes self-management, and in 
doing so, provided support for using Social Cognitive Theory as a theoretical foundation.  
Furthermore, the importance of addressing psychosocial issues in diabetes self-management support 
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interventions was demonstrated by included studies.  Essentially, findings reported in Paper 1 assisted 
with our decision to implement web-based, as opposed to telephone-based intervention, and presented 
a novel view to the scientific literature that may prompt consideration of the efficacy of particular 
behavioural components in telehealth. 
 An overview of the literature on qualitative studies that explored the views of patients with 
type 2 diabetes and health care professionals (Section 1.4) provided some scope on key facilitators and 
barriers to type 2 diabetes self-management, and further information could be derived from 
quantitative research.  The aim of the qualitative exploration (Stage 1) reported in Paper 2, or Chapter 
3, was to determine issues that specifically relate to Australian people with type 2 diabetes that was as 
recent as possible.  This provided a substantial foundation for the development of a type 2 diabetes 
self-management and dysphoria intervention.  Findings from the qualitative interviews revealed the 
depth to which type 2 diabetes patients experience emotional losses in response to their condition; the 
impacts of type 2 diabetes on their lives, and gave insight into their lived experiences with managing 
the condition.  Physicians’ perceptions indicated that they wished to support patients, but that 
motivational issues were key barriers to their effectiveness in delivering appropriate type 2 diabetes 
care as advised by recommendations.  Physicians also highlighted that although patients have 
individual experiences of their diabetes, their concerns and emotional difficulties come from some 
common sources, which doctors were mostly able to identify with sufficiently.  However, there were 
also some discrepancies between patients’ and physicians’ perceptions, with physicians taking a more 
practical perspective of patients’ self-management issues.  Overall, findings indicated that patients 
require further support with their day-to-day diabetes self-management, and that emotional support is 
also very much needed, and would be well received.  Further, both patients and physicians indicated 
perceiving that web-based support was an acceptable means by which to receive this support, and both 
samples offered many suggestions for program content.     
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 Stage 2 involved the development of the OnTrack Diabetes program.  Paper 3 (in Chapter 4), 
which describes the project protocol, was aimed to report on the overall study processes involved in 
the OnTrack Diabetes project.  The purpose of this was to elucidate these processes in the scientific 
literature so that they could be linked to final outcomes of the research, and used as a basis for 
replication or improvement in future trials.  This paper makes a contribution to the literature by 
demonstrating important links between the qualitative interviews (Stage 1; Paper 2), and Stages 2 
(program development) and 3 (pilot trial implementation) of the project.  Therefore, project 
procedures and sequence can be analysed and critiqued by others.  This lends to the scientific 
literature by providing information on what was involved in the development and evaluation of the 
first program of its kind in the context of type 2 diabetes self-management and dysphoria intervention 
in Australia. 
 As this research project involved the development of a novel form of technological 
intervention in the context of type 2 diabetes self-management and mood, the aim of the program 
development paper (Paper 4, or Chapter 5) was to outline the scientific community on the processes 
involved in its development.  In doing so, we made explicit the sequence of steps that were involved 
in the content, graphical, and technological design of the OnTrack Diabetes program.  The paper can 
thus be used as a point of comparison for researchers who wish to or who have developed web-based 
chronic disease self-management and/ or mood interventions.  The paper provides an indication of the 
typical time requirements involved in such a venture, although the time to develop OnTrack Diabetes 
was significantly reduced by the availability of pre-established web lay-out and some program tool 
features, as well as technological functionalities.  Paper 4 further provides a useful vantage point to 
refer to in future, as the expansion of technological interventions is in rapid development.  When 
methods of program development that are included in the paper become superseded, this paper will 
indicate the typical processes that were used in the early 2010’s to develop web-based interventions. 
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 Stage 3 was defined by the randomised controlled pilot trial of OnTrack Diabetes, and had two 
aims.  The first was to gain a preliminary indication of its effectiveness in improving clinical, 
behavioural, psychological/ emotional, and quality of life outcomes in people with type 2 diabetes.  It 
is noted that some of the measures listed in the project protocol paper are not mentioned in the paper 
on the pilot trial evaluation.  This is for the reason that the pilot evaluation paper aimed to present 
findings of primary significance out of the outcomes which were measured. This was in the context 
that clinically/ statistically significant outcomes were deemed unlikely with such limited statistical 
power, which was found to be the case.  The information that was collected will be used to inform the 
main randomised controlled trial, when the increased power will enable possible associations between 
these lifestyle factors and outcomes to be assessed.  The second aim was to evaluate users’ perceived 
acceptability, utility, and ease of use of the program, and the feasibility of its implementation.  This 
pilot trial also enabled the study protocol to undergo assessment, to inform any necessary refinements 
before going on to the larger, randomised controlled main trial of the program.  Overall, these aims 
were successfully fulfilled.  Paper 5 (in Chapter 6) reported on the pilot trial results and demonstrated 
that the program was useful in incorporating suggestions from participants who took part in the 
qualitative interviews in Stage 1 (Paper 2), as the program evidenced in producing high user 
evaluations.  This paper highlights the successes and difficulties associated with implementing 
automated web-based type 2 diabetes self-management and dysphoria support.  Results are discussed 
and suggestions for potential improvements to program implementation are considered.  This paper is 
the first scientific dissemination of research on an intervention of this kind within the Australian 
context, and hence it makes a substantially valuable contribution to the scientific literature in both its 
indication of study outcomes and user evaluations.  
7.4 Discussion of Findings in Relation to Social Cognitive Theory 
Social Cognitive Theory (SCT) proved to be a well suited approach to the overarching aims of 
this research project.  The systematic review on telehealth interventions (Paper 1) showed that SCT is 
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commonly used in remotely accessible interventions for diabetes self-management.  The theory is 
particularly applicable to the purpose of this project, as it aimed to address concomitant psychological 
and emotional issues, which are accounted for in SCT.  The qualitative exploration of patients’ 
experiences with managing type 2 diabetes (Paper 2) validated the use of SCT, as in their responses 
participants revealed that type 2 diabetes ultimately affects all aspects of their lives, including their 
social environments, their interpersonal relationships, and their psychological and emotional well-
being.  Participants’ accounts also indicated that when these factors were conducive to supporting 
them in their diabetes self-management, they were more successful in implementing recommended 
self-care, which indicated that there is scope for interventions that align with the principles of SCT.  
Further, SCT provided a logical and practical framework with which to structure an automated 
support program (Paper 4).  The specific ways in which SCT was incorporated into the OnTrack 
Diabetes program are outlined below.  The OnTrack Diabetes pilot trial (Paper 5) produced results 
that reflect on the incorporation of patients’ responses from the qualitative interviews (Paper 2) into 
the program.  In general, the high ratings obtained on user evaluations indicated that a web-based 
intervention that uses SCT as its primary theoretical foundation can create positive user impressions.  
However, motivational and other issues, which are also discussed below, potentially impacted on user 
engagement. 
7.5 Application of Social Cognitive Theory to the OnTrack Diabetes Program 
SCT was successfully incorporated into the OnTrack Diabetes program as a theoretical 
foundation, which demonstrated that the principles of this theory are well suited as a basis for web-
based chronic disease self-management intervention.  Specific aspects of SCT were applied to 
particular program features that promoted the principles of behavioural self-management and 
emotional regulation denoted by the theory. 
My Journey Map describes the program’s background lay-out, which enables users to view the 
journey on which they will embark in the program and to view their lists of options to undertake any 
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particular sections of the program that they wish to at any time.  This aspect encourages user 
autonomy and program personalisation.  As a whole, using the various aspects of My Journey aims to 
take users on a path towards higher self-efficacy, self-awareness, skill acquisition, and stress 
relaxation.  This is applied with the provision of cognitive guidance to implement behavioural 
changes, interactive self-efficacy promoting tools, self-monitoring functions and feedback, 
encouragement of performance accomplishments, vicarious learning, and building social supports.  A 
brief description of how the OnTrack Diabetes program fulfilled the requirements of SCT for 
motivating and potentially maintaining changes in the behavioural self-management of users with type 
2 diabetes is outlined below. 
Skill and ability enhancement for type 2 diabetes self-management – Extensive diabetes 
education resources on general type 2 diabetes information, self-care, information about the purpose 
and requirements for accessing allied health professionals, and support services can be accessed under 
the “resources” tab.  This informational support provided the basis for skill acquisition of self-
management behaviours and a strong knowledge base that informs users on the value of performing 
adequate self-care.  Hence, the program fulfilled the need for ability to enact desired behaviours, 
which is vital to making progress with behaviour change (Bandura, 1986). 
Self-monitoring – My Diary is a section of the program that contains self-monitoring tools for 
daily blood glucose levels (highest and lowest), mood (best to worst), physical activity and nutrition 
goal adherence (0% = not at all, to 100% = totally).  These tools encouraged self-observation and self-
evaluation, which are important to goal-setting and creating motivation for self-care by creating a 
negative feedback control loop that motivates individuals to reduce discrepancies between current and 
desired performance accomplishments (Bandura, 1991).  Regular self-monitoring and goal-setting 
tools enable participants to more readily develop and maintain self-awareness of their progress, and 
re-set their goals accordingly.  Printable and foldable self-monitoring cards enable them to undertake 
self-monitoring when they are not logged in to the program.  This encourages proximal self-evaluation 
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of progress towards their goals, which is considered important in SCT (Bandura, 1989), as distal self-
reflection is not as effective at producing motivation for improvement in performance attainments. 
Feedback control – Automated feedback graphs are produced from information entered into 
My Diary, and display goal progress in the past month and 3 months.  The function of feedback 
control is another essential constituent that is implicated in the process of self-evaluation (Bandura, 
1989).  Using the feedback graphs, participants can regularly assess their effectiveness in producing 
positive outcomes in their glycaemic control and diet and physical activity goals.  SCT proposes that 
failure to meet personal internal standards should create a negative feedback loop that promotes higher 
goal striving.  However, individuals with low self-efficacy may experience adverse emotional effects 
and reduced motivation when they fail to meet their standards.  The program aims to buffer possible 
detrimental effects of negative feedback on mood by providing interactive tools that encourage user 
self-efficacy (e.g. the Feeling Confident tool).  However, if users did not use or complete these 
particular tools they may have experienced a negative emotional reaction and/ or reduced motivation 
from observing regressions in progress.  This potential for a negative effect of self-monitoring on 
behaviour emphasises the importance of using at least the tools that are primarily aimed to impact 
self-efficacy beliefs in conjunction with the self-monitoring tools and graphs. 
Goal-Setting – Users were encouraged to set personalised goals.  Therefore, these goals should 
have had personal valence and been set at a level that was perceived to be appropriately challenging 
by each user.  Further, viewing goal progress using the feedback graphs enabled participants to 
perform goal attainment scaling which, as discussed, can lead to increased motivation when 
discrepancy between actual and desired outcomes is detected.  SCT proposes that these two aspects of 
goal-setting are necessary to produce the incentive to increase performance accomplishments.  
However, poor user engagement in the program means that this process is unlikely to have occurred in 
most pilot trial participants.  Once again, although the program included guidelines via interactive 
tools that advised on setting goals in small, incremental steps (e.g. “My Physical Activity Goal Plan”), 
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if users had not accessed these tools they may have set easy goals for themselves, which failed to 
enhance their motivation and led to inaction. 
Problem Solving – Interactive tools on problem solving strengthen participants’ self-efficacy 
by enhancing their beliefs in their capabilities to cope with challenges, including behavioural set-
backs from treatment regime non-adherence.  Making an effort to overcome barriers to change which 
results in success leads to more positive expectancies when similar difficulties are faced in future.  
Therefore, these tools encourage the strengthening of cognitive guidance to endure through challenges 
as well as motivation to do so via practice effects. 
Mastery of performance accomplishments – Interactive tools (e.g. “My Physical Activity Plan” 
and “My Health Actions Routine”) encouraged participants to create a plan to master personally set 
performance accomplishments.  This is consistent with the SCT notion of mastery achievements 
motivating performance and thereby leading to increased self-efficacy and goal pursuits (Bandura, 
1977).  Mastering desired performance attainments are also associated with positive effects on mood.  
Hence, these tools serve the purpose of aiming to improve type 2 diabetes self-care behaviours and 
mood. 
Vicarious learning – Videos in the program demonstrate scenarios in which actors discuss 
their strategies for overcoming low mood; gaining motivation to participate in physical activity; 
overcoming problems with alcohol, and communicating more effectively to improve their intimate 
relationships.  The actors are average Australians who are likely to be similar in age (middle-aged) to 
most participants, and to report experiencing similar behaviour change and mood issues as 
participants.  Therefore they are people with whom participants in the project would be thought to 
have identified with.  Viewing the videos is a source of efficacy by enabling symbolic modelling to be 
performed, wherein even though videos of people with type 2 diabetes were not included due to 
budgeting issues, participants could have generated applications of the rules extracted from the 
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examples and applied them to diabetes self-management.  For example, the video of overcoming 
issues with alcohol could have been applied to personal dietary issues.  People with dial-up internet 
access and/ or slow internet connection speeds may have had difficulties uploading the videos so 
verbatim transcripts of video content were also available.  Viewing the transcripts changes the 
vicarious reinforcement effect, however, in that it does not use modelling. 
Verbal persuasion – Interactive tools are based on verbal persuasion regarding providing users 
with instructions on diet, physical activity, health behaviours, emotional well-being, and maintaining 
change.  This is the weakest source of efficacy beliefs (Bandura, 1977).  However, it is the basis of 
most psychotherapeutic and web-based interventions, and combined with the other sources of efficacy 
incorporated in the program, is sufficiently enriched.  Participants are not provided with instructions 
per se, but rather are encouraged to exercise their own judgement in deciding the course of action that 
they wish to take.  This should encourage patient empowerment and autonomy in making decisions 
about implementing personalised changes.  The program then merely provides guidance to facilitate 
this process. 
Physiological state – Stress relaxation has demonstrated efficacy in mitigating the negative 
effects of aversive physiological arousal on behaviour, including on defensive or avoidance 
behaviours (Bandura, 1989).  Furthermore, perceived inefficacy to cope with potential threats tends to 
result in avoidance behaviour regardless of whether aversive arousal is present.  Meditation and 
mindfulness-based audio files in the program train users to relax, which according to SCT, has the 
effect of increasing their perceived efficacy to cope with potential threats and physiological arousal 
(Bandura, 1989).  Hence, the audios are potentially useful for reducing negative physiological 
symptoms and affective disturbance, and may have longer-term effects on diabetes self-care 
avoidance behaviours. 
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Forethought/ Cognitive guidance – SCT denotes that initially, calculated judgements are 
required for the implementation of novel desired behaviours.  However, after repeated practices, the 
behaviour becomes less cognitively effortful, which is represented neurologically by a change from 
the activation of top-down processing to that of lower level neural processing in response to 
behavioural activation.  OnTrack Diabetes implements guided imagery techniques that work on this 
function to train users to implement their desired behaviours using cognitive guidance to establish 
cognitive behavioural patterns in their thought processing.  For example, one of the first interactive 
tools contained in each program module (e.g. “Ideas About Fun Physical Activity”) asks participants 
for suggestions about a physical activity that they would like to participate in during the following 
week.  Specification that the activity should be implemented in a short-term time frame represents is 
consistent with the importance of proximal temporality in exercising cognitive forethought to increase 
motivation.  Further, printable summaries enable users to apply program-based cognitive guidance in 
even closer proximal temporality to the event. 
Social support – Social support is an essential factor in successful type 2 diabetes self-
management, and accords with the importance of psychosocial interactions to health and wellbeing 
that is outlined in SCT (Bandura, 2004b).  Accordingly, “Building My Support Team” is an 
interactive tool in which users are taken through steps to create a list of people who can support them 
as they work through the program.  Supports can include family members, friends, or anyone from 
their wider support network, for example work colleagues and community members.  “Building My 
Support Team” includes a section wherein users can complete a support page that lists the health 
professionals that comprise their diabetes self-management team, including allied health professionals 
(e.g. diabetes educator, podiatrist, dietitian, optometrist, etcetera), as well as their primary care 
provider.  Along with the information resources on accessing each member of the diabetes care team, 
this section aims to encourage ease of access to contact details and to remind participants that there is 
both personal and medical social support available nearby.  SCT proposes that social support can 
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buffer against the negative effects of depression on self-care behaviours (Bandura, 1998).  Once again, 
the utility of this effect largely depends upon utilisation of this tool. 
 In sum, SCT can be seen as a suitable theoretical approach to have used as a foundation for the 
OnTrack Diabetes intervention.  SCT can also be used to understand the successes and shortcomings 
of the current research project. 
7.6 Understanding the Results of This Research in the Context of SCT 
It is interesting to note that the very motivational issues that were aimed to be improved in the 
pilot trial of the program may have borne the same issues for user engagement in the program as they 
did for engagement in type 2 diabetes self-management.  As discussed earlier, the issue of participant 
attrition and poor user engagement is common to a number of prior research studies on web-based 
interventions, including those for diabetes self-management.   
OnTrack Diabetes incorporated a socio-ecological approach to self-management, and therefore 
encouraged participants to establish their own environments for creating behaviour change, for 
example by increasing social support and making plans for desired changes.  However, it is possible 
that participants needed some assistance with implementing these changes initially, or at least required 
assistance with the motivation to do so.  Some may have experienced behavioural avoidance which 
resulted in their failure to implement change.  Presenting participants with extensive informational 
support and tools for self-management makes salient their need to improve their self-care and, in 
accordance with motivational interviewing, emphasises the discrepancies between their current and 
desired situations.  Consistent with SCT, participants may then have avoided using the program due to 
their perceived inefficacy to cope with the self-management regimen. 
Qualitative interviews indicated that most people experienced substantial emotional challenges 
but did not consider themselves to be depressed.  A similar issue may have been responsible for poor 
user engagement in the pilot trial, as participants were possibly reluctant to admit that they had 
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emotional issues due to their perceived inefficacy to cope with them.  This suggests the need for more 
support to at least get started with the intervention, and probably also intermediate additional health 
professional/ research team support to encourage the maintenance of program use.  The program 
includes quizzes that participants can undertake to do quick assessments of their dysphoria and 
diabetes self-management.  These quizzes are incorporated into the program with the intention that 
participants can develop greater self-awareness of dysphoria symptoms, and upon their recognition of 
problems seek help as required.  However, low program engagement indicates that these quizzes were 
not used as intended. 
7.7 Practical Implications of Findings 
The Stages of this project and the scientific papers that resulted from each have a variety of 
implications.  The systematic review on behavioural telehealth interventions (Paper 1) illuminated the 
uncertainties that remain inherent in determining a thoroughly efficacious approach in the field.  The 
paper builds a foundation for empirical inquiry into the efficacy of providing primarily behavioural 
support for diabetes self-management, and gave scope as to how telehealth can be expanded to 
improve upon current findings.   
Qualitative interview findings (Paper 2) may assist with health professionals’ understanding of 
the experiences of type 2 diabetes patients, and that dysphoria, though rarely presented in the clinic 
room, is commonplace for many throughout the course of the condition.  As such, this paper may 
contribute to closing the gaps in communication between health professionals and patients.  The paper 
may also serve as a foundation for other studies that wish to further explore dysphoria in type 2 
diabetes patients, or as the basis for development of other interventions. 
The protocol (Paper 3) and development papers (Paper 4) are useful in assisting researchers to 
identify the typical processes involved in implementing a randomised controlled trial of a web-based 
intervention, and what is involved in program development.  Dissemination of these papers is 
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particularly foundational due to the novel nature of OnTrack Diabetes.  Further, these papers elucidate 
what could have been improved upon, or where new techniques could replace superseded ones in the 
development of future programs. 
  Pilot trial results (Paper 5) contribute important information on user perceptions of 
automated, web-based interventions, which indicate that there is promise for expansion in this area.  
Hence, results may form the impetus for further studies that seek to build upon the foundation that this 
trial has provided. 
7.8 Strengths and Limitations of this Project 
This research project has a number of strengths that are in part associated with using SCT as a 
theoretical foundation, and also some that are associated with the project design.  A mixed models 
approach was used throughout this study, in terms of implementing both qualitative and quantitative 
techniques.  The use of both approaches adds strength to the methodological design, as this approach 
is commonly regarded to be the gold standard of conventional research.  
 The qualitative interviews first and foremost opened the researcher’s eyes to the issues 
experienced by type 2 diabetes patients in managing their condition.  It is difficult to step into the 
shoes of people and understand their lived experiences without having explored this meaningfully.  
Hence, using mixed methodology was highly facilitative to the development of a patient-empowered 
program for people with type 2 diabetes.  Furthermore, the qualitative study provided the chance to 
tailor the intervention to a range of patients’ needs, whilst it provided a standardised, hence more cost-
effective (Radhakrishnan, 2012) intervention approach.  Stage 1 also provided scope as to some of the 
potential reasons for poor user engagement in the pilot trial, such as the issue of the avoidance of 
emotional issues possibly prompting participants’ needs for more follow-up support.    
 Having a pre-designed web-based program lay-out was helpful in providing structure to the 
OnTrack Diabetes program interface from the outset, which would otherwise have taken considerable 
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time in designing.  Further, it was cost effective to have had some of the information technology 
content; the mood self-monitoring tool; the mindfulness and meditation audios and videos, and some 
of the tool structures established.  The major contribution of the PhD candidate to the content input 
and eXtensive Markup Language (XML) programming also resulted in considerable savings in 
intervention production costs.   
 A number of strengths are associated with the pilot trial of OnTrack Diabetes.  The randomised 
controlled trial design is methodologically robust in controlling for issues associated with participant 
randomisation and the effects of individual differences and inequalities between research groups. 
Additionally, random allocation of participants to research groups via computerised random 
permutations enabled participant allocation concealment from the researcher.  Advice to participants 
not to reveal their experimental condition upon 3-month Post-Baseline assessments meant that the 
researcher was also blinded to participants’ experimental conditions.  Both of these criteria assist with 
ensuring the quality and validity of study methodology according to the Cochrane tool for assessing 
risk of bias.   
The pilot trial evaluation measures were valid and reliable instruments that are typically used 
in diabetes research.  Adding the timeline follow-back method for assessing dietary intake and 
physical activity adherence had the potential advantage of greater accuracy for cueing participants’ 
recall of their behaviours in the previous week (Sobell & Sobell, 1992).  User evaluation measures 
provided a comprehensive indication of participants’ experiences with using the program, and 
incorporated the use of both qualitative and quantitative measures.  
Particular strengths of the OnTrack Diabetes program included users’ high evaluations, which 
in general indicated that they are satisfied with the program and perceive it to be highly acceptable, 
accessible, and user-friendly.  Patients reported valuing the option to personalise the program 
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according to their needs.  As well as the positive evaluations, responses also provided scope for 
improvements on particular aspects of intervention delivery.      
Online administration of the OnTrack Diabetes Baseline and 3-month study surveys enabled 
greater accuracy, and may have assisted with the relatively high participant retention rate (89.47%), 
due to convenience.  Using an automated web-based intervention required relatively minimal person 
support, as one researcher was able to conduct a randomised controlled trial when the intervention.  
Finally, the pilot trial provided a preliminary indication of the program’s potential for real-world 
implementation and reach, with analyses to follow this up with analyses on the larger sample that will 
be recruited to a main randomised controlled trial of the program.  
There were also a number of limitations to various aspects of the project of which it is 
important to make mention.  In terms of the Stage 1 qualitative interviews, including a sample of 
people with type 2 diabetes and physicians from regional and rural areas would have assisted with 
better tailoring of the program to the needs of rural and regional residents with type 2 diabetes.  
OnTrack Diabetes accommodates the needs of a variety of people to a large degree, as users are able 
to personalise the program by selecting personally appropriate options amongst the interactive tools 
and undertaking personally relevant areas of the program.  However, there would have been 
foreseeable value in nonetheless gaining the perspective of those in regional populations to evaluate 
whether there were any substantial differences in their perspectives on type 2 diabetes self-
management and emotional challenges.  The reason for not doing so was that it was important to take 
notes of non-verbal communication from patients with type 2 diabetes, and hence the face-to-face 
format of the interviews was an integral factor in deriving themes from the data.  There were also 
limitations to the researcher travelling to remote locations alone to conduct interviews.   
Program development in Stage 2 raised a number of unexpected hurdles in progressing with 
the project.  The common issue of learning to understand information technology rules and limitations 
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made some stages of program development difficult to work through.  It can be difficult for 
researchers to adapt to the limitations of information technology programming, in which case what 
would seem to have been a simple request to implement a seemingly simple feature of program 
functionality was revealed to take much longer than had been supposed.  Further, at various points in 
the development stage, bugs were discovered in the system even after initial testing of the 
functionality and pages had been conducted.  Such is the issue of combining psychological and 
behavioural research with the field of technology. 
The pilot trial may have been improved in some aspects, including that few participants were 
from rural or regional areas, which limited the thorough assessment of implementation feasibility to 
these populations.  However, aims to recruit a much larger, more geographically diverse sample to the 
main trial will advance from this limitation.  A major issue that contributed to the failure to find 
significant outcomes on primary and secondary outcomes was the relatively small sample size that 
was enrolled, which limited the power to detect significant differences between study conditions.  Part 
of this issue was associated with delays in programming, as discussed, which limited recruitment time.  
The small sample size also limited the ability to undertake analyses of the variety of factors that can 
influence the improvement of diabetes self-management, which include educational attainment 
(Sacco, Bykowski, Mayhew, & White, 2012), demographic (McCabe, 2004) and psychosocial 
characteristics  (Akimoto et al., 2004; Chida & Hamer, 2008).   
Furthermore, some participants commented that the 3-month follow-up timeline follow-back 
phone call may have motivated improvements in their self-management in the week prior, although 
randomised allocation would have controlled for differential impacts between experimental 
conditions.  This suggests the potential for therapist-based support or coaching to enhance the effects 
of an automated intervention.  It also indicates the difficulties in maintaining treatment fidelity in 
research on automated interventions, for example due to the potentially reinforcing effects of contact 
with the researcher.   
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A final limitation relates to issues associated with user engagement in the program.  However, 
the literature indicates that participant attrition is common in web-based interventions, including for 
diabetes self-management.  For example, a trial of the Diabetes Network (D-Net) intervention in 270 
diabetes patients indicated that user engagement decreased over a 4-month implementation period, 
from 70% of participants visiting at least weekly during the first 6 weeks to 47% during weeks 7 to 16 
(Glasgow et al., 2011).  This was the case despite the website having included features to enhance user 
engagement that included “Ask an Expert” to enhance dietary, physical activity, and medication 
adherence.  Additionally, Heinrich and colleagues (2012) trialled the web-based Diabetes Interactive 
Education Program (DIEP) in 99 people with type 2 diabetes, and found that only a minority of 
participants used the included self-management tools and functionalities as the researchers had 
intended (Heinrich et al., 2012).  They concluded that health care professionals must play an active 
role in program implementation to achieve improved user engagement and outcomes. 
7.9 Future Directions for This Research 
 This research project was instrumental in planting the seeds for future outcome-related 
developments.  A main randomised controlled trial of the OnTrack Diabetes program is planned for 
implementation in the near future which will extend upon findings from this PhD project.  A larger 
sample size will provide more statistical power to enable the detection of statistically significant 
differences in study outcomes.  In addition, the resulting increased statistical power will allow 
analyses of program effects according to various participant sub- groups to be performed, such as 
higher and lower HbA1c level, and mood cohorts.   
The pilot trial clearly indicated the need to increase user engagement in the program.  
Suggestions to do so include supplementing the automated intervention with reminders or 
reinforcements to log in to the program, such as automated e-mails, Short Message Service texts, and/ 
or therapist coaching.  Web-based support programs for affective disorders have demonstrated 
efficacy when combined with enhanced health provider care over and above the effects of enhanced 
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provider care (Hickie et al., 2010).  Therefore, automated interventions may add benefits to the effects 
of consulting with a primary care provider alone, but there is potentially greater strength in integrating 
the health care system into their delivery.   
 Other trials of web-based diabetes self-management interventions have demonstrated that no 
additional benefit is derived from implementing moderate versus minimal support in interventions 
(Glasgow et al., 2010).  However, studies have not compared the effects of a fully automated web-
based program with those obtained by a minimal and/ or moderate support web-based program.  
Evidence on pharmacological and psychotherapeutic treatments for diabetes self-management and 
mood demonstrate that combining treatment approaches obtains the best outcomes.  This may also be 
the case in terms of web-based intervention. 
 Health professional integration into technological intervention delivery is a rapidly emerging 
field, and hence further suggestions for project advancement include integrating OnTrack Diabetes 
with e-mails from health professionals, or creating an interface via which electronic medical health 
records could be shared with patients, and health professionals could access patients’ self-monitoring 
progress graphs, blood glucose levels, mood ratings, dietary and physical activity records within the 
program.   
 An additional suggestion is the incorporation of enhanced social support features, such as a 
blog, forum, or chat rooms, so that users can contact other program users and/ or health professionals 
from within the program.  This form of social support was suggested by patients in qualitative 
interviews for web-based program content.  However, limitations to implementing this form of 
support include the need for monitoring contacts between users, and increased financial costs, and it 
was not practical to do so with the time and personnel constraints of the current project.   
 Aside from enhancing user engagement and current aspects of OnTrack Diabetes is the 
possibility of advancing the program’s technological scope.  For example, pilot trial participants 
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suggested translating the program to tablet form so that it could be accessed via an ipad or iphone for 
increased portability.  Another suggestion was made to convert various program features such as the 
self-monitoring tools, into a smart phone application.  Australia has substantial access to mobile 
phone coverage, and the use of apps for monitoring and diary-keeping, as well as for health adherence 
have become the norm.  However, many health-related monitoring apps are available and are often not 
used regularly.  Adding OnTrack Diabetes program features could be successful in increasing user 
engagement in an app.  Smart phone apps have already demonstrated implementation feasibility in 
people with type 2 diabetes for self-monitoring and feedback purposes (Nes et al., 2012). 
Adding a smart phone application to a web-based program may assist with strengthening the 
program.  For example, reminders could be sent to the mobile phone to encourage users to log in or 
perform self-monitoring.  In relation to SCT, the temporal proximity of cognitive guidance may be 
increased using an app, and this would eliminate users’ need to print out self-monitoring cards from 
the program to undertake self-monitoring and guided imagery exercises.  Finally, smart phones can be 
used to provide an Ecological Momentary Assessment function that enables situational constituents to 
be recorded with present behaviours so that users can gain even greater self-awareness of their need to 
correct their behaviour or progress. 
 A final suggestion for future developments of OnTrack Diabetes is the development and 
evaluation of OnTrack Juvenile Diabetes for children and adolescents with type 1 diabetes.  Type 1 
diabetes prevalence is rapidly increasing in juveniles and self-management and dysphoria are also 
major issues in this cohort (WHO, 2011b).  Targeting issues in the younger population can strengthen 
self-management efficacy and emotional coping skills before problems arise.  Potential for working on 
child-parent collaborations by including a shared interface with the parent is a possibility.  
 Overall, suggestions for future directions related to this research are overflowing, with many 
exciting potentials to build upon the experiences and findings of this PhD project. 
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7.10 Concluding Remarks 
Overall, this research project has resulted in the fulfilment of its overarching objective to 
develop and trial a unique, web-based type 2 diabetes self-management and dysphoria intervention.  
Results from Paper 1 informed the potential for behavioural diabetes self-management intervention 
using telehealth methods.  Paper 2 informed the basis for web-based program development.  Patients’ 
struggles with managing type 2 diabetes and strategies for effective self-care and coping were 
uncovered.  Paper 3 has provided scope regarding the processes used to develop and implement 
OnTrack Diabetes.  This paper may be used to establish protocols, and/ or as a basis for research 
design improvement.  Paper 4 outlined processes involved in creating a web-based support program.  
Finally, Paper 5 presented preliminary results of the pilot trial of OnTrack Diabetes.  Results indicate 
that users are satisfied with the program and gave it moderate to high evaluation ratings. However, 
user engagement and restricted sample size presented limitations.  Scope has been provided to 
enhance the efficacy of OnTrack Diabetes in the upcoming main randomised controlled trial.  Overall, 
this research project has been successful in crossing previously unchartered territories regarding type 
2 diabetes self-management and dysphoria intervention and, in doing so, has paved the way for future 
developments.   
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PARTICIPANT INFORMATION for QUT RESEARCH PROJECT 
 
Exploration of the Impact of Type 2 Diabetes on Self-Care Towards Development of An 
Innovative Online Support Program 
 
Research Team Contacts 
Ms Mandy Cassimatis – Student Professor David Kavanagh – Supervisor 
Phone:  0488 666 760 Phone:  3138 6143 
E-mail:  m1.cassimatis@qut.edu.au E-mail:  david.kavanagh@qut.edu.au  
 
Description 
This project is being undertaken as part of a postgraduate research project for Mandy Cassimatis.  The project 
is funded by Queensland University of Technology. The source of all information obtained during the project 
will remain confidential. 
The purpose of this project is to explore the experiences of people who are living with Type 2 diabetes in 
terms of their participation in physical activity, nutrition and medication-taking and experience with 
emotional challenges. 
The research team requests your assistance as a representative of those in the population group of interest. 
Participation 
Your participation in this project is voluntary. If you do agree to participate, you can withdraw from participation at any time 
during the project without comment or penalty. Your decision to participate will in no way impact upon your current or future 
relationship with QUT or with any other external body. Furthermore, the details of your participation including the results 
obtained or your withdrawal from the project at any stage remain confidential. 
Please note that you may withdraw from participating at any time before, during, or directly after the interview. However, due 
to the anonymous coding of information for confidentiality purposes thereafter, you may not withdraw information which was 
procured during the study at a later stage. 
Your participation will involve an initial session which includes a 30 – 40-minute interview with the researcher 
in which you will be asked questions relating to your experience of living with Type 2 diabetes and your 
participation in relevant self-care behaviors, including physical activity, nutrition, and medication-taking as 
well as the impact of any emotional challenges.  
Interviews will take place in a quiet room at either the Wesley Research Institute, located at the Wesley Hospital, 
Brisbane, or in the IHBI building at QUT Kelvin Grove. You will further have the opportunity to provide your opinions on 
the inclusion of particular components for an internet program which will be designed based on information obtained 
from interviews conducted in this preliminary research. You will be reimbursed for any parking and/ or travel costs 
associated with your participation in the project. 
293 
 
 
Expected benefits 
This project is expected to provide you with the opportunity to share your experiences of living with type 2 diabetes so that this 
can be used to develop a unique and effective form of support for people in their day-to-day diabetes management.  
Risks 
There is a chance that participants may experience some discomfort discussing issues relating to their diabetes management. 
Please see the questions that are provided with this form to see if you are likely to experience this and if so, you may wish not 
to take part or to inform the researcher at any stage of the interview that you would not like to continue participating. 
All participants will be provided with links to resources for emotional support which can be accessed by telephone or online. In 
the event that you experience psychological distress as a result of your participation in the study, QUT offers independent 
counselling services.  
QUT provides limited free counseling for research participants of QUT projects, who may experience some distress as a 
result of their participation in the research.  Should you wish to access this service please contact the Clinic Receptionist 
of the QUT Psychology Clinic on 3138 0999.  Please indicate to the receptionist that you are a research participant. 
 
Confidentiality 
Whilst your name is required for the purpose of the interview appointment, data obtained will be coded using an anonymous 
identification number following your participation. All information provided will remain strictly confidential. Following the 
study, all data will be filed in a highly secure archive at QUT facilities.  
Consent to Participate 
We would like to ask you to sign a written consent form (provided by the researcher) to confirm your agreement to participate. 
Alternatively, you may indicate your wish to participate via telephone or e-mail, in which case a verbal or alternative written 
consent mechanism will be used. 
Questions / further information about the project 
Please contact the research team members named above to have any questions answered or if you require further 
information about the project. 
Concerns / complaints regarding the conduct of the project 
QUT is committed to researcher integrity and the ethical conduct of research projects.  However, if you do have any concerns 
or complaints about the ethical conduct of the project you may contact the QUT Research Ethics Unit on 3138 5123 or 
ethicscontact@qut.edu.au. The Research Ethics Unit is not connected with the research project and can facilitate a 
resolution to your concern in an impartial manner. 
Thank you for helping with this research project.  Please keep this sheet for your information.   
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CONSENT FORM for QUT RESEARCH PROJECT 
 
Exploration of the Impact of Type 2 Diabetes on Self-Care Towards Development of An 
Innovative Online Support Program 
 
Research Team Contacts 
Ms Mandy Cassimatis – Student Professor David Kavanagh – Supervisor 
Phone:  0488 666 760 Phone:  3184 6143 
E-mail:  m1.cassimatis@qut.edu.au  E-mail:  david.kavanagh@qut.edu.au  
 
 
 
Statement of consent 
By signing below, you are indicating that you: 
• have read and understood the information document regarding this project 
• have had any questions answered to your satisfaction 
• understand that if you have any additional questions you can contact the research team 
• understand that you are free to withdraw at any time, without comment or penalty 
• understand that you can contact the Research Ethics Unit on 3138 5123 or email 
ethicscontact@qut.edu.au if you have concerns about the ethical conduct of the project 
• agree to participate in the project 
 
Name  
Signature  
Date   
 
 
Please return this sheet to the investigator. 
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PARTICIPANT INFORMATION for QUT RESEARCH PROJECT 
 
Exploration of the Impact of Type 2 Diabetes on Self-Care Towards Development of An 
Innovative Online Support Program 
 
Research Team Contacts 
Ms Mandy Cassimatis – Student Professor David Kavanagh – Supervisor 
Phone:  0488 666 760 Phone:  3138 6143 
E-mail:  m1.cassimatis@qut.edu.au E-mail:  david.kavanagh@qut.edu.au  
 
Description 
This project is being undertaken as part of a postgraduate research project for Mandy Cassimatis.  The project 
is funded by Queensland University of Technology. The source of all information obtained during the project 
will remain confidential. 
The purpose of this study is to explore the views of General Practitioners who treat patients with Type 2 
diabetes, particularly in terms of the helpful factors and challenges involved in meeting self-management 
targets and the impact of emotional challenges. 
The research team requests your assistance as a representative of those in the population group of interest. 
Participation 
Your participation in this project is voluntary. If you do agree to participate, you can withdraw from participation at any time 
during the project without comment or penalty. Your decision to participate will in no way impact upon your current or future 
relationship with QUT or with any other external body. Furthermore, the details of your participation including the results 
obtained or your withdrawal from the project at any stage remain confidential. 
Please note that you may withdraw from participating at any time before, during or directly after the interview. However, due 
to the anonymous coding of information for confidentiality purposes, you may not withdraw information which was procured 
during the study at a later stage. 
Your participation will involve an initial session which includes a 10 – 15 minute interview with the researcher 
in which you will be asked questions relating to patients living with Type 2 diabetes and common enablers of 
and barriers to meeting recommended self-management targets. In particular, the areas of physical activity, 
nutrition, and medication-taking and the impact of emotional challenges will be addressed. Further, you will 
be asked to provide your professional opinion on component areas for inclusion in an online support program.  
Interviews will take place at a time of greatest convenience to you. An appointment will be arranged whereby the 
interviewer will attend the General Practice in which you work. Alternatively, arrangements can be made to conduct the 
interview in a private interview room at the Wesley Research Institute, Auchenflower, or in the IHBI building at QUT 
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Kelvin Grove. You will be reimbursed for any parking and/ or travel costs associated with your participation in the project. 
Expected benefits 
This project is expected to provide you with the opportunity to indicate your experiences of the issues faced by patients living 
with Type 2 diabetes so that this can be used to develop a unique and effective form of support for people in their day-to-day 
Type 2 diabetes self-management. 
Risks 
You are highly unlikely to experience discomfort as a result of your participation in the interview. However, if you wish not to 
take part at any stage, please inform the researcher and the interview will be ceased. 
QUT provides limited free counseling for research participants of QUT projects, who may experience some distress as a 
result of their participation in the research.  Should you wish to access this service please contact the Clinic Receptionist 
of the QUT Psychology Clinic on 3138 0999.  Please indicate to the receptionist that you are a research participant. 
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Confidentiality 
Whilst your name is required for the purpose of the interview appointment, data obtained will be coded using an anonymous 
identification number following your participation. All information provided will remain strictly confidential. Following the 
study, all data will be filed in a highly secure archive at QUT facilities. 
Consent to Participate 
We would like to ask you to sign a written consent form (provided by the researcher) to confirm your agreement to participate. 
Alternatively, you may indicate your wish to participate via telephone or e-mail, in which case a verbal or alternative written 
consent mechanism will be used. 
Questions / further information about the project 
Please contact the research team members named above to have any questions answered or if you require further 
information about the project. 
Concerns / complaints regarding the conduct of the project 
QUT is committed to researcher integrity and the ethical conduct of research projects.  However, if you do have any concerns 
or complaints about the ethical conduct of the project you may contact the QUT Research Ethics Unit on 3138 5123 or 
ethicscontact@qut.edu.au. The Research Ethics Unit is not connected with the research project and can facilitate a 
resolution to your concern in an impartial manner. 
Thank you for helping with this research project.  Please keep this sheet for your information. 
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Study 1a. Qualitative Interview for Participants 
1. What things are helpful in supporting you to manage your diabetes? 
 
(Unless clarified already)... What makes this helpful? 
 
2. Many people find that there are ups-and-downs in controlling their diabetes. 
 
What things make it particularly challenging for you to follow your treatment plan, or keep 
your diabetes well-controlled? 
 
(Unless clarified already) In what way is that challenging? 
 
3. Are there any particular times when it is easiest to be physically active and eat healthy foods? 
 
a. What kinds of things make it difficult to do these things? 
 
4. In your experience, what has been most emotionally challenging about having diabetes? 
 
5. We are currently developing an online program to support diabetes self-management, to 
complement usual health care. 
 
What things do you think we should include in an online program to support people like 
yourself to manage diabetes? 
 
6. Under what circumstances would you use an online program on diabetes? 
 
a. Are there any (other) program features that would give you greater confidence in using 
it? 
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Demographics Survey 
This survey provides us with some details about the sample of people who are taking part in 
the interviews. Please do not write your name on this form as all information provided here 
and in the interview will be coded so that it is anonymous. 
1. Age: _______ years 
 
2. Occupation: ___________________ 
 
3. Relationship status:  Single    Married    In a relationship 
 
4. Time period since Type 2 diabetes diagnosis: _________________ 
 
5. Current treatment regimen:   
 Diet & exercise only (no medication) 
 + Tablets for diabetes (e.g. Metformin, Diabex, Januvia...) 
 + Insulin 
6. Which health professional/s do you consult for your diabetes management? 
 
 General Practitioner 
 Endocrinologist 
 Allied health professional/s (e.g. Dietitian, diabetes educator...)  
 Please list _____________________________________________________ 
 ______________________________________________________________ 
7. Do you receive any additional form/s of regular support for your diabetes 
management? (e.g. diabetes support group, counselling...)  
If so, please list. 
_______________________________________________________________________
_______________________________________________________________________
__________________________________________________ 
8. On average, my diabetes control in the past 6 months has been: 
 
 Excellent    Good    Fairly stable    Fairly unstable    Mostly unstable 
 
300 
 
Kessler-10 Scale 
1. In the past 30 days, about how often did you feel tired out for no good reason? 
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
2. In the past 30 days, about how often did you feel nervous?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
3. Do not answer this question if you answered “none of the time” to question 2.  
In the past 30 days, about how often did you feel so nervous that nothing could calm 
you down?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
4. In the past 30 days, about how often did you feel hopeless?  
None of the time  
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A little of the time  
Some of the time  
Most of the time  
All of the time  
5. In the past 30 days, about how often did you feel restless or fidgety?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
6. Do not answer this question if you answered “none of the time” to question 5.  In 
the past 30 days, about how often did you feel so restless you could not sit still?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
7. In the past 30 days, about how often did you feel depressed?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
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8. In the past 30 days, about how often did you feel that everything was an effort?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
 
9. In the past 30 days, about how often did you feel so sad that nothing could cheer 
you up?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time  
10. In the past 30 days, about how often did you feel worthless?  
None of the time  
A little of the time  
Some of the time  
Most of the time  
All of the time 
 
Thank you  
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Pre-Interview Script 
Thank you for coming in today to take part in an interview. First, I’ll provide you with an 
Informed Consent form. This contains details about the study and the rules and regulations 
related to conducting research at QUT. Anything discussed in the interview today is strictly 
confidential and you will remain anonymous. 
If you don’t wish to proceed with taking part at any stage at all, it is perfectly ok. Even if it’s 
just before or during the interview, just let me know, ok?  
[Provide PIS and allow to sign] 
There is a quick, one-page survey to complete. This is so that we have some details about 
who is taking part in the research. This information will also be confidential. It’s just so that 
we can describe our sample of participants in writing up the study. 
[Provide Demographics Survey, & allow to complete] 
While we call it an interview, this is really a discussion about your own experience with 
managing Type 2 diabetes. I will ask you some questions to guide the discussion, but please 
feel free to give answers that are as detailed as you like. If I ask you anything which you 
would prefer not to discuss, then please let me know and we can either move onto the next 
question or stop the interview. If you’d like a short break at any stage, please let me know.  
[RECORDER] 
I am recording the interviews so that information can be transcribed from them. So, if you 
don’t mind, I’ll just press record now. I actually become a little audio-shy, so it’s probably 
best to forget that the recorder is in the room.  
[Press RECORD]   
Begin interview 
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CONSENT FORM for QUT RESEARCH PROJECT 
 
Exploration of the Impact of Type 2 Diabetes on Self-Care Towards Development of An 
Innovative Online Support Program 
 
Research Team Contacts 
Ms Mandy Cassimatis – Student Professor David Kavanagh – Supervisor 
Phone:  0488 666 760 Phone:  3184 6143 
E-mail:  m1.cassimatis@qut.edu.au  E-mail:  david.kavanagh@qut.edu.au  
 
 
 
Statement of consent 
By signing below, you are indicating that you: 
• have read and understood the information document regarding this project 
• have had any questions answered to your satisfaction 
• understand that if you have any additional questions you can contact the research team 
• understand that you are free to withdraw at any time, without comment or penalty 
• understand that you can contact the Research Ethics Unit on 3138 5123 or email 
ethicscontact@qut.edu.au if you have concerns about the ethical conduct of the project 
• agree to participate in the project 
 
Name  
Signature  
Date   
 
 
Please return this sheet to the investigator. 
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 Study 1b. Qualitative Interview for General Practioners  
1. What things do your patients find helpful in supporting them to manage to their diabetes?  
 
2. What things make it particularly challenging for your patients to follow their treatment plan, or keep 
their diabetes well-controlled?  
 
3. In your experience, what do patients most commonly find emotionally challenging about having 
diabetes?  
 
4. Are there any particular times when you think patients tend to find it easiest to be physically active 
and eat healthy foods?  
 
a. What major barriers do you associate with making these things difficult?  
 
5. We are currently developing an online program to support diabetes self-management to complement 
usual health care.  
 
What things do you think we should include in an online program to support people to manage diabetes?  
6. Under what circumstances would you refer patients to an online program on diabetes?  
 
a. Are there any (other) program features that would give you greater confidence in referring patients to 
the program?  
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PARTICIPANT INFORMATION FOR QUT RESEARCH PROJECT 
Online Type 2 Diabetes Trial 
 
Evaluation of OnTrack Diabetes:  
An Online Type 2 Diabetes Self-Care and Emotional Support Program  
UnitingCare Queensland Approval Number Cassimatis9111 
QUT Ethics Approval Number 1100000 
 
RESEARCH TEAM 
Lead Investigator: Ms Mandy Cassimatis, Lead Investigator 
Principal Investigator: Prof David Kavanagh, Principal Investigator 
DESCRIPTION 
This project is undertaken as part of a PhD for Mandy Cassimatis.   
The purpose of this project is to test the effectiveness of the OnTrack Diabetes program. This is an online program 
aimed to support people with Type 2 diabetes to improve their self-care and day-to-day stress/emotional coping. 
The project team is interested in finding out if people with Type 2 diabetes find the program useful, and 
whether it can help them with their diabetes management and mood. You don’t need to have problems with 
your mood to take part. It’s about seeing if the program helps anyone with Type 2 diabetes enjoy life to the 
full and have improved diabetes outcomes. 
You are invited to participate in this project if you: have had Type 2 diabetes for at least 3 months, are aged 
18-75 years, live in Australia, have regular access to a computer with the internet, are contactable by 
telephone, and have at least grade 5-level written English. Please contact the Lead Investigator by phone or e-
mail (details below), who will go through some further criteria with you. Or, you can go online to see if you 
are eligible to participate using this link: (Provide link to online screening tool) 
PARTICIPATION 
Participation in this project is entirely voluntary. If you do agree to participate, you can withdraw from the project without 
comment or penalty. Your decision to participate or not participate will in no way affect your current or future relationship with 
the Queensland University of Technology or the Wesley Research Institute. 
Participation involves receiving access to the OnTrack Diabetes program. As we are testing which parts of the 
program improve specific areas of diabetes and emotional outcomes, participants may receive access to some 
content for the first 3 months. Then, all participants have access to the full program for the next 3 months. 
Participants are given a secure username and password with which they can access the program from any 
computer or smartphone with the internet. 
Participants are asked to complete study measures which include online surveys about Type 2 diabetes self-
care and mood, and some interview questions by telephone about nutrition and physical activity. This is done 
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at the start of participation and at 3, 6 and 12 months. Most measures are online and take approximately 1 
hour to complete. The interview may take 30-45 minutes.  
Participants’ most recent glycosylated haemoglobin (HbA1c) result (if it was taken less than 4 weeks ago), 
weight, height and waist measurements, are requested. With their consent, we can get the HbA1c level from 
their doctor if this is easier. If it has been longer than 4 weeks since an HbA1c test was done, we ask that 
another test is taken so that the result is recent. Following this, the participant is given a secure username and 
password and can access the OnTrack Diabetes program. At 12 months, the research team contact 
participants to see how they are going after using the program, and ask them to undertake final measures 
which are the same as the ones they have done.  
EXPECTED BENEFITS 
It is expected that this project will benefit you by providing information and support for your Type 2 diabetes management and 
mood. The research team expects that you will enjoy taking part in the OnTrack Diabetes program and that it may be of 
benefit to your mood and assist you with your diabetes management. However, your participation in this project is part 
of testing the program, so we cannot be certain of these benefits. 
 
 
 
RISKS 
There are minimal risks associated with your participation in this project. These include the possibility that disclosing sensitive 
information about your Type 2 diabetes control/ mood may be uncomfortable for you. However, as most measures are 
undertaken online anonymously, we expect that there would be minimal, if any, impact. Participation remains anonymous 
throughout and following the trial, so participants can be assured that their privacy is maintained. 
Should you wish to access additional support services for any discomfort or distress experienced during the trial, there will be 
information about relevant support services on the OnTrack Diabetes program site. You are also encouraged to contact the 
researcher to enquire about additional support services, if required.  
QUT provides for limited free counselling for research participants of QUT projects who may experience discomfort or distress 
as a result of their participation in the research.  Should you wish to access this service please contact the Clinic Receptionist of 
the QUT Psychology Clinic on (07) 3138 0999.  Please indicate to the receptionist that you are a research participant. 
PRIVACY AND CONFIDENTIALITY 
All comments and responses will be treated confidentially.  Your information will be coded anonymously in the study’s 
database so that there is no risk of your personal details being revealed to any person outside the research team. This database 
is only accessible by secure username and password by authorised research personnel. There is extremely minimal risk that 
privately disclosed information which you provide during the study could be accessed by unauthorised personnel. 
The project is funded by the Wesley Research Institute (WRI). The WRI will not have access to the data obtained 
during the project. 
Please note that non-identifiable data collected in this project may be used as comparative data in future projects. 
CONSENT TO PARTICIPATE 
We would like to ask you to confirm your agreement to participate by either signing a written consent form provided by the 
researcher; online following online eligibility screening; or via a verbal consent mechanism. Due to the nature of the project, 
any of these methods are sufficient to obtain your consent to participate. 
QUESTIONS / FURTHER INFORMATION ABOUT THE PROJECT 
If have any questions or require any further information about the project please contact one of the research team members 
below. 
Mandy Cassimatis – Lead Investigator Prof David Kavanagh –  Principal Investigator 
308 
 
 
Wesley Research Institute 
The Wesley Hospital, Brisbane 
School of Psychology & Counselling, Faculty of Health 
Institute of Biomedical Health and Innovation, QUT 
Phone (07) 3721 1703 Phone (07) 3138 6143 
Email m1.cassimatis@qut.edu.au  Email david.kavanagh@qut.edu.au  
 
CONCERNS / COMPLAINTS REGARDING THE CONDUCT OF THE PROJECT 
UnitingCare Queensland and QUT are committed to research integrity and the ethical conduct of research projects. 
This research has received ethics approval from the UnitingCare Health Human Research Ethics Committee. However, in the 
case of any concerns that you have about your participation in this research or its conduct, please contact the UCQ HREC 
Coordinator, Ms Pat Patterson, on (07) 3025-2000 or email uc.ucare@ucareqld.com.au.  Alternatively you may contact the 
QUT Research Ethics Unit on (07) 3138 5123 or email ethicscontact@qut.edu.au.  
Uniting Care Queensland and QUT Research Ethics Unit are not connected with the research project and can facilitate a 
resolution to your concern in an impartial manner. 
Thank you for helping with this research project.  Please keep this sheet for your information. 
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CONSENT FORM FOR QUT RESEARCH PROJECT 
Online Type 2 Diabetes Trial 
 
Evaluation of OnTrack Diabetes:  
An Online Type 2 Diabetes Self-Care and Emotional Support Program  
UnitingCare Queensland Approval Number Cassimatis9111 
QUT Ethics Approval Number 1100000 
 
RESEARCH TEAM CONTACTS 
Mandy Cassimatis – Lead Investigator Prof David Kavanagh –  Principal Investigator 
Wesley Research Institute 
The Wesley Hospital, Brisbane 
School of Psychology & Counselling, Faculty of Health 
Institute of Biomedical Health and Innovation, QUT 
Phone (07) 3721 1703 Phone (07) 3138 6143 
Email m1.cassimatis@qut.edu.au  Email david.kavanagh@qut.edu.au  
STATEMENT OF CONSENT 
By signing below, you are indicating that you: 
• have read and understood the information document regarding this project 
• have had any questions answered to your satisfaction 
• understand that if you have any additional questions you can contact the research team 
• understand that you are free to withdraw at any time, without comment or penalty 
• understand that you can contact either UCQ HREC Coordinator, Ms Pat Patterson, on (07) 3025-2000 or email 
uc.ucare@ucareqld.com.au or the Research Ethics Unit on (07) 3138 5123 or email ethicscontact@qut.edu.au 
if you have concerns about the ethical conduct of the project 
• understand that non-identifiable data collected in this project may be used as comparative data in future projects 
• agree to participate in the project 
 
Name  
Signature  
Date   
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MEDIA RELEASE PROMOTIONS 
From time to time, we may like to promote our research to the general public through, for example, newspaper articles.  
Would you be willing to be contacted by QUT Media and Communications for possible inclusion in such stories?  By ticking this 
box, it only means you are choosing to be contacted – you can still decide at the time not to be involved in any promotions. 
 Yes, you may contact me about inclusion in promotions 
 No, I do not wish to be contacted about inclusion in promotions 
 
 
 
Please return this sheet to the investigator. 
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Authorised Consent to Release Pathology Result 
 
[Ethics approval ref: Cassimatis9111] 
As part of my pending/ current participation in the OnTrack Diabetes Project, I, ____NAME____ 
hereby consent to my doctor providing the project’s researcher, Mandy Cassimatis, with my HbA1c 
pathology result.  
 
I understand that this result will only be used for the purpose of this research, and that it is important 
to help determine the effects of the program. As such, I consent to the release of this result to the 
researcher under the condition that this information will remain confidential to those outside the 
research team. I acknowledge that, while at first this result will be identifiable as my own, once 
entered into the system, it will be anonymously coded. 
 
Signature: __________________________________                            Date: 
_________________________  
 
Doctor’s name: ________________________ 
Contact details 
Phone: ______________________ 
Fax: _______________________ 
 
[Please note that in the majority of circumstances, the participant will be e-mailed this form and given the 
option to provide oral consent for their convenience.] 
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The OnTrack Diabetes Survey 
 
Today’s Date                 /            / 
Age        Date of Birth    /  /   
Sex         Male       Female 
What treatment are you currently receiving for Type 2 diabetes? 
Diet only   
Tablets 
Insulin   
Insulin and tablets   
Other   
HbA1c Result  (within past 4 weeks)   .  % 
Waist and Hip 
1.Waist (cm)                 .               2.Waist (cm)            .                3.Waist (cm)             . 
       Hip (cm)                 .                       Hip (cm)            .                        Hip (cm)             .  
Height (cm)              . 
Demographic Information 
1. What is your highest level of education completed? 
    Never attended school 
    Primary school 
    Some high school 
    Completed high school (Yr 12 or equivalent)  
    University, TAFE etc 
2. Are you of Aboriginal or Torres Strait Islander origin? 
    No 
    Aboriginal 
    Torres Strait Islander 
    Both 
 
3. In which country were you born? 
    Overseas 
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    Australia  
 
4. What is your marital status? 
    Married 
    De facto 
    Separated 
    Divorced 
    Widowed 
    Never married 
   
5. Which of the following best describes your household type? 
    Person living ALONE 
    Married or de facto couple ONLY 
    Married or de facto couple living with children 
    One person living with children 
    Shared household 
    All other households 
 
6. What language do you usually speak in this household? 
    English 
    Italian 
    Greek 
    Cantonese 
    Mandarin 
    Other (specify) _______________ 
The following questions are about your health 
7. Have you ever been told by a doctor or nurse that you have high blood pressure or 
hypertension? 
    Yes                             No            Don’t know 
 
8. Are you currently taking tablets for high blood pressure? 
    Yes                             No            Don’t know 
 
9. Have you ever been told by a doctor or other health professional that your blood cholesterol 
or triglycerides are high? 
    Yes                             No            Don’t know 
The following questions are about drinking alcohol 
10. In terms of drinking alcohol, which category would you generally put yourself in? 
    I have never drunk alcohol (Go to Question 16) 
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    I used to drink but gave it up 
    I’m a heavy drinker 
    I’m a moderate drinker 
    I’m a light drinker 
 
11. Have you ever felt that you should cut down on your drinking? 
    Yes          No 
 
12. Have people ever annoyed you by criticizing your drinking? 
    Yes          No 
 
13. Have you ever felt bad or guilty about drinking? 
    Yes          No 
 
14. Have you ever taken a drink first thing in the morning to steady your nerves or get rid of a 
hangover? 
    Yes          No 
 
15. Have you ever been treated for alcoholism or a drinking problem? 
    Yes          No 
The following questions are about smoking. 
16. Do you currently smoke cigarettes, cigars, pipes or any other tobacco product? 
    Daily 
    At least weekly (not daily) 
    Less often than weekly 
    Not at all  
 
17. Over your lifetime, would you have smoked at least 100 cigarettes or a similar amount of 
tobacco? 
    Yes (Go to Question 18)                        No (Go to Question 21) 
 
18. In the past, have you ever been a daily smoker? 
    Yes (Go to Question 19)                        No (Go to Question 20) 
 
19. Did you stop smoking in the last 5 years? 
    Yes (Go to Question 20)                        No (Go to Question 21) 
 
20. In what year did you stop smoking? 
    2005 
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    2006 
    2007 
    2008 
    2009 
    2010 
    2011 
The next questions are about income and employment 
21. Which number best describes your total household income before tax? 
    $1 500 or more per week  ($78 000 or more per year) 
    $800 - $1 499 per week  ($41 600 - $77 999 per year) 
    $600 - $799 per week  ($31 200 - $41 599 per year) 
    $400 - $599 per week  ($20 800 - $31 199 per year) 
    $200 - $399 per week  ($10 400 - $20 799 per year) 
    $80 - $199 per week  ($4 160 - $10 399 per year) 
    $1 - $79 per week  ($52 - $4 159 per year) 
    no income 
    I do not wish to answer this question 
 
22. Are you the main income earner in your household? 
    Yes 
    No 
    Joint income earners 
    Don’t know 
 
23. Do you have a full time job or part time job of any kind? 
    Yes 
    No (Go to Question 36) 
 
24. Which of the following categories best describes your areas of employment? 
     Managers and Administrators 
    (Magistrate, Farm Manager, General Manager, Director of Nursing, School  
      School Principal) 
     Professionals 
    (Scientist, Doctor, Registered Nurse, Allied Health Professional, Teacher, Artist,  
     Engineer, Accountant) 
     Associate Professionals 
     (Technician, Manager, Youth Worker, Police Officer, Program Administrator) 
     Tradespersons and Related Workers 
     (Hairdresser, Gardener, Florist, Mechanic, Machinist, Cook) 
     Clerical and Service Workers I 
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     (Secretary, Personal Assistant, Flight Attendant, Law Clerk) 
     Clerical, Sales and Service Workers II 
     (Typist, Word Processing/ Data Entry Operator, Receptionist, Child Care Worker,  
      Nursing Assistant, Hospitality Worker, Sales Clerk) 
     Clerical, Sales and Service Workers III 
     (Filing/Mail Clerk, Parking Inspector, Sales Assistant, Telemarketer, Housekeeper) 
     Intermediate Production and Transport Workers 
     (Sewing Machinist, Machine Operator, Bus Driver) 
     Labourers and Related Workers 
     (Cleaner, Factory Worker, General Farm Hand, Fast Food Cook) 
 
25. Which of the following describe your current employment status? You can pick more than 
one. 
     Working full-time 
     Working part-time 
     Not working (but not retired) 
     Home duties 
     Full-time student 
     Part-time student 
     Retired 
     Permanently unable to work/ ill    
     Other 
These questions are about your health. 
26. In the last 12 months, how well do you think your diabetes has been controlled? 
     Very well controlled 
     Well controlled 
     Average control 
     Poorly controlled 
     Very poorly controlled 
     Very variable control 
     Don’t know 
      
27. In the last week how well do you think your diabetes has been controlled? 
      Very well controlled 
     Well controlled 
     Average control 
     Poorly controlled 
     Very poorly controlled 
     Very variable control 
     Don’t know 
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28. Have you ever been shown how to test your blood sugar level? 
     Yes                             No            Don’t know 
 
29. Have you ever been shown how to test your urine for sugar? 
    Yes                             No            Don’t know 
 
30. What method do you mainly use for testing your own sugar level? 
     Monitor glucose at the doctor’s office only 
     Blood glucose test strips read by eye at home 
     Blood glucose test strips read by meter at home 
     Urine glucose test strips at home 
     None 
 
31. Have you ever tested for sugar in either your blood or urine? 
    Yes                             No      
 
32. How often have you tested your sugar levels in the last month (4 weeks)? 
     Never 
     Once a week or less 
     About 2 – 6 times a week 
     Once a day 
     2 or more times a day 
 
33. Do you write down your test results? 
(If you use a blood glucose meter, and check through the results but you do not write them 
down, answer how often you check through the meter memory). 
     Never 
     Occasionally 
     Often 
     Always 
 
34. Which test do you use most often to monitor your diabetes? 
Answer one response only. 
     Urine test for sugar (Go to Question 47) 
     Blood test for sugar (Go to Question 48) 
 
35. Over the past month your urine tests have been mostly: 
     0 
     Trace 
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     + 
     ++ 
     +++ 
     ++++ 
     Can’t recall 
 
36. Over the past month your blood tests have been mostly: 
     Less than 4 
     4 – 10 mmol/L 
     10 – 15 mmol/L 
     15 – 20 mmol/L 
     Over 20 mmol/L 
     Can’t recall 
37. In the last month, approximately how many times have you experienced the symptoms of 
hypoglycaemia (low blood sugar)? 
 
            times (write “0” if none) 
 
38. Before this research trial, had you ever heard of glycosylated haemoglobin A1c (HbA1c) or 
haemoglobin “A one C”? This is often referred to as the “long term sugar test”. 
     Yes                                           No (Go to Q51)                  Don’t know (Go to Q51) 
 
39. About how many times in the last year has a doctor, nurse or other health professional 
checked your haemoglobin “A one C”? 
     None 
     Once 
     Twice 
     Three or more times 
     Don’t know 
 
40. Have you ever been treated for or suffered from any of these conditions? 
                    Yes             No    Don’t know 
Trouble with the back of your eyes or retinopathy                           
Kidney disease                                                                         
Nerve damage             
Gangrene                                  
Heart disease (e.g. angina, heart attack)         
Stroke              
(Men) Impotence (difficulty getting or  
Sustaining an erection)           
Poor circulation to the feet or legs                                           
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41. How many times have you ever been admitted to hospital because of any of the above 
conditions? 
     None 
     Once 
     2 to 5 times 
     More than 5 times 
     I don’t know 
42. Have you ever been told by a doctor or nurse that you have any of the following conditions? 
If you answer ‘yes’ to any of these questions, write what age you were when you were first 
diagnosed with that condition in the box. 
                      Yes          No       Age of diagnosis 
Asthma  
COPD, chronic bronchitis or emphysema      
Kidney disease or renal disease 
Angina, heart disease, a heart attack, an 
Irregular heart rhythm, missed heart beats, 
or a blocked artery in the heart 
Stroke or TIA (“mini stroke”) 
Arthritis  
(including osteoarthritis, rheumatoid arthritis) 
Hypertension (High Blood Pressure) 
Osteoporosis 
Lung cancer 
Malignant Melanoma 
Prostate cancer 
Breast cancer 
Other types of cancer (malignancy) 
Alzheimer’s disease 
Dementia 
Schizophrenia or psychosis 
Depression 
Bipolar disorder/ manic depression 
Anxiety disorder or Nervous Disorder (e.g.  
panic disorder or post-traumatic stress disorder) 
Substance use disorder (abuse of or 
dependence on alcohol or other drugs)  
 
43. Have you ever had a foot ulcer (defined as – full thickness skin breaks below the malleoli for 
more than 1 week)? 
    Yes                             No            Don’t know 
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44. If yes, what was the cause (e.g. shoes)? 
________________________________________________________ 
 
45. How long ago did you have the ulcer? 
     In the last month 
     In the last year 
     In the last 3 years 
     More than 3 years ago 
 
46. Do you get any pain or discomfort in your legs or feet? 
    Yes                             No            Don’t know 
 
If no, go on to Question 66. 
 
47. How would you describe the pain or discomfort? (Mark all types of pain) 
     Burning/ numb/ tingling 
     Aching/ cramp-like/ tired 
     Other 
 
48. When is the pain the worst? 
     During the night 
     Day and night the same 
     During the day 
 
49. Does the pain ever wake you at night? 
    Yes                             No     
 
50. Do any of the following help or reduce the pain?   
    Walking 
     Standing 
     Sitting down or lying down 
     Other (including medication) 
 
51. Where do you get this pain or discomfort? (Click on the box which says the most painful site). 
     Feet 
     Knee to ankle 
     Anywhere else 
 
52. Do you ever get a pain or discomfort in your leg(s) when you walk? 
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     Yes 
     No (Go to Question 67) 
     I am unable to walk 
  
53. Does this pain ever begin when you are standing still or sitting? 
    Yes                             No            Don’t know 
 
54. Do you get this pain if you walk uphill or hurry? 
    Yes                             No            Don’t know 
 
55. What happens to this pain if you stand still? 
     Usually continues for more than 10 minutes 
     Usually disappears in 10 minutes or less 
 
56. Is a foot ulcer present? 
    Yes                             No    
 
57. If yes, where is the ulcer located? ______________________________________  
 
58. The normal range for blood glucose is: 
     4 – 8 mmol/L 
     7 – 15 mmol/L 
     2 – 10 mmol/L 
[SF-12 items] 
These questions are about how you feel and how well you are able to do your usual activities. If you 
are unsure about how to answer a question, please give the best answer you can and make a written 
comment beside your answer. 
1. In general, would you say your health is: 
    Excellent 
     Very good 
     Good 
     Fair 
     Poor 
The following two questions are about activities you might do during a typical day. Does YOUR 
HEALTH NOW LIMIT YOU in these activities? If so, how much? 
2. MODERATE ACTIVITIES, such as moving a table, pushing a vacuum cleaner, bowling or playing 
golf: 
     Yes, Limited A Lot 
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     Yes, Limited A Little 
     No, Not Limited At All 
 
3. Climbing SEVERAL flights of stairs: 
     Yes, Limited A Lot 
     Yes, Limited A Little 
     No, Not Limited At All 
During the PAST 4 WEEKS have you had any of the following problems with your work or other 
regular activities AS A RESULT OF YOUR PHYSICAL HEALTH? 
4. ACCOMPLISHED LESS than you would like: 
    Yes                             No    
 
5. Were limited in the KIND of work or other activities: 
    Yes                             No    
During the PAST 4 WEEKS, were you limited in the kind of work you do or other regular activities AS 
A RESULT OF ANY EMOTIONAL PROBLEMS such as feeling depressed or anxious? 
6. ACCOMPLISED LESS than you would like: 
    Yes                             No    
 
7. Didn’t do work or other activities as CAREFULLY as usual: 
    Yes                             No    
8. During the PAST 4 WEEKS, how much did PAIN interfere with your normal work including 
both work outside the home and housework? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
The next three questions are about how you feel and how things have been DURING THE PAST 4 
WEEKS. For each question, please give the one answer that comes closest to the way you have been 
feeling. How much of the time during the PAST 4 WEEKS – 
9. Have you felt calm and peaceful? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
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     A Little of the Time 
     None of the Time 
 
10. Did you have a lot of energy? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
 
11. Have you felt downhearted and blue? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
 
12. During the PAST 4 WEEKS, how much of the time has your PHYSICAL HEALTH OR EMOTIONAL 
PROBLEMS interfered with your social activities (like visiting with friends, relatives, etc)? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
[EQ-5D items] 
Under each heading, please check the box that best describes your health TODAY 
1. Mobility 
     I have no problems walking around 
     I have slight problems walking around 
     I have moderate problems walking around 
     I have severe problems walking around 
     I am unable to walk around 
 
2. Self-Care 
     I have no problems washing or dressing myself 
     I have slight problems washing or dressing myself 
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     I have moderate problems washing or dressing myself 
     I have severe problems washing or dressing myself 
     I am unable to wash or dress myself 
 
3. Usual Activities (e.g. work, study, housework, family or leisure activities) 
     I have no problems doing my usual activities 
     I have slight problems doing my usual activities 
     I have moderate problems doing my usual activities 
     I have severe problems doing my usual activities 
     I am unable to do my usual activities 
 
4. Pain/ Discomfort 
     I have no pain or discomfort 
     I have slight pain or discomfort 
     I have moderate pain or discomfort 
     I have severe pain or discomfort 
     I have extreme pain or discomfort 
 
5. Anxiety/ Depression 
     I am not anxious or depressed 
     I am slightly anxious or depressed 
     I am moderately anxious or depressed 
     I am severely anxious or depressed 
     I am extremely anxious or depressed 
[Diabetes Self-Care] 
These questions are designed to find out about how you have managed your diabetes over the last 7 
days. If you were sick during the last 7 days, please think back to the last 7 days you were not sick. 
1. On how many of the last 7 days did you eat 5 or more servings of fruit and vegetables? 
     0 
     1 
     2 
     3 
     4 
     5 
     6 
     7   
     2.   How many days during the past week did you eat high-fat foods, such as full-fat  
           dairy products, full-fat pastries or other desserts? 
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     0 
     1 
     2 
     3 
     4 
     5 
     6 
     7  
      3.  How many days during the past week did you participate in at least 30 minutes total    
           (one session, or several smaller sessions) of physical activity? 
     0 
     1 
     2 
     3 
     4 
     5 
     6 
     7  
     4.  On how many of the last 7 days did you test your blood sugar? 
     0 
     1 
     2 
     3 
     4 
     5 
     6 
     7  
     5. On how many of the last 7 days did you check your feet? 
     0 
     1 
     2 
     3 
     4 
     5 
     6 
     7  
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[Medication Adherence] 
1. Do you ever forget to take your diabetes medicine? 
    Yes                             No    
 
2. Are you careless at times about taking your diabetes medicine? 
    Yes                             No    
 
3. When you feel better, do you sometimes stop taking your diabetes medicine? 
    Yes                             No    
 
4. Sometimes, if you feel worse when you take the diabetes medicine, do you stop taking it? 
    Yes                             No    
 
[Diabetes Distress Scale-17] 
Living with diabetes can sometimes be tough. There may be many problems and hassles concerning 
diabetes and they can vary greatly in severity. Problems may range from minor hassles to major life 
difficulties. Listed below are 17 potential problems that people with diabetes may experience. 
Consider the degree to which each of the items may have distressed or bothered you DURING THE 
PAST MONTH and circle the appropriate number. 
 Please note that we are asking to indicate the degree to which each item may be bothering 
you in your life NOT whether the item is merely true for you. If you feel that a particular item is not a 
bother or a problem for you, you would click on the box “1”. If it is very bothersome to you, you 
might click on “6”. 
Problem                            Not a               Moderate      Serious
        
                                                 Problem             Problem     Problem
  
                  1            2            3            4            5            6 
1. Feeling that diabetes is taking up too much of                                                                                      
my mental and physical energy every day. 
 
2. Feeling angry, scared and/or depressed when I                                                                               
think about living with diabetes. 
3. Feeling that diabetes controls my life. 
 
4. Feeling that I will end up with serious long-term 
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complications, no matter what I do. 
 
5. Feeling overwhelmed by the demands of living  
with diabetes.    
    
6. Feeling that friends or family are not supportive  
enough of my self-care efforts (eg planning 
activities that conflict with my schedule,  
encouraging me to eat the “wrong” foods).   
   
7. Feeling that friends or family don’t appreciate 
how difficult living with diabetes can be.                
                                                                        
8. Feeling that friends or family don’t give me the 
emotional support that I would like.             
[Self-efficacy for overcoming depression/negative thoughts. Kavanagh et al., 1993] 
These scales are about your ability to make your time enjoyable and satisfying and control 
unpleasant thoughts. We want to know what you can do without any professional help, so please 
imagine you are not coming to us when you make your ratings. 
Moderately enjoyable time 
Look at the first scale below. Over the next 12 months, can you make a total of 30 minutes each day 
at least moderately enjoyable? 
1.      Rate the percentage of occasions that you followed your blood glucose testing as 
recommended (e.g. by your Doctor or Diabetes Educator) over the past 8 weeks. 
            0                   100 
   10 20 30 40 50 60 70 80 90  
 Not at all Moderately         Totally 
                                                                       
 
2. Rate how many days each week, on average, that you followed your recommended eating 
plan over the past 8 weeks. 
      0                   7 
      ½             1               2        3                4                5           6               
Number of days I followed my eating plan 
 
3. Rate the percentage of occasions that you followed your exercise program over the past 8 
weeks. 
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   0                   100 
   10 20 30 40 50 60 70 80 90  
 Not at all    Moderately            Totally 
The next questions are about how confident you are in doing certain activities. For each of the 
following questions, please slide the rating scale to the number which corresponds with your 
confidence that you can do the tasks as recommended, over the next 8 weeks. 
1. Rate the percentage of occasions that you feel confident that you can test your blood 
glucose level as recommended (e.g. by your Doctor or Diabetes Educator) over the next 8 
weeks. 
        
             0                   100 
   10 20 30 40 50 60 70 80 90  
 Can’t do it Moderately certain   Certain 
                                                                                   can do it                                                 can do it  
2. Rate how many days each week you feel confident that you can follow your recommended 
diet over the next 8 weeks. 
       0                   7 
      ½             1               2        3                4                5           6               
Number of days I can do it 
 
3. Rate the percentage of occasions you feel confident that you can follow your exercise 
program over the next 8 weeks.  
             0                   100 
   10 20 30 40 50 60 70 80 90  
 Can’t do it Moderately certain   Certain 
                                                                                   can do it                                                 can do it  
                                                               
[DASS-21] 
Please read each statement and click on the box for the number 0, 1, 2, or 3 which indicates how 
much the statement applied to you over the past week. There are no right or wrong answers. Do not 
spend too much time on any statement. 
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1. I found myself getting upset by quite trivial things 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
2. I was aware of dryness of my mouth 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
3. I couldn’t seem to experience any positive feeling at all 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
4. I experienced breathing difficulty (eg. excessively rapid breathing, breathlessness in the 
absence of physical exertion) 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
5. I just couldn’t seem to get going 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
6. I tended to over-react to situations 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
7. I had a feeling of shakiness (eg. legs going to give way) 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
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     3 Applied to me very much, or most of the time 
 
8. I found it difficult to relax 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
9. I found myself in situations that made me so anxious I was most relieved when they ended 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
10. I felt that I had nothing to look forward to 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
11. I found myself getting upset rather easily 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
12. I felt that I was using a lot of nervous energy 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
13. I felt sad and depressed 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
14. I found myself getting impatient when I was delayed in any way (eg. lifts, traffic lights, being 
kept waiting) 
     0 Did not apply to me at all 
331 
 
 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
15. I had a feeling of faintness 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
16. I felt that I had lost interest in just about everything 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
17. I felt I wasn’t worth much as a person 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
18. I felt that I was rather touchy 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
19. I perspired noticeably (eg. hands sweaty) in the absence of high temperatures or physical 
exertion 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
20. I felt scared without any good reason 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
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21. I felt that life wasn’t worthwhile 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
[Health Service Utilisation] 
 
The following questions relate to your use of a variety of health services over the past 6 
months. 
 
1. Have you visited a doctor (General Practitioner) in the last 6 months? 
     Yes                No   
 
If yes, please complete the table below for each doctor you have visited over the last 6 
months. If you do not know the exact date of your appointment, please provide an 
estimate of the number of appointments over the last 6 months.  
Doctor Practice Suburb Appointment 
date/s 
(or number of 
appointments) 
Cost for each 
visit* 
Dr. Brown Kelpie Medical 
Centre 
Ipswich 07/05/2011 $60 
     
     
     
     
*This is how much it cost you out of pocket. If you were bulk-billed, you would write ‘$0’ 
OR Please write how much you payed and the cost covered by your health insurance. 
 
2. Have you had an appointment with any other health professionals over the past 6 
months? 
 
This does not include health professionals you have seen while you have been admitted to 
hospital, but does include health professionals you have had an appointment with at the 
hospital as an outpatient. 
 
Examples of health professionals include specialists such as a cardiologist or an 
endocrinologist, a dietician, a physiotherapist, a counsellor/psychologist, a diabetes 
educator, etc. 
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      Yes                No  (Go to Question xx) 
  
If yes, please complete the table below for each health professional you have visited over the 
past 6 months (remembering that this does not include any health professionals you may 
have seen while you were admitted to hospital). If you do not know the exact date of your 
appointment, please provide an estimate or the number of appointments over the last 6 
months. 
Type of health professional Appointment date/s (or number 
of appointments) 
Cost for each visit* 
Examples: Endocrinologist 05/01/2011, 10/06/2011  
Dietician 5 appointments – 01/02/2011 to 
05/06/2011 
 
   
   
   
   
   
*This is how much it cost you out of pocket. If you were bulk-billed, you would write ‘$0’ 
OR Please write how much you payed and the cost covered by your health insurance. 
 
3. Have you been admitted to hospital during the last 6 months? 
     Yes                No   
If yes, please provide details in the table below. If you do not know the exact date of 
submission, please provide an estimate or the number of admissions over the last 6 
months. 
Hospital Date of admission/s 
(or number of admissions) 
Cost 
Example: Wesley Hospital 02/04/2011 and 08/06/2011  
   
   
334 
 
 
   
   
*This is how much it cost you out of pocket. If you were bulk-billed, you would write ‘$0’ 
OR Please write how much you payed and the cost covered by your health insurance. 
 
4. Other hospital utilisation 
Have you utilised any other hospital service over the past 6 months other than hospital 
based specialists (such as a cardiologist) or hospital admissions? 
     Yes                No  (Go to Section x) 
If yes, please provide details in the table below. If you do not know the exact date you 
accessed the service, please provide an estimate or the number of times you accessed the 
service over the last 6 months. 
Hospital service Name of hospital Date service accessed 
(or number of times 
accessed) 
Cost for this service 
Emergency clinic    
Day procedure at a 
hospital that did not 
involve admission, e.g. 
angioplasty 
   
Cardiac rehabilitation 
program 
   
Others?     
    
*This is how much it cost you out of pocket. If you were bulk-billed, you would write ‘$0’ 
OR Please write how much you payed and the cost covered by your health insurance. 
 
5. How much time did you take off work due to your health (e.g. feeling sick, having a 
medical procedure done, unable to work), over the past 6 months? 
                   weeks                       days                      hours 
 
6. Have you been on any medications over the past 6 months which were prescribed by 
your doctor? 
     Yes                No   
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If yes, please write the brand names of medications, strength (e.g. milligrams, grams, or 
millilitres), and how much you take of this medication each day in the table below.  
1. Brand name of 
medication 
2. Unit strength 
as shown on 
the pack (e.g. 
milligrams, 
grams, 
millilitres) 
3. Amount taken 
each day (e.g. 2 
tablets, 2 times 
a day) 
Example: Coversyl 5 mg 1 tablet, 2 times/day 
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The OnTrack Diabetes  
3-month Follow-up Survey 
2.0 
 
Today’s Date                 /            / 
Section 1. My Details 
Age        Date of Birth    /  /   
Sex         Male       Female 
What treatment are you currently receiving for Type 2 diabetes? 
Diet only   
Tablets 
Insulin   
Insulin and tablets   
Other   
HbA1c Result  (within past 4 weeks)   .  % 
Waist and Hip 
1. Waist (cm)                 .               2. Waist (cm)            .                3.Waist (cm)             
. 
Weight (kg)                . 
Section 2. My Health 
1. Have you ever been told by a doctor or nurse that you have any of the following 
conditions? If you answer ‘yes’ to any of these questions, write what age you were 
when you were first diagnosed with that condition in the box. 
                      Yes     Age of diagnosis        No        
Don’t know 
Asthma                                                                                                                              
COPD, chronic bronchitis or emphysema      
Kidney disease or renal disease                      
Angina, heart disease, a heart attack, an 
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irregular heart rhythm, missed heart beats, 
or a blocked artery in the heart 
Stroke or TIA (“mini stroke”) 
Arthritis  
(including osteoarthritis, rheumatoid arthritis) 
Hypertension (High Blood Pressure) 
Osteoporosis 
Malignant Melanoma 
Prostate cancer 
Breast cancer 
Other types of cancer (malignancy) 
Depression 
Anxiety disorder or Nervous Disorder (e.g.  
panic disorder or post-traumatic stress  
disorder) 
Substance use disorder (abuse of or 
dependence on alcohol or other drugs) 
Trouble with the back of your eyes or  
retinopathy                           
Nerve damage             
Gangrene                                  
Men: Impotence (difficulty getting or  
sustaining an erection)           
Poor circulation to the feet or legs  
                                          
2. How many times have you ever been admitted to hospital because of any of the 
above conditions? 
     None 
     Once 
     2 to 5 times 
     More than 5 times 
     I don’t know 
Alcohol 
3. In terms of drinking alcohol, which category would you generally put yourself in? 
    I have never drunk alcohol (Go to Question 6) 
    I used to drink but gave it up 
    I’m a heavy drinker 
    I’m a moderate drinker 
    I’m a light drinker 
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4. Have you ever felt that you should cut down on your drinking? 
    Yes          No 
 
5. Have you ever felt bad or guilty about drinking? 
    Yes          No 
 
6. Have you ever been treated for alcoholism or a drinking problem? 
    Yes          No 
Smoking 
7. Do you currently smoke cigarettes, cigars, pipes or any other tobacco product? 
    Daily 
    At least weekly (not daily) 
    Less often than weekly 
    Not at all  
 
8. Over your lifetime, would you have smoked at least 100 cigarettes or a similar 
amount of tobacco? 
    Yes (Go to Question 18)                        No (Go to Question 5) 
 
9. In the past, have you ever been a daily smoker? 
    Yes (Go to Question 19)                        No (Go to Question 20) 
 
10. Did you stop smoking in the last 5 years? 
    Yes (Go to Question 20)                        No (Go to ) 
 
11. In what year did you stop smoking? 
    2005 
    2006 
    2007 
    2008 
    2009 
    2010 
    2011 
    2012 
Type 2 Diabetes 
12. In the last 3 months, how well do you think your diabetes has been controlled? 
     Very well controlled 
     Well controlled 
     Average control 
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     Poorly controlled 
     Very poorly controlled 
     Very variable control 
     Don’t know 
      
13. In the last week how well do you think your diabetes has been controlled? 
      Very well controlled 
     Well controlled 
     Average control 
     Poorly controlled 
     Very poorly controlled 
     Very variable control 
     Don’t know 
 
14. What method do you mainly use for testing your own sugar level? 
     Monitor glucose at the doctor’s office only 
     Blood glucose test strips read by eye at home 
     Blood glucose test strips read by meter at home 
     Urine glucose test strips at home 
     None 
 
15. How often have you tested your sugar levels in the last month (4 weeks)? 
     Never 
     Once a week or less 
     About 2 – 6 times a week 
     Once a day 
     2 or more times a day 
 
16. Do you write down your test results? 
(If you use a blood glucose meter, and check through the results but you do not 
write them down, answer how often you check through the meter memory). 
     Never 
     Occasionally 
     Often 
     Always 
 
17. Over the past month your urine tests have been mostly: 
     0 
     Trace 
     + 
     ++ 
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     +++ 
     ++++ 
     Can’t recall 
 
18. Over the past month your blood glucose tests have been mostly: 
     Less than 4 
     4 – 10 mmol/L 
     10 – 15 mmol/L 
     15 – 20 mmol/L 
     Over 20 mmol/L 
     Can’t recall 
Mobility  
 [SF-12 items] 
These questions are about how you feel and how well you are able to do your usual 
activities. If you are unsure about how to answer a question, please check the box which 
describes the best answer you can give. 
2. In general, would you say your health is: 
    Excellent 
     Very good 
     Good 
     Fair 
     Poor 
The following two questions are about activities you might do during a typical day. Does 
YOUR HEALTH NOW LIMIT YOU in these activities? If so, how much? 
13. MODERATE ACTIVITIES, such as moving a table, pushing a vacuum cleaner, bowling 
or playing golf: 
     Yes, Limited A Lot 
     Yes, Limited A Little 
     No, Not Limited At All 
 
14. Climbing SEVERAL flights of stairs: 
     Yes, Limited A Lot 
     Yes, Limited A Little 
     No, Not Limited At All 
During the PAST 4 WEEKS have you had any of the following problems with your work or 
other regular activities AS A RESULT OF YOUR PHYSICAL HEALTH? 
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15. ACCOMPLISHED LESS than you would like: 
    Yes                             No    
 
16. Were limited in the KIND of work or other activities: 
    Yes                             No    
During the PAST 4 WEEKS, were you limited in the kind of work you do or other regular 
activities AS A RESULT OF ANY EMOTIONAL PROBLEMS such as feeling depressed or 
anxious? 
17. ACCOMPLISED LESS than you would like: 
    Yes                             No    
 
18. Didn’t do work or other activities as CAREFULLY as usual: 
    Yes                             No    
 
19. During the PAST 4 WEEKS, how much did PAIN interfere with your normal work 
including both work outside the home and housework? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
The next three questions are about how you feel and how things have been DURING THE 
PAST 4 WEEKS. For each question, please give the one answer that comes closest to the way 
you have been feeling. How much of the time during the PAST 4 WEEKS – 
20. Have you felt calm and peaceful? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
 
21. Did you have a lot of energy? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
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     None of the Time 
 
22. Have you felt downhearted and blue? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
 
23. During the PAST 4 WEEKS, how much of the time has your PHYSICAL HEALTH OR 
EMOTIONAL PROBLEMS interfered with your social activities (like visiting with 
friends, relatives, etc)? 
     All of the Time 
     Most of the Time 
     A Good Bit of the Time 
     Some of the Time 
     A Little of the Time 
     None of the Time 
Quality of Life 
[EQ-5D items] 
Under each heading, please check the box that best describes your health TODAY 
6. Mobility 
     I have no problems walking around 
     I have slight problems walking around 
     I have moderate problems walking around 
     I have severe problems walking around 
     I am unable to walk around 
 
7. Self-Care 
     I have no problems washing or dressing myself 
     I have slight problems washing or dressing myself 
     I have moderate problems washing or dressing myself 
     I have severe problems washing or dressing myself 
     I am unable to wash or dress myself 
 
8. Usual Activities (e.g. work, study, housework, family or leisure activities) 
     I have no problems doing my usual activities 
     I have slight problems doing my usual activities 
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     I have moderate problems doing my usual activities 
     I have severe problems doing my usual activities 
     I am unable to do my usual activities 
 
9. Pain/ Discomfort 
     I have no pain or discomfort 
     I have slight pain or discomfort 
     I have moderate pain or discomfort 
     I have severe pain or discomfort 
     I have extreme pain or discomfort 
 
10. Anxiety/ Depression 
     I am not anxious or depressed 
     I am slightly anxious or depressed 
     I am moderately anxious or depressed 
     I am severely anxious or depressed 
     I am extremely anxious or depressed 
Section 4. My Diabetes Self-Care 
[Diabetes Self-Care] 
These questions are about how you have managed your diabetes over the last 7 days. (If 
you were sick during the last 7 days, please think back to the last 7 days you were NOT sick). 
Blood Sugar Testing 
2. a) Approximately how many days per week has your doctor/diabetes care team 
recommended that you test your blood sugar levels? (Select “0” if this has not been 
recommended) 
0 1 2 3 4 5 6 7 
 b) On how many of the last 7 days did you actually test your blood sugar? 
0 1 2 3 4 5 6 7 
Diabetes Medication 
3. a) Has your doctor/diabetes care team recommended that you take diabetes 
medications every day? 
    Yes                             No    
 
b) On how many of the last 7 days did you take your diabetes medications exactly as 
recommended by your doctor/diabetes care team? 
0 1 2 3 4 5 6 7 
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[Medication Adherence] 
4. Do you ever forget to take your diabetes medicine? 
    Yes                             No    
 
5. Are you careless at times about taking your diabetes medicine? 
    Yes                             No    
 
6. When you feel better, do you sometimes stop taking your diabetes medicine? 
    Yes                             No    
 
7. Sometimes, if you feel worse when you take the diabetes medicine, do you stop 
taking it? 
    Yes                             No    
Foot Care 
8. a) Approximately how many days per week has your doctor/diabetes care team 
recommended you check your feet? (Select “0” if this has not been recommended) 
0 1 2 3 4 5 6 7 
 
b) On how many of the last 7 days did you actually check your feet? 
0 1 2 3 4 5 6 7 
 
9. Have you ever had a foot ulcer (defined as – full thickness skin breaks below the 
malleoli for more than 1 week)? 
    Yes                             No            Don’t know 
 
10. How long ago did you have the ulcer? 
     In the last month 
     In the last year 
     In the last 3 years 
     More than 3 years ago 
 
11. Do you get any pain or discomfort in your legs or feet? 
    Yes                             No            Don’t know 
 
If no, go on to Question  
 
12. How would you describe the pain or discomfort?  
     Burning/ numb/ tingling 
     Aching/ cramp-like/ tired 
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     Other 
 
13. Do you ever get a pain or discomfort in your leg(s) when you walk? 
     Yes 
     No  
     I am unable to walk 
  
14. Is a foot ulcer present? 
    Yes                             No    
 [Diabetes Self-Efficacy Scale. Kavanagh et al.] 
These questions are about how much you followed your recommended treatment plan over 
the past 8 weeks.  
Please slide each rating scale to the number that best describes how much you followed 
your treatment regimen in each of these areas over the past 8 weeks. 
4. Rate the percentage of occasions that you followed your blood glucose testing as 
recommended (e.g. by your Doctor or Diabetes Educator) over the past 8 weeks. 
            0                   100 
   10 20 30 40 50 60 70 80 90  
 Not at all Moderately         
Totally 
                                                                       
 
5. Rate how many days each week, on average, that you followed your recommended 
eating plan over the past 8 weeks. 
      0                   7 
      ½             1               2        3                4                5           6               
Number of days I followed my eating plan 
 
6. Rate the percentage of occasions that you followed your exercise program over the 
past 8 weeks. 
   0                   100 
   10 20 30 40 50 60 70 80 90  
 Not at all    Moderately            Totally 
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The next questions are about how confident you are in doing certain activities. For each of 
the following questions, please slide the rating scale to the number which corresponds with 
your confidence that you can do the tasks as recommended, over the next 8 weeks. 
4. Rate the percentage of occasions that you feel confident that you can test your 
blood glucose level as recommended (e.g. by your Doctor or Diabetes Educator) over 
the next 8 weeks. 
        
             0                   100 
   10 20 30 40 50 60 70 80 90  
 Can’t do it Moderately certain   Certain 
                                                                                   can do it                                                 can do it  
5. Rate how many days each week you feel confident that you can follow your 
recommended diet over the next 8 weeks. 
       0                   7 
      ½             1               2        3                4                5           6               
Number of days I can do it 
 
6. Rate the percentage of occasions you feel confident that you can follow your 
exercise program over the next 8 weeks.  
             0                   100 
   10 20 30 40 50 60 70 80 90  
 Can’t do it Moderately certain   Certain 
                                                                                   can do it                                                 can do it  
Section 5. My Feelings 
[Diabetes Distress Scale-17] 
Listed below are some problems that people with diabetes may experience. Consider the 
degree to which each of the items may have distressed or bothered you DURING THE PAST 
MONTH and click on the box under the appropriate number. 
Please note that we are asking to indicate the degree to which each item may be bothering 
you in your life NOT whether the item is merely true for you. If you feel that a particular 
item is NOT a bother or a problem for you, you would click on the box “1”. If it is very 
bothersome to you, you might click on “6”. 
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Problem                            Not a               Moderate      
Serious       
                                                 Problem             Problem     
Problem  
                  1            2            3            4            5            
6 
9. Feeling that diabetes is taking up too much of                                                                                      
my mental and physical energy every day. 
 
10. Feeling angry, scared and/or depressed when I                                                                               
think about living with diabetes. 
11. Feeling that diabetes controls my life. 
 
12. Feeling that I will end up with serious long-term 
complications, no matter what I do. 
 
13. Feeling overwhelmed by the demands of living  
with diabetes.    
    
14. Feeling that friends or family are not supportive  
enough of my self-care efforts (eg planning 
activities that conflict with my schedule,  
encouraging me to eat the “wrong” foods).   
   
15. Feeling that friends or family don’t appreciate 
how difficult living with diabetes can be.                
                                                                        
16. Feeling that friends or family don’t give me the 
emotional support that I would like.                                                                                
 [DASS-21] 
Please read each statement and click on the box for the answer which indicates how much 
the statement applied to you over the past week. There are no right or wrong answers. Do 
not spend too much time on any statement. 
22. I found myself getting upset by quite trivial things 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
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     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
23. I was aware of dryness of my mouth 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
24. I couldn’t seem to experience any positive feeling at all 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
25. I experienced breathing difficulty (eg. excessively rapid breathing, breathlessness in 
the absence of physical exertion) 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
26. I just couldn’t seem to get going 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
27. I tended to over-react to situations 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
28. I had a feeling of shakiness (eg. legs going to give way) 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
29. I found it difficult to relax 
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     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
30. I found myself in situations that made me so anxious I was most relieved when they 
ended 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
31. I felt that I had nothing to look forward to 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
32. I found myself getting upset rather easily 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
33. I felt that I was using a lot of nervous energy 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
34. I felt sad and depressed 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
35. I found myself getting impatient when I was delayed in any way (eg. lifts, traffic 
lights, being kept waiting) 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
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     3 Applied to me very much, or most of the time 
 
36. I had a feeling of faintness 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
37. I felt that I had lost interest in just about everything 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
38. I felt I wasn’t worth much as a person 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
39. I felt that I was rather touchy 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
40. I perspired noticeably (eg. hands sweaty) in the absence of high temperatures or 
physical exertion 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
41. I felt scared without any good reason 
     0 Did not apply to me at all 
     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
 
42. I felt that life wasn’t worthwhile 
     0 Did not apply to me at all 
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     1 Applied to me to some degree, or some of the time 
     2 Applied to me to a considerable degree, or a good part of time 
     3 Applied to me very much, or most of the time 
Section 6. My Health Service Use 
[Health Service Utilisation] 
The following questions relate to your use of a variety of health services over the past 3 
months. 
 
7. What health insurance cover do you have? 
     Hospital and extras cover 
     Hospital cover only 
     Extras cover only 
     None 
     Don’t know 
 
8. a)    How many times have you seen a General Practitioner (GP) in the last 3 
months? 
                       times 
 
b) How much do you pay to see your GP (after Medicare rebates)? $ 
c) Approximately how many times have you seen the following health 
professionals in the last 3 months? 
Health Professional Number of visits Cost for each visit (before 
health insurance claim) 
Diabetes Specialist, 
Endocrinologist, or 
Physician 
  
Podiatrist or Chiropodist   
Opthalmologist or 
Optometrist 
  
Other medical specialist 
(e.g. cardiac specialist, 
nephrologist) 
  
Diabetes Educator or 
Diabetes Nurse (including 
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home visits) 
Nutritionist or Dietician   
Psychologist or Counsellor   
Physiotherapist or Exercise 
Physiologist 
  
Dentist   
Other health professional 
(Please specify) 
  
 
d) How many times have you been admitted to hospital during the last 3 
months?    
Hospital Number of admissions Cost to you (before any 
health insurance claim) 
Example: Wesley Hospital 1    $320 
   
   
   
   
   
   
 
e) Other hospital utilisation 
How many times have you utilised any other hospital service over the past 3 
months other than hospital based specialists (such as a cardiologist) or hospital 
admissions? 
Hospital service Name of hospital Number of times 
accessed 
Cost to you 
(before any health 
insurance claim) 
Emergency clinic    
Day procedure at a 
hospital that did not 
involve admission, e.g. 
angioplasty 
   
Cardiac rehabilitation 
program 
   
Others?     
    
    
xviii 
 
 
    
    
    
    
    
    
 
f) How much time did you take off work due to your health (e.g. feeling sick, 
having a medical procedure done, unable to work), over the past 3 months? 
                  full days                  part days         
 
g) Please list all medications you have been on over the past 3 months which 
were prescribed by your doctor. 
Please write the names of medications, strength (e.g. milligrams, grams, or 
millilitres), and how much you take of this medication each day in the table 
below.  
 
4. Name of 
medication 
5. Unit strength as 
shown on the 
pack (e.g. 
milligrams, 
grams, millilitres) 
6. Amount taken each 
day (e.g. 2 tablets, 2 
times a day) 
Example: Coversyl 5 mg 1 tablet, 2 times/day 
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OnTrack Diabetes 3-month Evaluation Survey 
PARTICIPANT #:  ___ 
 
Extent of computer use (Experience with computers) 
1) Over the LAST 3 MONTHS, how many hours per week, on average, did you spend 
online? 
 
a) Less than 2.5 
b) 2.5 – 5 
c) 5 – 8 
d) 8 + 
 
2) I accessed OnTrack Diabetes most often from... 
 
a) Home 
b) Work 
c) Friend or family member’s computer 
d) Library 
e) Internet cafe, or public kiosk 
f) Other (please comment)  
 
3) On average, I accessed OnTrack Diabetes... 
 
a) Once 
b) A few times 
c) Once a fortnight 
d) Once a week 
e) 2 – 3 times a week 
f) Every day 
Appreciation/ Acceptability 
1) Please slide the bar to show how much you would you recommend the OnTrack 
Diabetes program to other people with Type 2 diabetes (Not at all to extremely)? 
 
2) I felt safe entering personal information into the program (Not at all to extremely) 
Usability 
Please slide the bar (least to most) to show how much you agree with the following items: 
ii 
 
 
I found that the OnTrack Diabetes program... 
1)  Was user friendly 
Comments? 
 
2) Let me tailor it to get what I wanted 
Comments 
 
3) Was easy to understand  
Comments 
 
4) Had information I could trust 
Comments 
 
5) Focused on things I wanted to work on 
Comments 
Engagement & Graphics 
6) Had attractive pages 
Comments 
 
7) Was engaging to use 
Comments 
 
8) Was boring 
Comments 
 
9) The text and graphics were easy to read 
Comments 
 
10) The program’s web pages opened quickly 
Comments 
 
11) There were problems getting enough online access to do the program 
Comments 
 
12) It was hard to find time to use the program 
Comments 
Ease of Use 
1) The program was easy to use 
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Comments 
2) I could easily work out what to write or select in the tools 
Comments 
 
3) I felt confident using the program’s suggestions 
Comments 
Perceived Utility/ Usefulness 
1) I found the information resources useful 
Comments 
 
2) I found the program useful 
Comments 
 
4) I could easily apply the program to myself 
Comments 
How well did the program address each of the following areas? 
13) Physical activity 
Comments 
 
14) Healthy eating 
Comments 
 
15) Following health routines e.g. blood glucose monitoring 
Comments 
 
16) Emotional challenges 
Comments 
 
17) Please comment on what you think the most useful component of the program was 
for you: 
 
Qualitative comments 
1) What did you like most about the OnTrack Diabetes program? 
 
Please give some feedback about why you liked this part of the program most: 
 
2) What did you like least about the OnTrack Diabetes program? 
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Please give some feedback about why you liked this part of the program least. 
 
3) Please comment on any suggestions you have that would help us improve the 
program for future users. 
 
Ease of Use 
1) Please rate, from 1 to 5, being least to most, how easy you found your way around in 
the program: 
Comments? 
 
 
2) From 1 to 5, how confident would you feel using the program’s suggestions? 
Comments? 
 
 
 
Perceived usefulness/ utility 
1) How well do you think the program addresses: 
 
a) Physical activity (from 1 – 5)? 
 
Comments? 
 
b) Healthy eating (1 – 5)? 
 
Comments? 
 
c) Following health routines, for example blood glucose monitoring (1 – 5)? 
 
Comments? 
 
d) Emotional challenges (1 – 5)? 
 
Comments? 
 
Qualitative Comments 
1) What did you like most about the OnTrack Diabetes program? 
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Please give some feedback about why you liked this part of the program the most: 
 
 
 
 
2) What did you like least about the OnTrack Diabetes program? 
 
Please give some feedback about why you liked this part of the program least: 
 
 
 
3) Please comment on any suggestions you have that would help us to improve the 
program for future users: 
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